[{"title01":"Correspondence to “A novel lncRNA SNHG29 regulates EP300-related histone acetylation modification and inhibits FLT3-ITD AML development”","title02":"Correspondence to “A novel lncRNA SNHG29 regulates EP300-related histone acetylation modification and inhibits FLT3-ITD AML development”","journal":"Leukemia","issue":"2025 May 20. doi: 10.1038\/s41375-025-02643-1. Online ahead of print.","author":"Wang X, Yao H, Chen J, Liu X.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40394212"},{"title01":"Durable remission achieved in pediatric patients with TCF3-HLF-positive relapsed \/ refractory B-cell acute lymphoblastic leukemia by dual CD19 and CD22-targeted chimeric antigen receptor T-cell therapy","title02":"Durable remission achieved in pediatric patients with TCF3-HLF<\/i>-positive relapsed \/ refractory B-cell acute lymphoblastic leukemia by dual CD19 and CD22-targeted chimeric antigen receptor T-cell therapy","journal":"Haematologica","issue":"2025 May 22. doi: 10.3324\/haematol.2024.287023. Online ahead of print.","author":"Wan X, Wang T, Yang J, Yang X, Li W, Ding L, Yang L, Zhang J, Su M, An K, Zhou Z, Li Y, Wang X, Zhu H, Luo C, Gu L, Chen J, Song L, Tang Y, Li B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40400462"},{"title01":"Dexamethasing acute myeloid leukemia: new opportunities for an “old” drug","title02":"Dexamethasing acute myeloid leukemia: new opportunities for an “old” drug","journal":"Haematologica","issue":"2025 May 29. doi: 10.3324\/haematol.2025.287404. Online ahead of print.","author":"Duque-Afonso J, List J, L\u00fcbbert M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40438984"},{"title01":"Comment on “Acute pro-B-cell lymphoblastic leukemia evolving from myelodysplastic neoplasm post cytotoxic therapy: a case report”","title02":"Comment on “Acute pro-B-cell lymphoblastic leukemia evolving from myelodysplastic neoplasm post cytotoxic therapy: a case report”","journal":"Haematologica","issue":"2025 May 15. doi: 10.3324\/haematol.2025.288110. Online ahead of print.","author":"Borkhardt A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40371896"},{"title01":"Uncommon phenotypes of BCR::ABL1-positive chronic myelogenous leukemia: a review","title02":"Uncommon phenotypes of BCR::ABL1<\/i>-positive chronic myelogenous leukemia: a review","journal":"Haematologica","issue":"2025 May 15. doi: 10.3324\/haematol.2025.287792. Online ahead of print.","author":"Jajosky AN, Lichtman MA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40371899"},{"title01":"Prognostic value of CEBPA bZIP signatures in cytogenetically normal acute myeloid leukaemia","title02":"Prognostic value of CEBPA<\/i> bZIP signatures in cytogenetically normal acute myeloid leukaemia","journal":"Br J Haematol","issue":"2025 May 26. doi: 10.1111\/bjh.20164. Online ahead of print.","author":"Wu LX, Liao MY, Zhao MY, Yan N, Zhang P, Liu LX, Qin JY, Cao SB, Feng J, Jiang Q, Chang YJ, Xu LP, Zhang XH, Huang XJ, Jiang H, Zhang HY, Ruan GR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40419412"},{"title01":"Induction of p53-mediated apoptosis by azacitidine in patient-derived xenograft follicular helper T-cell lymphoma model","title02":"Induction of p53-mediated apoptosis by azacitidine in patient-derived xenograft follicular helper T-cell lymphoma model","journal":"Leukemia","issue":"2025 May 20. doi: 10.1038\/s41375-025-02628-0. Online ahead of print.","author":"Tari Crochet G, Ari-Yuka S, Fischer A, Chour M, Claudel A, Sako N, Robe C, Naudet J, Gonon A, Mboumba DL, Ortonne N, Alcazer V, Delfau-Larue MH, Siebert R, Gaulard P, Lemonnier F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40394210"},{"title01":"Radiate equity: the inclusion of radiation oncology and other specialties in lymphoma collaborative groups","title02":"Radiate equity: the inclusion of radiation oncology and other specialties in lymphoma collaborative groups","journal":"Lancet Haematol","issue":"2025 May 16:S2352-3026(25)00080-8. doi: 10.1016\/S2352-3026(25)00080-8. Online ahead of print.","author":"Saifi O, Pinnix CC, Kelsey CR, Ballas LK, Milgrom SA, Advani R, Kasner MT, Flampouri S, Terezakis SA, Sellmyer M, Plastaras JP, Hoppe BS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40388957"},{"title01":"Optimizing Chimeric Antigen Receptor T-Cell Therapy for Mantle Cell Lymphoma","title02":"Optimizing Chimeric Antigen Receptor T-Cell Therapy for Mantle Cell Lymphoma","journal":"J Clin Oncol","issue":"2025 May 19:JCO2500568. doi: 10.1200\/JCO-25-00568. Online ahead of print.","author":"Arunachalam AK, Gilmour CK, Melenhorst JJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40388673"},{"title01":"Evaluation of MYD88 p.L265P detection by digital droplet polymerase chain reaction in cerebrospinal fluid for integrated diagnosis of primary large B-cell lymphoma of the central nervous system","title02":"Evaluation of MYD88<\/i> p.L265P detection by digital droplet polymerase chain reaction in cerebrospinal fluid for integrated diagnosis of primary large B-cell lymphoma of the central nervous system","journal":"Br J Haematol","issue":"2025 May 25. doi: 10.1111\/bjh.20167. Online ahead of print.","author":"Harlay V, Gallardo C, Beaufils N, Astier A, Testud B, Amri A, Fritz S, Abbou N, Robert P, Garcia J, Roll P, Ouafik L, Schenone L, Petrirena G, Bertucci A, Bequet C, Chinot O, Tabouret E, Nanni I, Appay R, Kaspi E, Frankel D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40415280"},{"title01":"Immunotherapy response: is it all in the DLBCL-IQs?","title02":"Immunotherapy response: is it all in the DLBCL-IQs?","journal":"Blood","issue":"2025 May 22;145(21):2402-2403.","author":"Okosun J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40402529"},{"title01":"Adult T-cell leukemia\/lymphoma coexistent with immune dysregulation-associated EBV+ lymphoproliferative disorder","title02":"Adult T-cell leukemia\/lymphoma coexistent with immune dysregulation-associated EBV+ lymphoproliferative disorder","journal":"Blood","issue":"2025 May 15;145(20):2396.","author":"Wang X, Yi H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40372737"},{"title01":"An Updated Understanding of Follicular Lymphoma Transformation","title02":"An Updated Understanding of Follicular Lymphoma Transformation","journal":"Blood","issue":"2025 May 15:blood.2024026016. doi: 10.1182\/blood.2024026016. Online ahead of print.","author":"Parry EM, Okosun J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40373273"},{"title01":"A phase 2 Trial of CHOP with Anti-CCR4 Antibody Mogamulizumab for older Patients with Adult T-Cell Leukemia\/Lymphoma","title02":"A phase 2 Trial of CHOP with Anti-CCR4 Antibody Mogamulizumab for older Patients with Adult T-Cell Leukemia\/Lymphoma","journal":"Blood","issue":"2025 May 15:blood.2024027902. doi: 10.1182\/blood.2024027902. Online ahead of print.","author":"Yoshimitsu M, Choi I, Kusumoto S, Shimokawa M, Utsunomiya A, Suehiro Y Dr, Hidaka T, Nosaka K, Sasaki H, Rai S, Tamura S, Owatari S, Koh KR, Nakamura D, Tokunaga M, Sekine M, Sakamoto Y, Inagaki H, Ishida T, Ishitsuka K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40373281"},{"title01":"Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma","title02":"Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma","journal":"Haematologica","issue":"2025 May 22. doi: 10.3324\/haematol.2025.287526. Online ahead of print.","author":"Cantafio MEG, Valentino I, Torcasio R, Ganino L, Veneziano C, Murfone P, Mesuraca M, Perrotta I, Tallarigo F, Agosti V, De Marco C, Pasqua T, Giallongo C, Cappello AR, Fiorillo M, Gentile M, Tibullo D, Viglietto G, Neri A, Amodio N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40400476"},{"title01":"Improving predictive accuracy in multiple myeloma using a plasma cell profile derived from single-cell RNA sequencing","title02":"Improving predictive accuracy in multiple myeloma using a plasma cell profile derived from single-cell RNA sequencing","journal":"Haematologica","issue":"2025 May 29. doi: 10.3324\/haematol.2025.287586. Online ahead of print.","author":"Liu L, Sun H, Feng F, Sun X, Ma J, Lv R, Yu T, Ye L, Li X, Yu Z, Zhang X, Jing H, Yao Y, Ma F, Qiu L, Hao M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40438979"},{"title01":"Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma","title02":"Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma","journal":"Haematologica","issue":"2025 May 15. doi: 10.3324\/haematol.2025.287559. Online ahead of print.","author":"Poletti A, Taurisano B, Mazzocchetti G, Lionetti M, Martello M, Vuong VM, Solli V, Marzocchi G, Maeda A, Vigliotta I, Borsi E, Armuzzi S, Pistis I, Marella A, Fabris S, Tacchetti P, Mancuso K, Rizzello I, Pantani L, Testoni N, Cavo M, Zamagni E, Bolli N, Terragna C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40371906"},{"title01":"Prognostic impact of the immune microenvironment in multiple myeloma: a meta-analysis of current studies","title02":"Prognostic impact of the immune microenvironment in multiple myeloma: a meta-analysis of current studies","journal":"Haematologica","issue":"2025 May 15. doi: 10.3324\/haematol.2024.286264. Online ahead of print.","author":"Susca N, Borrelli P, Botta C, Solimando AG.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40371907"},{"title01":"Monoclonal immunoglobulin measurement by mass spectrometry in patients with multiple myeloma and kidney failure: Analysis from the EuLITE trial","title02":"Monoclonal immunoglobulin measurement by mass spectrometry in patients with multiple myeloma and kidney failure: Analysis from the EuLITE trial","journal":"Br J Haematol","issue":"2025 May 25. doi: 10.1111\/bjh.20168. Online ahead of print.","author":"McIlroy G, Giles HV, Rollins A, Malin G, Jones L, Wright NJ, Berlanga O, North S, Cook M, Hutchison C, Heyne N, Weisel K, Pinney J, Harding S, Cockwell P, Pratt G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40415308"},{"title01":"The progression of multiple myeloma is regulated by LILRB1 via the GATA2-SAGE1 pathway","title02":"The progression of multiple myeloma is regulated by LILRB1 via the GATA2-SAGE1 pathway","journal":"Br J Haematol","issue":"2025 May 25. doi: 10.1111\/bjh.20144. Online ahead of print.","author":"Chen C, Zhou X, Cao L, Yang W, Weng L, Yuan J, Zhou W, Yu Z, Zheng J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40415416"},{"title01":"Classic hairy cell leukemia and concomitant smoldering myeloma","title02":"Classic hairy cell leukemia and concomitant smoldering myeloma","journal":"Blood","issue":"2025 May 22;145(21):2533.","author":"Jum'ah H, Viswanatha D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40402524"},{"title01":"Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment","title02":"Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment","journal":"Blood","issue":"2025 May 22:blood.2025029234. doi: 10.1182\/blood.2025029234. Online ahead of print.","author":"Lasa M, Gonzalez C, Notarfranchi L, Zherniakova A, Alignani D, Burgos L, Calasanz MJ, Rodriguez-Otero P, Perez JJ, Gomez C, Gonzalez-Calle V, de Arriba F, Palomera Bernal L, Alvarez Rivas MA, Clavero Sanchez E, Ocio EM, Gonzalez-Rodriguez AP, Lakhwani S, Iba\u00f1ez A, Oriol A, Sureda A, Rosi\u00f1ol L, Siewert C, Orfao A, Lahuerta JJ, Blad\u00e9 J, Mateos MV, San-Miguel JF, Cedena MT, Martinez-Lopez J, Puig N, Paiva B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40403320"},{"title01":"Right time: stopping multiple myeloma maintenance","title02":"Right time: stopping multiple myeloma maintenance","journal":"Blood","issue":"2025 May 15;145(20):2241-2242.","author":"McCarthy P, Mohammadpour H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40372740"},{"title01":"It takes two to tango: allogeneic stem cell transplantation and FLT3 tyrosin kinase inhibitor therapy","title02":"It takes two to tango: allogeneic stem cell transplantation and FLT3 tyrosin kinase inhibitor therapy","journal":"Haematologica","issue":"2025 May 22. doi: 10.3324\/haematol.2025.287627. Online ahead of print.","author":"Cornelissen JJ, Versluis J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40400473"},{"title01":"Kaposi sarcoma and Kaposi inflammatory cytokine syndrome following allogeneic haematopoietic stem cell transplantation: A case report","title02":"Kaposi sarcoma and Kaposi inflammatory cytokine syndrome following allogeneic haematopoietic stem cell transplantation: A case report","journal":"Br J Haematol","issue":"2025 May 20. doi: 10.1111\/bjh.20158. Online ahead of print.","author":"Laspa E, Neofytos D, Boutboul D, Giannotti F, Masouridi-Levrat S, Simonetta F, Royer-Chardon C, de Leval L, Blum S, Chalandon Y, Mamez AC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40394966"},{"title01":"Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed\/refractory acute myeloid leukaemia: A multicentre cohort study","title02":"Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed\/refractory acute myeloid leukaemia: A multicentre cohort study","journal":"Br J Haematol","issue":"2025 May 21. doi: 10.1111\/bjh.20147. Online ahead of print.","author":"Ye Y, Liu X, Dai H, Hu J, Yu G, Zhang Y, Weng G, Lin D, Du X, Xiao J, Sun Z, Zhang H, Liang X, Guo Z, Xu N, Fan Z, Xuan L, Lin R, Yin Z, Huang F, Dai M, Li Z, Liu Q, Jin H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40399765"},{"title01":"It takes two to tango: allogeneic stem cell transplantation and FLT3 tyrosin kinase inhibitor therapy","title02":"It takes two to tango: allogeneic stem cell transplantation and FLT3 tyrosin kinase inhibitor therapy","journal":"Haematologica","issue":"2025 May 22. doi: 10.3324\/haematol.2025.287627. Online ahead of print.","author":"Cornelissen JJ, Versluis J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40400473"},{"title01":"Kaposi sarcoma and Kaposi inflammatory cytokine syndrome following allogeneic haematopoietic stem cell transplantation: A case report","title02":"Kaposi sarcoma and Kaposi inflammatory cytokine syndrome following allogeneic haematopoietic stem cell transplantation: A case report","journal":"Br J Haematol","issue":"2025 May 20. doi: 10.1111\/bjh.20158. Online ahead of print.","author":"Laspa E, Neofytos D, Boutboul D, Giannotti F, Masouridi-Levrat S, Simonetta F, Royer-Chardon C, de Leval L, Blum S, Chalandon Y, Mamez AC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40394966"},{"title01":"Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed\/refractory acute myeloid leukaemia: A multicentre cohort study","title02":"Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed\/refractory acute myeloid leukaemia: A multicentre cohort study","journal":"Br J Haematol","issue":"2025 May 21. doi: 10.1111\/bjh.20147. Online ahead of print.","author":"Ye Y, Liu X, Dai H, Hu J, Yu G, Zhang Y, Weng G, Lin D, Du X, Xiao J, Sun Z, Zhang H, Liang X, Guo Z, Xu N, Fan Z, Xuan L, Lin R, Yin Z, Huang F, Dai M, Li Z, Liu Q, Jin H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40399765"},{"title01":"Haploidentical HSCT: more curative options for patients with CGD","title02":"Haploidentical HSCT: more curative options for patients with CGD","journal":"Blood","issue":"2025 May 22;145(21):2408-2409.","author":"Morris EC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40402531"},{"title01":"PERK Maintains Hematopoietic Stem Cell Pool Integrity under Endoplasmic Reticulum Stress by Promoting Proliferation","title02":"PERK Maintains Hematopoietic Stem Cell Pool Integrity under Endoplasmic Reticulum Stress by Promoting Proliferation","journal":"Blood","issue":"2025 May 28:blood.2024027846. doi: 10.1182\/blood.2024027846. Online ahead of print.","author":"Zheng M, Peng Q, Kropp EM, Shen Z, Liu S, Yin Z, Matono S, Iwawaki T, Wang X, Inoki K, Mei Y, Li Q, Liu L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40435413"},{"title01":"Myopathy, lactic acidosis and sideroblastic anemia syndrome 1 (MLASA1) : clinical hallmarks in a large pedigree with a novel PUS1 R144Q mutation, remarkable response to somatropin, and review of the literature","title02":"Myopathy, lactic acidosis and sideroblastic anemia syndrome 1 (MLASA1) : clinical hallmarks in a large pedigree with a novel PUS1<\/i> R144Q mutation, remarkable response to somatropin, and review of the literature","journal":"Haematologica","issue":"2025 May 29. doi: 10.3324\/haematol.2025.287393. Online ahead of print.","author":"Parisi L, Escher R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40438980"},{"title01":"Physical activity, vaso-occlusive crises and pain in patients with sickle cell anaemia in Senegal","title02":"Physical activity, vaso-occlusive crises and pain in patients with sickle cell anaemia in Senegal","journal":"Br J Haematol","issue":"2025 May 19. doi: 10.1111\/bjh.20150. Online ahead of print.","author":"Diaw M, Coly MS, Charlot K, Gallou-Guyot M, Miyachi M, Yoshida T, Gadji M, Diop S, Faye BF, Mbengue A, Samb A, Skinner S, Nader E, Ranque B, Connes P, Tripette J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40390109"},{"title01":"Imaging Mass Cytometry Reveals the Order of Events in the Pathogenesis of Immune-Mediated Aplastic Anemia","title02":"Imaging Mass Cytometry Reveals the Order of Events in the Pathogenesis of Immune-Mediated Aplastic Anemia","journal":"Blood","issue":"2025 May 22:blood.2025028723. doi: 10.1182\/blood.2025028723. Online ahead of print.","author":"Pool ES, Luk SJ, IJsselsteijn ME, van Unen V, de Miranda NFCC, Falkenburg JHF, Koning F, Heemskerk MHM, Tjon JM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40403228"},{"title01":"Daratumumab in Relapsed or Refractory Pediatric Immune Thrombocytopenia","title02":"Daratumumab in Relapsed or Refractory Pediatric Immune Thrombocytopenia","journal":"N Engl J Med","issue":"2025 May 29;392(20):2069-2071.","author":"Sun T, Chen Y, Zhang L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40435473"},{"title01":"Avatrombopag for the treatment of children and adolescents with immune thrombocytopenia (AVA-PED-301): a multicentre, randomised, double-blind, placebo-controlled, phase 3b study","title02":"Avatrombopag for the treatment of children and adolescents with immune thrombocytopenia (AVA-PED-301): a multicentre, randomised, double-blind, placebo-controlled, phase 3b study","journal":"Lancet Haematol","issue":"2025 May 23:S2352-3026(25)00107-3. doi: 10.1016\/S2352-3026(25)00107-3. Online ahead of print.","author":"Grace RF, Leblebisatan G, Aydinok Y, \u00dcnal \u015e, Grainger JD, Zhang J, Smallwood L, de Le\u00f3n E, Jamieson BD; AVA-PED-301 Study Group.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40418942"},{"title01":"Risk of cancer in adults with primary immune thrombocytopenia: a binational population-based real-world cohort study from Denmark and France","title02":"Risk of cancer in adults with primary immune thrombocytopenia: a binational population-based real-world cohort study from Denmark and France","journal":"Haematologica","issue":"2025 May 22. doi: 10.3324\/haematol.2025.287330. Online ahead of print.","author":"Mannering N, Zadro Y, Hansen DL, Maquet J, Lafaurie M, Potteg\u00e5rd A, Moulis G, Frederiksen H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40400464"},{"title01":"CD19(+)IL-10(+) regulatory B cells induced by IL-12p35 regulates functional T-cell subsets in patients with immune thrombocytopenia","title02":"CD19(+)IL-10(+) regulatory B cells induced by IL-12p35 regulates functional T-cell subsets in patients with immune thrombocytopenia","journal":"Br J Haematol","issue":"2025 May 25. doi: 10.1111\/bjh.20173. Online ahead of print.","author":"Hua F, Sun L, Li Y, Meng Y, Fan X, Wang X, Lu Y, Cheng Y, Li F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40415408"},{"title01":"The ‘Stop TPO-RA in ITP Patients’ study: Clinical and immune modulatory effects of romiplostim tapering","title02":"The ‘Stop TPO-RA in ITP Patients’ study: Clinical and immune modulatory effects of romiplostim tapering","journal":"Br J Haematol","issue":"2025 May 19. doi: 10.1111\/bjh.20100. Online ahead of print.","author":"Nelson VS, Amini SN, Netelenbos T, Kartachova MS, Schutgens REG, Visser O, Westerweel PE, Zwaginga JJ, Hofstede-van Egmond S, Kapur R, de Haas M, Porcelijn L, Schipperus MR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40384450"},{"title01":"Trajectories from single-cells to PAX5-driven leukemia reveal PAX5-MYC interplay in vivo","title02":"Trajectories from single-cells to PAX5-driven leukemia reveal PAX5-MYC interplay in vivo","journal":"Leukemia","issue":"2025 May 20. doi: 10.1038\/s41375-025-02626-2. Online ahead of print.","author":"Auer F, Morcos MNF, Sipola M, Akhtar I, Moisio S, Vogt J, Haag R, Lahnalampi M, Tuononen TJ, Hanel A, Viitasalo A, Friedrich UA, Dahl A, Prexler C, Pandyra AA, Stepensky P, Takagi M, Borkhardt A, Hein\u00e4niemi M, Hauer J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40394211"},{"title01":"Bisecting GlcNAc expression by bone marrow stromal cells modulates TGF-\u03b21-driven macrophage polarization in myeloid leukemias","title02":"Bisecting GlcNAc expression by bone marrow stromal cells modulates TGF-\u03b21-driven macrophage polarization in myeloid leukemias","journal":"Haematologica","issue":"2025 May 22. doi: 10.3324\/haematol.2024.287091. Online ahead of print.","author":"Feng J, Gou J, Wang Y, Wei W, Ma Y, Ren X, Zhao C, Cheng X, Lei L, Tan Z, Guan F, Li X.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40400458"},{"title01":"Characteristics and outcomes of newly diagnosed pediatric acute myeloid leukemia patients who were removed from standard regimens and received alternative therapy","title02":"Characteristics and outcomes of newly diagnosed pediatric acute myeloid leukemia patients who were removed from standard regimens and received alternative therapy","journal":"Haematologica","issue":"2025 May 22. doi: 10.3324\/haematol.2025.287487. Online ahead of print.","author":"Wahba A, Catueno S, Na K, Dickson S, Stevens A, Cuglievan B, Redell MS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40400478"},{"title01":"Treatment-related mutagenic processes in acute lymphoblastic leukemia","title02":"Treatment-related mutagenic processes in acute lymphoblastic leukemia","journal":"Haematologica","issue":"2025 May 15. doi: 10.3324\/haematol.2025.287774. Online ahead of print.","author":"Van der Ham CG, Van Leeuwen FN, Kuiper RP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40371888"},{"title01":"RETRACTION: IPO-trimethylation of Histone H3-lysine(9) Associated with P210 BCR-ABL Tyrosine Kinase of Chronic Myeloid Leukaemia","title02":"RETRACTION: IPO-trimethylation of Histone H3-lysine(9) Associated with P210 BCR-ABL Tyrosine Kinase of Chronic Myeloid Leukaemia","journal":"Br J Haematol","issue":"2025 May 23. doi: 10.1111\/bjh.20189. Online ahead of print.","author":"No authors listed","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40405758"},{"title01":"Diagnosis and treatment of early T-cell precursor acute lymphoblastic leukaemia","title02":"Diagnosis and treatment of early T-cell precursor acute lymphoblastic leukaemia","journal":"Br J Haematol","issue":"2025 May 23. doi: 10.1111\/bjh.20163. Online ahead of print.","author":"Xu K, Maharaj C, Kaffo E, Vitsaras E, Orfinada K, Baker R, Nacheva E, Wilson A, O'Nions J, Gupta R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40407010"},{"title01":"RETRACTION: P210 Bcr-abl Tyrosine Kinase Interaction with Histone Deacetylase 1 Modifies Histone H4 Acetylation and Chromatin Structure of Chronic Myeloid Leukaemia Haematopoietic Progenitors","title02":"RETRACTION: P210 Bcr-abl Tyrosine Kinase Interaction with Histone Deacetylase 1 Modifies Histone H4 Acetylation and Chromatin Structure of Chronic Myeloid Leukaemia Haematopoietic Progenitors","journal":"Br J Haematol","issue":"2025 May 26. doi: 10.1111\/bjh.20188. Online ahead of print.","author":"No authors listed","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40415499"},{"title01":"Hairy cell leukaemia and pregnancy: A systematic review and review of literature","title02":"Hairy cell leukaemia and pregnancy: A systematic review and review of literature","journal":"Br J Haematol","issue":"2025 May 19. doi: 10.1111\/bjh.20174. Online ahead of print.","author":"Borja-Montes OF, Toro-Pedroza A, Epperla N, Andritsos LA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40389354"},{"title01":"Venetoclax-based non-intensive combinations for relapsed\/refractory acute myeloid leukaemia-Real-world data from a UK-wide programme","title02":"Venetoclax-based non-intensive combinations for relapsed\/refractory acute myeloid leukaemia-Real-world data from a UK-wide programme","journal":"Br J Haematol","issue":"2025 May 20. doi: 10.1111\/bjh.20149. Online ahead of print.","author":"Wood H, O'Nions J, Chan WY, Borg A, Veitch S, Elder P, Jain M, Aries J, Leak S, Mitchell E, Pavlu J, Othman J, Dillon R, Mehta P, Murthy V, Knapper S, Potter V, Copland M, Craddock C, Krishnamurthy P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40394961"},{"title01":"Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed\/refractory acute myeloid leukaemia: A multicentre cohort study","title02":"Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed\/refractory acute myeloid leukaemia: A multicentre cohort study","journal":"Br J Haematol","issue":"2025 May 21. doi: 10.1111\/bjh.20147. Online ahead of print.","author":"Ye Y, Liu X, Dai H, Hu J, Yu G, Zhang Y, Weng G, Lin D, Du X, Xiao J, Sun Z, Zhang H, Liang X, Guo Z, Xu N, Fan Z, Xuan L, Lin R, Yin Z, Huang F, Dai M, Li Z, Liu Q, Jin H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40399765"},{"title01":"Classic hairy cell leukemia and concomitant smoldering myeloma","title02":"Classic hairy cell leukemia and concomitant smoldering myeloma","journal":"Blood","issue":"2025 May 22;145(21):2533.","author":"Jum'ah H, Viswanatha D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40402524"},{"title01":"Chromatin dynamics in CLL: a matter of balance","title02":"Chromatin dynamics in CLL: a matter of balance","journal":"Blood","issue":"2025 May 22;145(21):2403-2405.","author":"Rosenquist R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40402525"},{"title01":"Inflammation conjoins differentiation and resistance in AML","title02":"Inflammation conjoins differentiation and resistance in AML","journal":"Blood","issue":"2025 May 22;145(21):2405-2407.","author":"Janssen M, M\u00fcller-Tidow C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40402530"},{"title01":"RBM15-MKL1 fusion protein promotes leukemia via m6A methylation and WNT pathway activation","title02":"RBM15-MKL1 fusion protein promotes leukemia via m6A methylation and WNT pathway activation","journal":"Blood","issue":"2025 May 28:blood.2024027712. doi: 10.1182\/blood.2024027712. Online ahead of print.","author":"Mayday MY, Biancon G, Wei M, Ramirez C, Moratti I, Pintado-Urbanc AP, Espinosa JA, Chen M, Wang L, Simon MD, Ofir-Rosenfeld Y, Rausch O, Tebaldi T, Halene S, Krause DS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40435410"},{"title01":"HNRNPC and m6A RNA methylation control oncogenic transcription and metabolism in T-cell leukemia","title02":"HNRNPC and m6A RNA methylation control oncogenic transcription and metabolism in T-cell leukemia","journal":"Blood","issue":"2025 Apr 15:blood.2024026848. doi: 10.1182\/blood.2024026848. Online ahead of print.","author":"De Kesel J, Fijalkowski I, Pieters T, Borin C, Christensen KT, Wittouck M, Van Laere J, Guerrero L, Reunes L, Caruso M, Thakkar B, Sleeckx W, Xu LK, Van Nieuwerburgh F, Deforce D, De Keersmaecker K, Lammens T, Goossens S, Taghon T, Han C, Veltri G, Serafin V, Palhais B, Sharma ND, Huang H, Liu H, Matlawska-Wasowska K, Milovanovic A, Novoa EM, Wang E, Ntziachristos P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40435411"},{"title01":"Differentiation-dependent EBF1 Activity Determines CD22 Transcription and Leukemia Sensitivity to Inotuzumab Ozogamicin","title02":"Differentiation-dependent EBF1 Activity Determines CD22 Transcription and Leukemia Sensitivity to Inotuzumab Ozogamicin","journal":"Blood","issue":"2025 May 28:blood.2024028215. doi: 10.1182\/blood.2024028215. Online ahead of print.","author":"Escherich CS, Li Z, Barnett KR, Li Y, Walker M, Yoshimura S, Yang W, Huang X, Yu J, Stock W, Paietta E, Konopleva MY, Kornblau SM, Jabbour E, Litzow MR, Inaba H, Pui CH, Loh ML, Evans WE, Savic D, Yang JJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40435412"},{"title01":"Adult T-cell leukemia\/lymphoma coexistent with immune dysregulation-associated EBV+ lymphoproliferative disorder","title02":"Adult T-cell leukemia\/lymphoma coexistent with immune dysregulation-associated EBV+ lymphoproliferative disorder","journal":"Blood","issue":"2025 May 15;145(20):2396.","author":"Wang X, Yi H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40372737"},{"title01":"How I Evaluate and Treat Resistance and Relapse in CML","title02":"How I Evaluate and Treat Resistance and Relapse in CML","journal":"Blood","issue":"2025 May 15:blood.2024026511. doi: 10.1182\/blood.2024026511. Online ahead of print.","author":"Soverini S, Castagnetti F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40373278"},{"title01":"A phase 2 Trial of CHOP with Anti-CCR4 Antibody Mogamulizumab for older Patients with Adult T-Cell Leukemia\/Lymphoma","title02":"A phase 2 Trial of CHOP with Anti-CCR4 Antibody Mogamulizumab for older Patients with Adult T-Cell Leukemia\/Lymphoma","journal":"Blood","issue":"2025 May 15:blood.2024027902. doi: 10.1182\/blood.2024027902. Online ahead of print.","author":"Yoshimitsu M, Choi I, Kusumoto S, Shimokawa M, Utsunomiya A, Suehiro Y Dr, Hidaka T, Nosaka K, Sasaki H, Rai S, Tamura S, Owatari S, Koh KR, Nakamura D, Tokunaga M, Sekine M, Sakamoto Y, Inagaki H, Ishida T, Ishitsuka K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40373281"},{"title01":"Common origin and somatic mutation patterns of composite lymphomas and leukemias","title02":"Common origin and somatic mutation patterns of composite lymphomas and leukemias","journal":"Leukemia","issue":"2025 May 22. doi: 10.1038\/s41375-025-02549-y. Online ahead of print.","author":"Berg V, Lollies A, Schneider M, Johansson P, Weniger MA, Albertini E, Facchetti F, Ascani S, Moawia A, Bens S, Fischer A, Siebert R, Klapper W, Lorenzi L, Tiacci E, Hartmann S, Budeus B, Hansmann ML, K\u00fcppers R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40404986"},{"title01":"A highly selective and orally bioavailable casein kinase 1 alpha degrader through p53 signaling pathway targets B-cell lymphoma cells","title02":"A highly selective and orally bioavailable casein kinase 1 alpha degrader through p53 signaling pathway targets B-cell lymphoma cells","journal":"Leukemia","issue":"2025 May 27. doi: 10.1038\/s41375-025-02647-x. Online ahead of print.","author":"Feng S, Kong R, Wang C, Hao Q, Xie X, Wang H, Han J, Zhang Y, Elsner J, Mendy D, Haughey M, Krenitsky P, Plantevin-Krenitsky V, Papa P, Mercurio F, Xie W, Zhou X.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40425803"},{"title01":"Risk prediction in diffuse large B-cell lymphoma improves when combining baseline PET features with interim PET response","title02":"Risk prediction in diffuse large B-cell lymphoma improves when combining baseline PET features with interim PET response","journal":"Haematologica","issue":"2025 May 15. doi: 10.3324\/haematol.2024.287241. Online ahead of print.","author":"Eertink JJ, Heymans MW, Wiegers SE, Bes AL, Duhrsen U, Huttmann A, Kurch L, Barrington SF, Mikhaeel GN, Lugtenburg PJ, Ceriani L, Zucca E, Gyorke T, Czibor S, Zwezerijnen GJC, Boellaard R, Zijlstra JM, Hanoun C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40371889"},{"title01":"Clinical benefit of tafasitamab plus lenalidomide in relapsed or refractory diffuse large Bcell lymphoma: real-world data from the EarlyMIND study","title02":"Clinical benefit of tafasitamab plus lenalidomide in relapsed or refractory diffuse large Bcell lymphoma: real-world data from the EarlyMIND study","journal":"Haematologica","issue":"2025 May 15. doi: 10.3324\/haematol.2024.287141. Online ahead of print.","author":"Brisou G, Paillassa J, Bernard S, Tournilhac O, Fornecker LM, Maloisel F, Gastaud L, Durot E, Tempescul A, Braun T, Ivanov V, Cherel B, Serrier C, Delage J, El Yamani A, Delapierre B, Lebras L, Lestang E, Villesuzanne C, Agape P, Escure G, Fouillet L, Nicol C, Olivier G, Levy A, Le Bris AS, Cassuto O, Jacquemelle L, Haioun C, Herbaux C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40371897"},{"title01":"Marginal zone lymphoma with anti-factor H IgM and atypical hemolytic uremic syndrome successfully treated with odronextamab","title02":"Marginal zone lymphoma with anti-factor H IgM and atypical hemolytic uremic syndrome successfully treated with odronextamab","journal":"Haematologica","issue":"2025 May 15. doi: 10.3324\/haematol.2025.287532. Online ahead of print.","author":"Ardissino G, Angelillo P, Mancuso MC, Griffini S, Grovetti E, Porcaro L, Ria T, Marktel S, Peyvandi F, Luminari S, Ferreri AJM, Merli M, Cugno M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40371898"},{"title01":"Robust CAR T-cell expansion and superior outcomes in DLBCL patients in complete response at infusion","title02":"Robust CAR T-cell expansion and superior outcomes in DLBCL patients in complete response at infusion","journal":"Br J Haematol","issue":"2025 May 25. doi: 10.1111\/bjh.20186. Online ahead of print.","author":"Hanajiri R, Wakabayashi H, Ishigiwa K, Ohara F, Hirano S, Yokota H, Kuwano S, Furukawa K, Shimada K, Sato T, Terakura S, Kiyoi H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40415166"},{"title01":"The role of PET\/CT in peripheral T-cell lymphoma: Results from the PET\/CT substudy of the UK NCRI phase 2 CHEMO-T trial","title02":"The role of PET\/CT in peripheral T-cell lymphoma: Results from the PET\/CT substudy of the UK NCRI phase 2 CHEMO-T trial","journal":"Br J Haematol","issue":"2025 May 26. doi: 10.1111\/bjh.20160. Online ahead of print.","author":"Gleeson M, Gonzalez Arias C, Cunningham D, Peckitt C, Thomas K, Du Y, Hujairi N, To YM, Chen HC, Patel S, Chau I, Johnson P, Wotherspoon A, Attygalle AD, Hawkes EA, Macheta MP, Collins GP, Cwynarski K, Chua S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40419413"},{"title01":"Involvement of the gastrointestinal tract by mantle cell lymphoma","title02":"Involvement of the gastrointestinal tract by mantle cell lymphoma","journal":"Br J Haematol","issue":"2025 May 15. doi: 10.1111\/bjh.20048. Online ahead of print.","author":"Hafi M, Iyengar S, Wotherspoon A, Cunningham D, Kohoutova D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40374582"},{"title01":"Effectiveness of rituximab and biosimilar rituximab in untreated diffuse large B-cell lymphoma, a Danish population-based analysis","title02":"Effectiveness of rituximab and biosimilar rituximab in untreated diffuse large B-cell lymphoma, a Danish population-based analysis","journal":"Br J Haematol","issue":"2025 May 15. doi: 10.1111\/bjh.20155. Online ahead of print.","author":"Haujir A, T\u00f8stesen M, El-Galaly TC, Larsen TS, Starklint J, Poulsen CB, Josefsson PL, Clasen-Linde E, Pedersen M, Dessau-Arp A, Clausen MR, M\u00e9sz\u00e1ros J\u00f8rgensen J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40375441"},{"title01":"Management of relapsed or refractory large B-cell lymphoma: A British Society for Haematology Guideline","title02":"Management of relapsed or refractory large B-cell lymphoma: A British Society for Haematology Guideline","journal":"Br J Haematol","issue":"2025 May 19. doi: 10.1111\/bjh.20129. Online ahead of print.","author":"Chaganti S, Fox CP, Maybury BD, Burton C, Barrington SF, Illidge T, Kalakonda N, Eyre TA, McKay P, Kuhnl A, Cwynarski K, Davies AJ; BSH Committee.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40384597"},{"title01":"Combination of fixed low-dose nivolumab and bendamustine in children with high-risk relapsed\/refractory classical Hodgkin lymphoma","title02":"Combination of fixed low-dose nivolumab and bendamustine in children with high-risk relapsed\/refractory classical Hodgkin lymphoma","journal":"Br J Haematol","issue":"2025 May 20. doi: 10.1111\/bjh.20148. Online ahead of print.","author":"Srinivasan S, Narayan A, Dhamne C, Chichra A, Khemani P, Dhariwal N, Ranjan R, Shah S, Shet T, Gollamudi VRM, Roy Moulik N, Banavali SD, Narula G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40394816"},{"title01":"Targeting lipid metabolism in acute myeloid leukemia: biological insights and therapeutic opportunities","title02":"Targeting lipid metabolism in acute myeloid leukemia: biological insights and therapeutic opportunities","journal":"Leukemia","issue":"2025 May 22. doi: 10.1038\/s41375-025-02645-z. Online ahead of print.","author":"Dembitz V, James SC, Gallipoli P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40404984"},{"title01":"KK2845, a PBD dimer-containing antibody-drug conjugate targeting TIM-3-expressing AML","title02":"KK2845, a PBD dimer-containing antibody-drug conjugate targeting TIM-3-expressing AML","journal":"Leukemia","issue":"2025 May 22. doi: 10.1038\/s41375-025-02642-2. Online ahead of print.","author":"Zou J, Kinosada H, Takayanagi SI, Ishii T, Amano T, Nihira K, Kanie S, Adachi M, Tahara H, Sakoda T, Kikushige Y, Akashi K, Satou H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40404985"},{"title01":"Common origin and somatic mutation patterns of composite lymphomas and leukemias","title02":"Common origin and somatic mutation patterns of composite lymphomas and leukemias","journal":"Leukemia","issue":"2025 May 22. doi: 10.1038\/s41375-025-02549-y. Online ahead of print.","author":"Berg V, Lollies A, Schneider M, Johansson P, Weniger MA, Albertini E, Facchetti F, Ascani S, Moawia A, Bens S, Fischer A, Siebert R, Klapper W, Lorenzi L, Tiacci E, Hartmann S, Budeus B, Hansmann ML, K\u00fcppers R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40404986"},{"title01":"Peripheral Blood Flow Cytometry-based Definition of Plasma Cell Leukemia","title02":"Peripheral Blood Flow Cytometry-based Definition of Plasma Cell Leukemia","journal":"Leukemia","issue":"2025 May 26. doi: 10.1038\/s41375-025-02653-z. Online ahead of print.","author":"Bohra A, Hassan R, Zanwar S, Jevremovic D, Olteanu H, Gonsalves WI, Otteson G, Horna P, Rajkumar SV, Kumar S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40419655"},{"title01":"High-dose cytarabine with idarubicin consolidation for acute myeloid leukemia in first complete remission: a randomized controlled trial","title02":"High-dose cytarabine with idarubicin consolidation for acute myeloid leukemia in first complete remission: a randomized controlled trial","journal":"Leukemia","issue":"2025 May 28. doi: 10.1038\/s41375-025-02655-x. Online ahead of print.","author":"Zhang Y, Feng Z, Du J, Liu H, Yu S, Liang X, Zhao W, Zhang Q, Zhang X, Nie D, Sun Z, Du X, Xu X, Yu G, Shi P, Liu Q, Shao R, Qu H, Xiong W, Wang S, Jiang Y, Zhang H, Guo Z, Dai M, Jiang X, Xu D, Huang F, Fan Z, Xu N, Liu C, Wu M, Lin R, Jin H, Sun J, Liu Q, Xuan L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40437173"},{"title01":"The evolving landscape of epigenetic target molecules and therapies in myeloid cancers: focus on acute myeloid leukemia and myeloproliferative neoplasms","title02":"The evolving landscape of epigenetic target molecules and therapies in myeloid cancers: focus on acute myeloid leukemia and myeloproliferative neoplasms","journal":"Leukemia","issue":"2025 May 15. doi: 10.1038\/s41375-025-02639-x. Online ahead of print.","author":"K\u00fchn MWM, Pemmaraju N, Heidel FH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40374809"},{"title01":"Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients","title02":"Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients","journal":"Br J Haematol","issue":"2025 May 26. doi: 10.1111\/bjh.20185. Online ahead of print.","author":"Hermans SJF, Versluis J, van Werkhoven ED, van Norden Y, Janssen JJWM, Huls GA, Pabst T, Breems DA, Berkx E, Dinmohamed AG, Huijgens PC, Str\u00e4ng E, Hern\u00e1ndez Rivas JM, Sobas M, Ayala Diaz R, Martinez Lopez J, Metzeler KH, Haferlach T, Thiede C, Uyl-de Groot CA, Bullinger L, L\u00f6wenberg B, Ossenkoppele GJ, Pignatti F, Cornelissen JJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40419286"},{"title01":"CD49d promotes T-cell senescence in chronic lymphocytic leukaemia","title02":"CD49d promotes T-cell senescence in chronic lymphocytic leukaemia","journal":"Br J Haematol","issue":"2025 May 15. doi: 10.1111\/bjh.20135. Online ahead of print.","author":"Wang M, Guo Z, Zhao S, Liu L, Shi Y, Li H, Su J, Zhang N, Li J, Wu Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40375447"},{"title01":"Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A rearrangements","title02":"Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A<\/i> rearrangements","journal":"Leukemia","issue":"2025 May 9. doi: 10.1038\/s41375-025-02634-2. Online ahead of print.","author":"Bataller A, Goulart HE, Issa GC, DiNardo CD, Daver N, Kadia T, Bazinet A, Bouligny IM, Senapati J, Haddad FG, Borthakur G, Sasaki K, Short NJ, Yilmaz M, Montalban-Bravo G, Tang G, Loghavi S, Garcia-Manero G, Ravandi F, Kantarjian H, Jabbour E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40346311"},{"title01":"Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia","title02":"Heterogeneity of IKZF1<\/i> genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia","journal":"Leukemia","issue":"2025 May 13. doi: 10.1038\/s41375-025-02633-3. Online ahead of print.","author":"Wang'ondu RW, Ashcraft E, Chang TC, Roberts KG, Brady SW, Fan Y, Evans W, Relling MV, Crews KR, Yang J, Yang W, Pounds S, Wu G, Devidas M, Maloney K, Mattano L, Schore RJ, Angiolillo A, Larsen E, Salzer W, Burke MJ, Loh ML, Jeha S, Pui CH, Inaba H, Cheng C, Mullighan CG.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40360879"},{"title01":"ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker","title02":"ATM<\/i> aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM<\/i> mutations is an adverse-prognostic biomarker","journal":"Leukemia","issue":"2025 Apr 24. doi: 10.1038\/s41375-025-02615-5. Online ahead of print.","author":"Thorvaldsdottir B, Mansouri L, Sutton LA, Nadeu F, Meggendorfer M, Parker H, Brieghel C, Laidou S, Moia R, Rossi D, Kotaskova J, Delgado J, Rodr\u00edguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarf\u00f2 L, Mattsson M, Davis Z, Baliakas P, Rapado I, Miras F, Martinez-Lopez J, de la Serna J, Hern\u00e1ndez Rivas JM, Larr\u00e1yoz MJ, Calasanz MJ, Smedby KE, Espinet B, Puiggros A, Bullinger L, Bosch F, Taz\u00f3n-Vega B, Baran-Marszak F, Oscier D, Nguyen-Khac F, Zenz T, Terol MJ, Cuneo A, Hern\u00e1ndez-S\u00e1nchez M, Pospisilova S, Gaidano G, Niemann CU, Campo E, Strefford JC, Ghia P, Stamatopoulos K, Rosenquist R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40275070"},{"title01":"Somatic mutations and outcomes in chronic myeloid leukemia adolescent and young adults compared to children, adults, and BCR::ABL1-positive acute lymphoblastic leukemia","title02":"Somatic mutations and outcomes in chronic myeloid leukemia adolescent and young adults compared to children, adults, and BCR::ABL1<\/i>-positive acute lymphoblastic leukemia","journal":"Leukemia","issue":"2025 Apr 28. doi: 10.1038\/s41375-025-02609-3. Online ahead of print.","author":"Krizkova J, Polivkova V, Laznicka A, Curik N, Benesova A, Suchankova P, Smazik T, Vysinova V, Mikulenkova D, Klamova H, Markova MS, Srbova D, Zuna J, Zaliova M, Trka J, Salek C, Polakova KM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40295826"},{"title01":"S-adenosylmethionine addiction confers sensitivity to methionine restriction in KMT2A-rearranged acute lymphoblastic leukemia","title02":"S-adenosylmethionine addiction confers sensitivity to methionine restriction in KMT2A<\/i>-rearranged acute lymphoblastic leukemia","journal":"Haematologica","issue":"2025 Apr 24. doi: 10.3324\/haematol.2023.284869. Online ahead of print.","author":"Tee T, Ruiter TJJ, Wu S, Zhang W, Schenau DVI, Rodionova M, Wajon D, Vervoort BMT, Grunewald KJT, Bosma M, Hagelaar R, Baker-Hernandez J, Dahaoui A, Schneider P, Verhoeven-Duif NM, Van der Meer LT, Van Leeuwen FN.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40270205"},{"title01":"Clinical characteristics and therapeutic determinants of RUNX1::RUNX1T1 differ from those of CBFB::MYH11 acute myeloid leukemia","title02":"Clinical characteristics and therapeutic determinants of RUNX1::RUNX1T1<\/i> differ from those of CBFB::MYH11<\/i> acute myeloid leukemia","journal":"Haematologica","issue":"2025 Apr 30. doi: 10.3324\/haematol.2024.287293. Online ahead of print.","author":"Yang M, Wang W, Zhang G, Qiu S, Liu B, Mi Y, Wang Y, Wang J, Wei H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40304077"},{"title01":"TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma","title02":"TP53<\/i> and CDKN2A<\/i> alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma","journal":"Leukemia","issue":"2025 May 2. doi: 10.1038\/s41375-025-02631-5. Online ahead of print.","author":"Ito Y, Shimono J, Kawamoto K, Hatanaka KC, Kogure Y, Tabata M, Saito Y, Mizuno K, Horie S, Mizukami Y, Koya J, Murakami K, Teshima T, Hatanaka Y, Chiba K, Okada A, Shiraishi Y, Miyoshi H, Matsuno Y, Ohshima K, Kataoka K, Nakagawa M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40316697"},{"title01":"Targeting the Tumor and the Immune System in Smoldering Multiple Myeloma","title02":"Targeting the Tumor and the Immune System in Smoldering Multiple Myeloma","journal":"N Engl J Med","issue":"2025 May 8;392(18):1858-1860.","author":"Maura F, Bergsagel PL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40334161"},{"title01":"Time for a paradigm shift in immunotherapy-based BCMA\/CD3 bispecific drug development in multiple myeloma","title02":"Time for a paradigm shift in immunotherapy-based BCMA\/CD3 bispecific drug development in multiple myeloma","journal":"Leukemia","issue":"2025 Apr 24. doi: 10.1038\/s41375-025-02610-w. Online ahead of print.","author":"Leleu X, Bobin A, Herbelin A, Gombert JM, Rajkumar SV.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40275071"},{"title01":"Evaluation of Sox4 levels in multiple myeloma patients","title02":"Evaluation of Sox4 levels in multiple myeloma patients","journal":"Haematologica","issue":"2025 May 8. doi: 10.3324\/haematol.2024.286794. Online ahead of print.","author":"Lombardi E, Kowal KE, Almanza G, Agostini F, Da Ros F, Valvasori M, Vicinanza C, Alzetta D, Montante B, Marangon M, Crestani S, Lamon G, Rupolo M, Mazzucato M, Durante C, Zanetti M, Michieli M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40336320"},{"title01":"LDHAL6B is a novel prognostic marker and promotes disease progression in multiple myeloma","title02":"LDHAL6B is a novel prognostic marker and promotes disease progression in multiple myeloma","journal":"Haematologica","issue":"2025 May 8. doi: 10.3324\/haematol.2024.286835. Online ahead of print.","author":"Zuo L, Li Z, Cai L, Li Q, Fan F, Zhang B, Zhao F, Luo S, Zheng Y, Hu Y, Sun C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40336322"},{"title01":"Myelodysplastic neoplasm with biallelic TP53 inactivation in a patient with plasma cell myeloma after cytotoxic therapy","title02":"Myelodysplastic neoplasm with biallelic TP53<\/i> inactivation in a patient with plasma cell myeloma after cytotoxic therapy","journal":"Blood","issue":"2025 May 8;145(19):2230.","author":"He R, Chen D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40338571"},{"title01":"Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children’s Oncology Group","title02":"Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children’s Oncology Group","journal":"J Clin Oncol","issue":"2025 Apr 28:JCO2401841. doi: 10.1200\/JCO-24-01841. Online ahead of print.","author":"Huang BJ, Meyer LK, Alonzo TA, Wang YC, Lamble AJ, Ries RE, Wang W, Hirsch B, Raca G, Ma X, Gamis AS, Aplenc R, Kolb EA, Cooper TM, Tarlock K, Loken MR, Meshinchi S, Chewning JH, Woods WG, Horan JT.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40294366"},{"title01":"Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy","title02":"Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy","journal":"Haematologica","issue":"2025 May 8. doi: 10.3324\/haematol.2025.287433. Online ahead of print.","author":"Webster JA, Reed M, Tsai HL, Imus PH, Smith DB, Ambinder AJ, Levis MJ, DeZern AE, Prince GT, Jain T, Bola\u00f1os-Meade J, Gondek LP, Ghiaur G, Dalton WB, Karantanos T, Paul S, Fuchs EJ, Sterling C, Swinnen LJ, Wagner-Johnston N, Ambinder RF, Gocke CB, Ali SA, Huff CA, Luznik L, Varadhan R, Jones RJ, Gojo I.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40336316"},{"title01":"Lenalidomide maintenance after bortezomib, thalidomide and dexamethasone (VTD) induction and autologous stem cell transplantation: an Italian real-life study of 602 patients","title02":"Lenalidomide maintenance after bortezomib, thalidomide and dexamethasone (VTD) induction and autologous stem cell transplantation: an Italian real-life study of 602 patients","journal":"Haematologica","issue":"2025 Apr 30. doi: 10.3324\/haematol.2024.286825. Online ahead of print.","author":"Baril\u00e0 G, Grassi A, Conticello C, Mina R, Marcon C, Fazio F, Cartia CS, Tinelli M, Del Giudice ML, Pilerci S, Belotti A, Pascarella A, Tafuri M, Rocchi S, Mancuso K, Sgherza N, Mele G, Scomazzon E, Gentile M, Porrazzo M, Pescosta N, Furlan A, Febbo MA, Clissa C, Casson A, Ribolla R, Maroccia A, Lisi C, Martino EA, Annibali O, Buda G, Antonioli E, Mangiacavalli S, Tosetto A, Musto P, Gay F, Zamagni E, Petrucci MT, Di Raimondo F, Patriarca F, Zambello R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40304063"},{"title01":"A rare complication during autologous stem cell transplantation in multiple myeloma","title02":"A rare complication during autologous stem cell transplantation in multiple myeloma","journal":"Br J Haematol","issue":"2025 May 7. doi: 10.1111\/bjh.20130. Online ahead of print.","author":"Tomarchio V, Faiella E, Tafuri M, Armiento D, Rigacci L, Annibali O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40338808"},{"title01":"A phase 2 study of single agent ibrutinib for first-line treatment of chronic graft-versus-host disease: A new paradigm and lessons learned","title02":"A phase 2 study of single agent ibrutinib for first-line treatment of chronic graft-versus-host disease: A new paradigm and lessons learned","journal":"Br J Haematol","issue":"2025 May 5. doi: 10.1111\/bjh.20069. Online ahead of print.","author":"El Jurdi N, Holtzman NG, Hishmeh R, Mina A, Schulz E, Stokes A, Li G, Schmidt KT, Figg WD, Micheletti N, Mays JW, Cowen EW, Pavletic SZ, Pusic I.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40322855"},{"title01":"Cord blood transplants: Advancing leukaemia treatments and addressing health disparities","title02":"Cord blood transplants: Advancing leukaemia treatments and addressing health disparities","journal":"Br J Haematol","issue":"2025 May;206(5):1312-1314.","author":"Scaradavou A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40275775"},{"title01":"How I approach hematopoietic stem cell transplantation for CML in a TKI world","title02":"How I approach hematopoietic stem cell transplantation for CML in a TKI world","journal":"Blood","issue":"2025 May 12:blood.2024026512. doi: 10.1182\/blood.2024026512. Online ahead of print.","author":"Chalandon Y, Simonetta F, Masouridi-Levrat S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40354577"},{"title01":"Donor regulatory\/conventional T-cell grafts for the GVHD win?","title02":"Donor regulatory\/conventional T-cell grafts for the GVHD win?","journal":"Blood","issue":"2025 May 1;145(18):1964-1965.","author":"Pierini A, Koreth J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40310660"},{"title01":"Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHD","title02":"Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHD","journal":"Blood","issue":"2025 Apr 25:blood.2024027301. doi: 10.1182\/blood.2024027301. Online ahead of print.","author":"Habenicht KM, Wanzek J, Bootz A, Sch\u00e4fer S, Vollmer L, Hiergeist A, Fante MA, Hasenbank JT, Schneider A, Vasova I, Spoerl S, Brandt A, Rehli M, Hoffmann P, Wirtz S, Kotorri J, Gerlach RG, Gessner A, Mackensen A, Winkler J, Wolff D, Winkler TH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40324063"},{"title01":"Phase 1\/2 Study of High-Dose Palifermin for GVHD Prophylaxis in Patients Undergoing HLA-Matched Unrelated Donor HCT","title02":"Phase 1\/2 Study of High-Dose Palifermin for GVHD Prophylaxis in Patients Undergoing HLA-Matched Unrelated Donor HCT","journal":"Blood","issue":"2025 May 7:blood.2024028303. doi: 10.1182\/blood.2024028303. Online ahead of print.","author":"Schulz E, Curtis LM, Holtzman NG, Sponaugle J, Wloka K, Ostojic A, Mina A, El Jurdi N, Pirsl F, Carpenter A, Golagha M, Sirajuddin A, Heller T, Shaffer BC, Hakim FT, Rubin JS, Gress RE, Pavletic SZ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40331908"},{"title01":"A new variable to study in transplant: APOE variant status","title02":"A new variable to study in transplant: APOE<\/i> variant status","journal":"Blood","issue":"2025 Apr 24;145(17):1839-1840.","author":"Kaito S, DeWolf S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40272859"},{"title01":"High Incidence of Severe TA-TMA Increases Mortality in adult Allogeneic Transplant recipients: A prospective MIDAS Consortium study","title02":"High Incidence of Severe TA-TMA Increases Mortality in adult Allogeneic Transplant recipients: A prospective MIDAS Consortium study","journal":"Blood","issue":"2025 Apr 29:blood.2025028390. doi: 10.1182\/blood.2025028390. Online ahead of print.","author":"Vasu S, Zhao Q, Miller EG, Elder P, Langenberg L, Cataland SR, Davies SM, Bejanyan N, Hahn T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40300075"},{"title01":"Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A","title02":"Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A","journal":"N Engl J Med","issue":"2025 May 1;392(17):1765.","author":"Sanal MG, Jindal A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40305727"},{"title01":"Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A","title02":"Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A","journal":"N Engl J Med","issue":"2025 May 1;392(17):1765-1766.","author":"Zhang K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40305728"},{"title01":"Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A. Reply","title02":"Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A. Reply","journal":"N Engl J Med","issue":"2025 May 1;392(17):1766.","author":"Srivastava A, Spencer T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40305729"},{"title01":"Acute myeloid leukemia stem cells remodel the bone marrow niche via TGF-\u03b2-activated Alcam(+) bone lining cells, creating a self-sustaining environment","title02":"Acute myeloid leukemia stem cells remodel the bone marrow niche via TGF-\u03b2-activated Alcam(+) bone lining cells, creating a self-sustaining environment","journal":"Leukemia","issue":"2025 May 13. doi: 10.1038\/s41375-025-02640-4. Online ahead of print.","author":"Nguyen NTK, Yao H, Hosokawa K, Esaki Y, Yuta R, Adachi S, Arai F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40360881"},{"title01":"Updated recommendations for the management of hepatitis B, C, and E virus infections in patients with haematological malignancies and those undergoing haematopoietic cell transplantation: recommendations from the 9th European Conference on Infections in Leukaemia (ECIL-9)","title02":"Updated recommendations for the management of hepatitis B, C, and E virus infections in patients with haematological malignancies and those undergoing haematopoietic cell transplantation: recommendations from the 9th European Conference on Infections in Leukaemia (ECIL-9)","journal":"Lancet Haematol","issue":"2025 May;12(5):e389-e399.","author":"Mikulska M, van B\u00f6mmel F, Mouliade C, Indolfi G, Kefalakes H, von Lilienfeld-Toal M, Pischke S, Hermine O, Moradpour D, Wedemeyer H, Berg T, Ljungman P, Mallet V.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40306834"},{"title01":"Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children’s Oncology Group","title02":"Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children’s Oncology Group","journal":"J Clin Oncol","issue":"2025 Apr 28:JCO2401841. doi: 10.1200\/JCO-24-01841. Online ahead of print.","author":"Huang BJ, Meyer LK, Alonzo TA, Wang YC, Lamble AJ, Ries RE, Wang W, Hirsch B, Raca G, Ma X, Gamis AS, Aplenc R, Kolb EA, Cooper TM, Tarlock K, Loken MR, Meshinchi S, Chewning JH, Woods WG, Horan JT.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40294366"},{"title01":"Targeting leukemic stem cell dormancy in NPM1c\/FLT3-ITD-driven acute myeloid leukemia","title02":"Targeting leukemic stem cell dormancy in NPM1c\/FLT3-ITD-driven acute myeloid leukemia","journal":"Haematologica","issue":"2025 May 8. doi: 10.3324\/haematol.2025.287644. Online ahead of print.","author":"Stelmach P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40336317"},{"title01":"Different features of acute myeloid leukemia stem cell quantification in intensively treated patients","title02":"Different features of acute myeloid leukemia stem cell quantification in intensively treated patients","journal":"Haematologica","issue":"2025 Apr 30. doi: 10.3324\/haematol.2024.287090. Online ahead of print.","author":"Ngai LL, Reuvekamp T, Hanekamp D, Janssen F, Marsbergen LO, Carbaat-Ham J, Hofland MAM, Fayed MMHE, Kelder A, Scholten WJ, Snel AN, Bachas C, Tettero JM, Breems DA, Fischer T, Gjertsen BT, Gri\u0161kevi\u010dius L, Juliusson G, Van de Loosdrecht AA, Maertens JA, Manz MG, Pabst T, Passweg JR, Porkka K, Valk PJM, Gradowska P, L\u00f6wenberg B, Ossenkoppele GJ, De Leeuw DC, Cloos J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40304060"},{"title01":"Lenalidomide maintenance after bortezomib, thalidomide and dexamethasone (VTD) induction and autologous stem cell transplantation: an Italian real-life study of 602 patients","title02":"Lenalidomide maintenance after bortezomib, thalidomide and dexamethasone (VTD) induction and autologous stem cell transplantation: an Italian real-life study of 602 patients","journal":"Haematologica","issue":"2025 Apr 30. doi: 10.3324\/haematol.2024.286825. Online ahead of print.","author":"Baril\u00e0 G, Grassi A, Conticello C, Mina R, Marcon C, Fazio F, Cartia CS, Tinelli M, Del Giudice ML, Pilerci S, Belotti A, Pascarella A, Tafuri M, Rocchi S, Mancuso K, Sgherza N, Mele G, Scomazzon E, Gentile M, Porrazzo M, Pescosta N, Furlan A, Febbo MA, Clissa C, Casson A, Ribolla R, Maroccia A, Lisi C, Martino EA, Annibali O, Buda G, Antonioli E, Mangiacavalli S, Tosetto A, Musto P, Gay F, Zamagni E, Petrucci MT, Di Raimondo F, Patriarca F, Zambello R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40304063"},{"title01":"A rare complication during autologous stem cell transplantation in multiple myeloma","title02":"A rare complication during autologous stem cell transplantation in multiple myeloma","journal":"Br J Haematol","issue":"2025 May 7. doi: 10.1111\/bjh.20130. Online ahead of print.","author":"Tomarchio V, Faiella E, Tafuri M, Armiento D, Rigacci L, Annibali O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40338808"},{"title01":"How I approach hematopoietic stem cell transplantation for CML in a TKI world","title02":"How I approach hematopoietic stem cell transplantation for CML in a TKI world","journal":"Blood","issue":"2025 May 12:blood.2024026512. doi: 10.1182\/blood.2024026512. Online ahead of print.","author":"Chalandon Y, Simonetta F, Masouridi-Levrat S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40354577"},{"title01":"Phase 1\/2 Study of High-Dose Palifermin for GVHD Prophylaxis in Patients Undergoing HLA-Matched Unrelated Donor HCT","title02":"Phase 1\/2 Study of High-Dose Palifermin for GVHD Prophylaxis in Patients Undergoing HLA-Matched Unrelated Donor HCT","journal":"Blood","issue":"2025 May 7:blood.2024028303. doi: 10.1182\/blood.2024028303. Online ahead of print.","author":"Schulz E, Curtis LM, Holtzman NG, Sponaugle J, Wloka K, Ostojic A, Mina A, El Jurdi N, Pirsl F, Carpenter A, Golagha M, Sirajuddin A, Heller T, Shaffer BC, Hakim FT, Rubin JS, Gress RE, Pavletic SZ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40331908"},{"title01":"Augmented CD47 expression impairs alloreactive T-cell clearance after allo-HCT","title02":"Augmented CD47 expression impairs alloreactive T-cell clearance after allo-HCT","journal":"Blood","issue":"2025 May 7:blood.2023023056. doi: 10.1182\/blood.2023023056. Online ahead of print.","author":"Flamann CS, Shaikh H, Matos C, Kreutz M, Ali H, Kern MA, B\u00fcttner-Herold M, Jacobs B, V\u00f6lkl S, Lischer C, Kellner C, Berges J, Bitterer K, Saul D, Goel M, Link-Rachner C, Zernecke A, Weber DA, Mougiakakos D, Mackensen A, Beilhack A, Bruns H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40332470"},{"title01":"STINGing leukemia stem cells through PSTK inhibition","title02":"STINGing leukemia stem cells through PSTK inhibition","journal":"Blood","issue":"2025 Apr 24;145(17):1833-1835.","author":"Garciaz S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40272853"},{"title01":"Myelodysplastic neoplasms with ring sideroblasts without SF3B1 mutations in adults: enrichment of germline variants in congenital sideroblastic anemia genes","title02":"Myelodysplastic neoplasms with ring sideroblasts without SF3B1<\/i> mutations in adults: enrichment of germline variants in congenital sideroblastic anemia genes","journal":"Leukemia","issue":"2025 May 7. doi: 10.1038\/s41375-025-02629-z. Online ahead of print.","author":"Novoa-J\u00e1uregui S, Huber S, Gabarr\u00f3s-Subir\u00e0 M, Chen-Liang TH, Torres-Esquius S, Carrillo-Tornel S, Santiago M, Bernal Del Castillo T, Mart\u00edn-Castillo I, Hernandez FM, Del Rey M, Liquori A, Tormo M, Cervera J, Bosch F, Valc\u00e1rcel D, Haferlach C, D\u00edez-Campelo M, Montoro MJ, Haferlach T, Jerez A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40335618"},{"title01":"The effects of revised haemoglobin cutoffs on the global burden of anaemia","title02":"The effects of revised haemoglobin cutoffs on the global burden of anaemia","journal":"Lancet Haematol","issue":"2025 May;12(5):e325-e326.","author":"Luo H, Liu L, Young MF, Suchdev PS; BRINDA working group.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40306825"},{"title01":"Prognostic and biological characteristics associated with multiple myeloma presenting only with anemia","title02":"Prognostic and biological characteristics associated with multiple myeloma presenting only with anemia","journal":"Haematologica","issue":"2025 Apr 30. doi: 10.3324\/haematol.2024.286457. Online ahead of print.","author":"Shamir G, Rouvio O, Reiner-Benaim A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40304075"},{"title01":"Increased incidence of autoimmune haemolytic anaemia with paroxysmal cold haemoglobinuria features in paediatric cases in a changing viral environment post-COVID-19 pandemic","title02":"Increased incidence of autoimmune haemolytic anaemia with paroxysmal cold haemoglobinuria features in paediatric cases in a changing viral environment post-COVID-19 pandemic","journal":"Br J Haematol","issue":"2025 May 8. doi: 10.1111\/bjh.20128. Online ahead of print.","author":"Harju T, Raiskila S, Lohi O, J\u00e4rvel\u00e4 L, Niinim\u00e4ki R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40342099"},{"title01":"Cholesterol-conjugated miR-29b induces fetal haemoglobin expression via \u03b3-globin promoter demethylation in the Townes mouse model for sickle cell anaemia","title02":"Cholesterol-conjugated miR-29b induces fetal haemoglobin expression via \u03b3-globin<\/i> promoter demethylation in the Townes mouse model for sickle cell anaemia","journal":"Br J Haematol","issue":"2025 May 4. doi: 10.1111\/bjh.20107. Online ahead of print.","author":"Palani CD, Smith A, Cao X, Li B, Pace BS, Starlard-Davenport A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40320590"},{"title01":"Targeting CD38 with Daratumumab for Platelet Transfusion Refractoriness in Aplastic Anemia","title02":"Targeting CD38 with Daratumumab for Platelet Transfusion Refractoriness in Aplastic Anemia","journal":"Blood","issue":"2025 May 7:blood.2025029006. doi: 10.1182\/blood.2025029006. Online ahead of print.","author":"Gao Z, Pan H, Zhang L, Li W, Li R, Zhao J, Luo Y, Lian Y, Yu X, Kuang Z, Nie N, Li J, Huang J, Zhao X, Li Y, Fang L, Ge M, Zheng Y, Shi J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40331918"},{"title01":"Echinococcus granulosus antigen B regulates T-cell function through inhibition of signal transducer and activator of transcription 3 in experimental immune thrombocytopenia","title02":"Echinococcus granulosus<\/i> antigen B regulates T-cell function through inhibition of signal transducer and activator of transcription 3 in experimental immune thrombocytopenia","journal":"Br J Haematol","issue":"2025 May 5. doi: 10.1111\/bjh.20064. Online ahead of print.","author":"Yue Y, Zhang Y, Cheng Y, Jiao H, Yan M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40325612"},{"title01":"Acute stroke in children with immune thrombocytopenia: A systematic review and meta-analysis","title02":"Acute stroke in children with immune thrombocytopenia: A systematic review and meta-analysis","journal":"Br J Haematol","issue":"2025 May;206(5):1450-1457.","author":"Ly A, Ahmad SA, Liu O, Feng SN, Kalra A, Dev A, Spann M, Chaturvedi S, Hong S, Cho SM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40269507"},{"title01":"PF4-associated immune thrombocytopenia and thrombosis (PITT)-More than heparin and vaccines","title02":"PF4-associated immune thrombocytopenia and thrombosis (PITT)-More than heparin and vaccines","journal":"Br J Haematol","issue":"2025 Apr 28. doi: 10.1111\/bjh.20125. Online ahead of print.","author":"Makris M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40289696"},{"title01":"BLAST: A Globally Applicable and Molecularly Versatile Survival Model for Chronic Myelomonocytic Leukemia","title02":"BLAST: A Globally Applicable and Molecularly Versatile Survival Model for Chronic Myelomonocytic Leukemia","journal":"Blood","issue":"2025 May 7:blood.2024027170. doi: 10.1182\/blood.2024027170. Online ahead of print.","author":"Tefferi A, Fathima S, Abdelmagid M, Alsugair A, Aperna F, Rezasoltani M, Yousuf M, Natu A, Csizmar CM, Gurney M, Lasho TL, Finke CM, Kanagal-Shamanna R, Hammond D, Chien KS, Bazinet A, DiNardo CD, Kadia TM, Mangaonkar AA, Daver NG, Pardanani AD, Borthakur G, Zepeda-Mendoza CJ, Reichard KK, He R, Loghavi S, Passamonti F, Ravandi F, Sasaki K, Larson D, Garcia-Manero G, Onida F, Gangat N, Montalban-Bravo G, Patnaik MM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40332442"},{"title01":"STINGing leukemia stem cells through PSTK inhibition","title02":"STINGing leukemia stem cells through PSTK inhibition","journal":"Blood","issue":"2025 Apr 24;145(17):1833-1835.","author":"Garciaz S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40272853"},{"title01":"Beyond conVENtional 7+3 in acute myeloid leukemia","title02":"Beyond conVENtional 7+3 in acute myeloid leukemia","journal":"Blood","issue":"2025 Apr 24;145(17):1831-1832.","author":"McMahon CM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40272856"},{"title01":"Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure","title02":"Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure","journal":"N Engl J Med","issue":"2025 May 8;392(18):1824-1835.","author":"Svoboda J, Landsburg DJ, Gerson J, Nasta SD, Barta SK, Chong EA, Cook M, Frey NV, Shea J, Cervini A, Marshall A, Four M, Davis MM, Jadlowsky JK, Chew A, Pequignot E, Gonzalez V, Noll JH, Paruzzo L, Rojas-Levine J, Plesa G, Scholler J, Siegel DL, Levine BL, Porter DL, Ghassemi S, Ruella M, Rech A, Leskowitz RM, Fraietta JA, Hwang WT, Hexner E, Schuster SJ, June CH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40334157"},{"title01":"Glofitamab with Polatuzumab Vedotin in Refractory Burkitt’s Lymphoma","title02":"Glofitamab with Polatuzumab Vedotin in Refractory Burkitt’s Lymphoma","journal":"N Engl J Med","issue":"2025 May 1;392(17):1760-1762.","author":"Prica A, Roschewski M, Beale P, Pittaluga S, Delabie J, Ortega C, Kridel R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40305722"},{"title01":"Refining histopathological growth pattern-based risk group discrimination in nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group","title02":"Refining histopathological growth pattern-based risk group discrimination in nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group","journal":"Leukemia","issue":"2025 May 13. doi: 10.1038\/s41375-025-02641-3. Online ahead of print.","author":"Eichenauer DA, Basaran A, B\u00fchnen I, Fuchs M, von Tresckow B, Rosenwald A, Hansmann ML, Bernd HW, Borchmann P, Klapper W, Hartmann S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40360880"},{"title01":"Age-related prognoses of genetic subtypes in B-cell acute lymphoblastic leukemia\/lymphoma (B-ALL): insights from a decade of national data","title02":"Age-related prognoses of genetic subtypes in B-cell acute lymphoblastic leukemia\/lymphoma (B-ALL): insights from a decade of national data","journal":"Leukemia","issue":"2025 Apr 24. doi: 10.1038\/s41375-025-02588-5. Online ahead of print.","author":"Zhou T, Short NJ, Jain N, Patel KP, Jabbour EJ, Kantarjian HM, Medeiros LJ, Iorgulescu JB.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40275068"},{"title01":"Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time?","title02":"Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time?","journal":"Leukemia","issue":"2025 Apr 24. doi: 10.1038\/s41375-025-02605-7. Online ahead of print.","author":"Gazeau N, Beauvais D, Tilmont R, Srour M, Ferrant E, Safar V, Fouillet L, Flandrin-Gresta P, Gower N, Chauvet P, Duployez N, Podvin B, Demaret J, Huet S, Sujobert P, Ghesqui\u00e8res H, Damaj G, Bachy E, Morschhauser F, Yakoub-Agha I, Heiblig M, Sesques P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40275069"},{"title01":"Sulforaphane promotes natural killer cell-mediated anti-tumor immune responses partially via cGAS-STING pathway in classical Hodgkin lymphoma","title02":"Sulforaphane promotes natural killer cell-mediated anti-tumor immune responses partially via cGAS-STING pathway in classical Hodgkin lymphoma","journal":"Leukemia","issue":"2025 Apr 28. doi: 10.1038\/s41375-025-02627-1. Online ahead of print.","author":"Xagoraris I, Yang Y, Bougka E, Trogrlic D, Xyderou P, Stathopoulou K, Herold N, Lundqvist A, Rassidakis GZ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40295827"},{"title01":"Low-dose moderate hypofractionated radiotherapy for indolent non-Hodgkin lymphoma: a multicentre, single-arm, phase 2 trial","title02":"Low-dose moderate hypofractionated radiotherapy for indolent non-Hodgkin lymphoma: a multicentre, single-arm, phase 2 trial","journal":"Lancet Haematol","issue":"2025 May 2:S2352-3026(25)00071-7. doi: 10.1016\/S2352-3026(25)00071-7. Online ahead of print.","author":"Wang XY, Zhang XM, Wang L, Gao LR, Chen K, Feng XL, Rao W, Zheng R, Wu YP, Song YW, Fang H, Chen B, Jin J, Liu YP, Jing H, Tang Y, Zhang WW, Zhai YR, Lu NN, Li N, Xia CF, Wang SL, Liu X, Li YX, Qi SN.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40324445"},{"title01":"Rituximab versus active surveillance in patients with follicular lymphoma","title02":"Rituximab versus active surveillance in patients with follicular lymphoma","journal":"Lancet Haematol","issue":"2025 May;12(5):e320-e321.","author":"Kimby E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40306823"},{"title01":"Is there still a role for CNS prophylaxis in diffuse large B-cell lymphoma?","title02":"Is there still a role for CNS prophylaxis in diffuse large B-cell lymphoma?","journal":"Lancet Haematol","issue":"2025 May;12(5):e332-e333.","author":"Smith J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40306829"},{"title01":"Is there still a role for CNS prophylaxis in diffuse large B-cell lymphoma?","title02":"Is there still a role for CNS prophylaxis in diffuse large B-cell lymphoma?","journal":"Lancet Haematol","issue":"2025 May;12(5):e333-e334.","author":"Wilson MR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40306830"},{"title01":"Early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma: long-term results of a randomised, phase 3 trial","title02":"Early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma: long-term results of a randomised, phase 3 trial","journal":"Lancet Haematol","issue":"2025 May;12(5):e335-e345.","author":"Northend M, Wilson W, Ediriwickrema K, Clifton-Hadley L, Qian W, Rana Z, Martin TL, Townsend W, Young M, Miall F, Cunningham D, Walewski J, Ferhanoglu B, Linton K, Johnston A, Seymour JF, Linch DC, Ardeshna KM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40306831"},{"title01":"Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma","title02":"Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma","journal":"J Clin Oncol","issue":"2025 May 1:101200JCO2500690. doi: 10.1200\/JCO-25-00690. Online ahead of print.","author":"Wang M, Salek D, Belada D, Song Y, Jurczak W, Kahl BS, Paludo J, Chu MP, Kryachok I, Fogliatto L, Cheah CY, Morawska M, Sancho JM, Li Y, Patti C, Forsyth C, Zhang J, Lesley R, Ramadan S, Rule S, Dreyling M; ECHO investigators.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40311141"},{"title01":"A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma","title02":"A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma","journal":"Haematologica","issue":"2025 Apr 24. doi: 10.3324\/haematol.2025.287509. Online ahead of print.","author":"Lia K, J\u00f8rgensen RRK, Wikman P, Wold BL, \u00d6vergaard N, Fluge \u00d8, Fagerli UM, Bersvendsen H, B\u00f8 IB, Bhargava S, Molin D, Foss\u00e5 A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40270216"},{"title01":"Clonality analysis of HTLV-1-infected cells enhances prognostic precision in smoldering adult T-cell leukemia\/lymphoma","title02":"Clonality analysis of HTLV-1-infected cells enhances prognostic precision in smoldering adult T-cell leukemia\/lymphoma","journal":"Haematologica","issue":"2025 Apr 30. doi: 10.3324\/haematol.2025.287521. Online ahead of print.","author":"Saito M, Sato T, Hasegawa H, Tanabe K, Yoshida-Furihata H, Horibe E, Coler-Reilly A, Nojiri N, Yamauchi S, Nakashima M, Araya N, Yagishita N, Takahashi K, Sasaki D, Sagara Y, Uchimaru K, Utsunomiya A, Ki-Ryang K, Kato T, Itonaga H, Miyazaki Y, Yanagihara K, Oshima K, Arai A, Watanabe T, Yamano Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40304064"},{"title01":"Anaplastic large cell lymphoma in children and adolescents","title02":"Anaplastic large cell lymphoma in children and adolescents","journal":"Br J Haematol","issue":"2025 May 12. doi: 10.1111\/bjh.20154. Online ahead of print.","author":"Lowe EJ, Woessmann W.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40351161"},{"title01":"Forecasting optimal treatments in relapsed\/refractory mature T- and NK-cell lymphomas: A global PETAL Consortium study","title02":"Forecasting optimal treatments in relapsed\/refractory mature T- and NK-cell lymphomas: A global PETAL Consortium study","journal":"Br J Haematol","issue":"2025 May 1. doi: 10.1111\/bjh.20063. Online ahead of print.","author":"Sorial MN, Han JX, Koh MJ, Boussi L, Li S, Duan R, Lu J, Lei MM, MacVicar CT, Freydman J, Malespini J, Aniagboso KN, McCabe SM, Peng L, Singh S, Iwasaki M, Eche-Ugwu IJ, Gabler J, Fernandez Turizo MJ, Garg A, Disciullo A, Chopra K, Ford J, Lenart A, Nwodo E, Barnes J, Koh MJ, Miranda E, Chiattone C, Stuver R, Merrill M, Jacobsen E, Manni M, Civallero M, Skrypets T, Lymboussaki A, Federico M, Kim Y, Kim JS, Cho JY, Eipe T, Shet T, Epari S, Shetty A, Saha S, Jain H, Sengar M, Van Der Weyden C, Prince HM, Hamouche R, Murdashvili T, Foss F, Gentilini M, Casadei B, Zinzani PL, Okatani T, Yoshida N, Yoon SE, Kim WS, Panchoo G, Mohamed Z, Verburgh E, Alturas JC, Al-Mansour M, Cabrera ME, Ku A, Bhagat G, Ma H, Sawas A, Kariya KM, Bhanushali F, Meharwal A, Mistry D, Kosovsky M, Yeterian M, O'Connor OA, Marchi E, Shen C, Shah D, Jain S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40310502"},{"title01":"Distinct characteristics and social determinants in adult T-cell leukaemia\/lymphoma patients at a tertiary cancer centre in Canada","title02":"Distinct characteristics and social determinants in adult T-cell leukaemia\/lymphoma patients at a tertiary cancer centre in Canada","journal":"Br J Haematol","issue":"2025 May 6. doi: 10.1111\/bjh.20132. Online ahead of print.","author":"Aoki T, Salib M, Suleman A, Ghanem N, Hong M, Boriano A, Vijenthira A, Prica A, Kuruvilla J, Kukreti V, Crump M, Kridel R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40328512"},{"title01":"An international real-world study of primary vitreoretinal lymphoma from the Australasian lymphoma alliance and collaborators","title02":"An international real-world study of primary vitreoretinal lymphoma from the Australasian lymphoma alliance and collaborators","journal":"Br J Haematol","issue":"2025 May 6. doi: 10.1111\/bjh.20115. Online ahead of print.","author":"Tang C, Downie C, Sagoo MS, Pringle E, Suleman A, Lewis KL, Zhang L, Quinn D, Poon LM, Hann W, Cherepanoff S, Coyle L, Kassam S, McKay P, Cheah CY, Prica A, Smith J, Hamad N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40328516"},{"title01":"Ciclosporin A potentiates venetoclax efficacy in FLT3-ITD AML by targeting the NFATC1-AKT-mTOR-BCL-2\/MCL-1 signaling axis","title02":"Ciclosporin A potentiates venetoclax efficacy in FLT3-ITD AML by targeting the NFATC1-AKT-mTOR-BCL-2\/MCL-1 signaling axis","journal":"Br J Haematol","issue":"2025 May 6. doi: 10.1111\/bjh.20137. Online ahead of print.","author":"Luo Y, Fu Y, Kuang M, Wang J, Zhao R, Luo S, Wang L, Chen J, Xu S, Zhou C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40328636"},{"title01":"Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed\/refractory B non-Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA group","title02":"Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed\/refractory B non-Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA group","journal":"Br J Haematol","issue":"2025 Apr 26. doi: 10.1111\/bjh.20109. Online ahead of print.","author":"Herbaux C, Bachy E, Bouabdallah R, Guidez S, Casasnovas O, Feugier P, Damaj G, Tilly H, Ysebaert L, Le Gouill S, Morineau N, Gyan E, Gressin R, Houot R, Cheminant M, Morschhauser F, Thieblemont C, Haioun C, Nicolas-Virelizier E, Fornecker LM, Daguindau N, Cartron G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40285420"},{"title01":"Aberrant antioxidant responses in B-cell non-Hodgkin lymphoma","title02":"Aberrant antioxidant responses in B-cell non-Hodgkin lymphoma","journal":"Br J Haematol","issue":"2025 Apr 30. doi: 10.1111\/bjh.20108. Online ahead of print.","author":"Vallet N, Picou F, Arbion F, Doyen H, Gyan E, H\u00e9rault O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40307193"},{"title01":"A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Circulating Tumor DNA","title02":"A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Circulating Tumor DNA","journal":"Blood","issue":"2025 May 13:blood.2024027355. doi: 10.1182\/blood.2024027355. Online ahead of print.","author":"Pirosa MC, Bruscaggin A, Terzi di Bergamo L, Salehi M, Jauk F, Forestieri G, Bocchetta S, Piffaretti D, Moia R, Cristaldi V, di Trani M, Galimberti GA, Pini K, Spina V, Giordano C, Condoluci A, Romano I, Annunziata S, Bergesio F, Boldorini R, Borsatti E, Bulian P, Calabretta E, Chauvie S, Corrado F, Crisci S, Cuzzocrea M, De Filippi R, Gerber B, Kurlapski M, Larocca LM, Merlo E, Rinaldi A, Rodari M, Romanowicz G, Sacchetti GM, Stathis A, Stussi G, Zangrilli I, Pinto A, Mazzucchelli L, Gattei V, Zaucha JM, Santoro A, Hohaus S, Cavalli F, Tzankov A, Carlo-Stella C, Gaidano G, Ceriani L Prof, Zucca E, Rossi D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40359477"},{"title01":"Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment","title02":"Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment","journal":"Blood","issue":"2025 May 13:blood.2024027877. doi: 10.1182\/blood.2024027877. Online ahead of print.","author":"Pelzl R, Benintende G, Gsottberger F, Scholz JK, Ruebner M, Yao H, Wendland K, Rejeski K, Altmann H, Petkovic S, Mellenthin L, K\u00fcbel S, Schmiedeberg M, Klein P, Petrera A, Baur R, Eckstein S, Hoepffner-Grundy S, R\u00f6llig C, Subklewe M, Huebner H, Schett G, Mackensen A, Laurenti L, Graw F, V\u00f6lkl S, Nganou-Makamdop K, M\u00fcller F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40359478"},{"title01":"When lymphoma mimics adenocarcinoma: signet ring morphology in follicular lymphoma","title02":"When lymphoma mimics adenocarcinoma: signet ring morphology in follicular lymphoma","journal":"Blood","issue":"2025 May 1;145(18):2104.","author":"Parisi X, Medeiros LJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40310656"},{"title01":"Class struggle in DLBCL","title02":"Class struggle in DLBCL","journal":"Blood","issue":"2025 May 1;145(18):1967-1969.","author":"Krupka JA, Hodson DJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40310657"},{"title01":"The specific transcriptional profile and clonal selection of monoclonal gammopathy of undetermined significance-like behavior predict an exceptionally favorable prognosis in multiple myeloma","title02":"The specific transcriptional profile and clonal selection of monoclonal gammopathy of undetermined significance-like behavior predict an exceptionally favorable prognosis in multiple myeloma","journal":"Haematologica","issue":"2025 Apr 24. doi: 10.3324\/haematol.2025.287523. Online ahead of print.","author":"Yan W, Qiu C, Zhou J, Xu J, Cui J, Liu Y, Du C, Yu T, Zhang S, Sui W, Deng S, Xu Y, Zou D, Yuan W, Qiu L, Hao M, Chu Y, An G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40270198"},{"title01":"Prognostic and biological characteristics associated with multiple myeloma presenting only with anemia","title02":"Prognostic and biological characteristics associated with multiple myeloma presenting only with anemia","journal":"Haematologica","issue":"2025 Apr 30. doi: 10.3324\/haematol.2024.286457. Online ahead of print.","author":"Shamir G, Rouvio O, Reiner-Benaim A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40304075"},{"title01":"A rare complication during autologous stem cell transplantation in multiple myeloma","title02":"A rare complication during autologous stem cell transplantation in multiple myeloma","journal":"Br J Haematol","issue":"2025 May 7. doi: 10.1111\/bjh.20130. Online ahead of print.","author":"Tomarchio V, Faiella E, Tafuri M, Armiento D, Rigacci L, Annibali O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40338808"},{"title01":"Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells","title02":"Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells","journal":"Blood","issue":"2025 May 13:blood.2024025536. doi: 10.1182\/blood.2024025536. Online ahead of print.","author":"Kasap C, Izgutdina A, Pati\u00f1o-Escobar B, Kang AS, Chilakapati N, Akagi N, Manoj AM, Johnson H, Rashid T, Werner J, Barpanda A, Geng H, Lin YT, Rampersaud S, Gil-Al\u00f3s D, Sobh A, Dup\u00e9r\u00e9-Richer D, Aleman A, Wicaksono G, Kelii KMK, Dalal R, Ramos E, Vijayanarayanan A, Lakhani K, Salangsang F, Phojanakong P, Camara Serrano JA, Zakraoui O, Tariq I, Chari A, Chung A, Kumar AD, Martin T, Wolf JL, Wong S, Steri V, Shanmugam M, Boise LH, Kortemme T, Parekh S, Stieglitz E, Licht JD, Karlon W, Barwick BG, Wiita A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40359480"},{"title01":"A phase 2 randomized study of modakafusp alfa as a single agent in patients with relapsed\/refractory multiple myeloma","title02":"A phase 2 randomized study of modakafusp alfa as a single agent in patients with relapsed\/refractory multiple myeloma","journal":"Blood","issue":"2025 Apr 25:blood.2024027873. doi: 10.1182\/blood.2024027873. Online ahead of print.","author":"Holstein SA, Atrash S, Mian H, Dimopoulos MA, Schjesvold F, Popat R, Shah N, Gatt ME, Gocke CB, Frenzel L, Touzeau C, Beksac M, Manier S, Magen H, Travis P, Nadeem O, Suryanarayan K, Li C, Li S, Nelson A, Cherepanov D, Parot X, Vogl DT.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40279508"},{"title01":"The mitochondrial protease ClpP is a metabolic vulnerability and an immunogenic trigger against multiple myeloma","title02":"The mitochondrial protease ClpP is a metabolic vulnerability and an immunogenic trigger against multiple myeloma","journal":"Blood","issue":"2025 Apr 29:blood.2024026340. doi: 10.1182\/blood.2024026340. Online ahead of print.","author":"Perini T, Zordan P, Del Pizzo R, Resnati M, Viviani L, Stefanoni D, Cassina L, Orfanelli UP, Trudu M, Oliva L, Lacidogna D, Samur MK, Materozzi M, Drago D, Andolfo A, Patrone M, Degano M, Boletta A, Milan E, Ciceri F, Munshi NC, Bellone M, Cenci S MD.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40300074"},{"title01":"Updated recommendations for the management of hepatitis B, C, and E virus infections in patients with haematological malignancies and those undergoing haematopoietic cell transplantation: recommendations from the 9th European Conference on Infections in Leukaemia (ECIL-9)","title02":"Updated recommendations for the management of hepatitis B, C, and E virus infections in patients with haematological malignancies and those undergoing haematopoietic cell transplantation: recommendations from the 9th European Conference on Infections in Leukaemia (ECIL-9)","journal":"Lancet Haematol","issue":"2025 May;12(5):e389-e399.","author":"Mikulska M, van B\u00f6mmel F, Mouliade C, Indolfi G, Kefalakes H, von Lilienfeld-Toal M, Pischke S, Hermine O, Moradpour D, Wedemeyer H, Berg T, Ljungman P, Mallet V.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40306834"},{"title01":"Age-related prognoses of genetic subtypes in B-cell acute lymphoblastic leukemia\/lymphoma (B-ALL): insights from a decade of national data","title02":"Age-related prognoses of genetic subtypes in B-cell acute lymphoblastic leukemia\/lymphoma (B-ALL): insights from a decade of national data","journal":"Leukemia","issue":"2025 Apr 24. doi: 10.1038\/s41375-025-02588-5. Online ahead of print.","author":"Zhou T, Short NJ, Jain N, Patel KP, Jabbour EJ, Kantarjian HM, Medeiros LJ, Iorgulescu JB.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40275068"},{"title01":"Possible impacts of cosmic radiation on leukemia development during human deep space exploration","title02":"Possible impacts of cosmic radiation on leukemia development during human deep space exploration","journal":"Leukemia","issue":"2025 Apr 24. doi: 10.1038\/s41375-025-02624-4. Online ahead of print.","author":"Ghani F, Zubair AC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40275072"},{"title01":"Prognostic impact of clonal representation of myelodysplasia-related gene mutations in acute myeloid leukemia","title02":"Prognostic impact of clonal representation of myelodysplasia-related gene mutations in acute myeloid leukemia","journal":"Leukemia","issue":"2025 Apr 28. doi: 10.1038\/s41375-025-02622-6. Online ahead of print.","author":"Mecklenbrauck R, Borchert N, Gabdoulline R, Poll P, Funke C, Brandes M, Dallmann LK, Fiedler W, Krauter J, Trummer A, Hertenstein B, M\u00fcller M, L\u00fcbbert M, Schwalenberg M, Voss A, Di Donato N, Bergmann A, Gaidzik V, D\u00f6hner K, D\u00f6hner H, Ganser A, Heidel FH, Thol FR, Heuser M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40295828"},{"title01":"Wnt5a induces ROR1 dependent NF-\u03baB activation to enhance MMP-9 expression and invasiveness in chronic lymphocytic leukemia","title02":"Wnt5a induces ROR1 dependent NF-\u03baB activation to enhance MMP-9 expression and invasiveness in chronic lymphocytic leukemia","journal":"Leukemia","issue":"2025 Apr 28. doi: 10.1038\/s41375-025-02616-4. Online ahead of print.","author":"Hasan MK, Widhopf Ii GF, Ghia EM, Kipps TJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40295829"},{"title01":"Molecular monitoring versus standard clinical care in younger adults with acute myeloid leukaemia: results from the UK NCRI AML17 and AML19 randomised, controlled, phase 3 trials","title02":"Molecular monitoring versus standard clinical care in younger adults with acute myeloid leukaemia: results from the UK NCRI AML17 and AML19 randomised, controlled, phase 3 trials","journal":"Lancet Haematol","issue":"2025 May;12(5):e346-e356.","author":"Potter N, Jovanovic J, Ivey A, Othman J, Thomas A, Gilkes A, Runglall M, Kanda A, Thomas I, Johnson S, Canham J, Villiers W, Knapper S, Khwaja A, McMullin MF, Cavenagh J, Overgaard UM, Clark RE, Solomon E, Freeman SD, Hills R, Burnett A, Russell N, Dillon R; UK AML Research Network.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40306832"},{"title01":"Updated recommendations for the management of hepatitis B, C, and E virus infections in patients with haematological malignancies and those undergoing haematopoietic cell transplantation: recommendations from the 9th European Conference on Infections in Leukaemia (ECIL-9)","title02":"Updated recommendations for the management of hepatitis B, C, and E virus infections in patients with haematological malignancies and those undergoing haematopoietic cell transplantation: recommendations from the 9th European Conference on Infections in Leukaemia (ECIL-9)","journal":"Lancet Haematol","issue":"2025 May;12(5):e389-e399.","author":"Mikulska M, van B\u00f6mmel F, Mouliade C, Indolfi G, Kefalakes H, von Lilienfeld-Toal M, Pischke S, Hermine O, Moradpour D, Wedemeyer H, Berg T, Ljungman P, Mallet V.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40306834"},{"title01":"Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children’s Oncology Group","title02":"Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children’s Oncology Group","journal":"J Clin Oncol","issue":"2025 Apr 28:JCO2401841. doi: 10.1200\/JCO-24-01841. Online ahead of print.","author":"Huang BJ, Meyer LK, Alonzo TA, Wang YC, Lamble AJ, Ries RE, Wang W, Hirsch B, Raca G, Ma X, Gamis AS, Aplenc R, Kolb EA, Cooper TM, Tarlock K, Loken MR, Meshinchi S, Chewning JH, Woods WG, Horan JT.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40294366"},{"title01":"Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy","title02":"Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy","journal":"Haematologica","issue":"2025 May 8. doi: 10.3324\/haematol.2025.287433. Online ahead of print.","author":"Webster JA, Reed M, Tsai HL, Imus PH, Smith DB, Ambinder AJ, Levis MJ, DeZern AE, Prince GT, Jain T, Bola\u00f1os-Meade J, Gondek LP, Ghiaur G, Dalton WB, Karantanos T, Paul S, Fuchs EJ, Sterling C, Swinnen LJ, Wagner-Johnston N, Ambinder RF, Gocke CB, Ali SA, Huff CA, Luznik L, Varadhan R, Jones RJ, Gojo I.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40336316"},{"title01":"Targeting leukemic stem cell dormancy in NPM1c\/FLT3-ITD-driven acute myeloid leukemia","title02":"Targeting leukemic stem cell dormancy in NPM1c\/FLT3-ITD-driven acute myeloid leukemia","journal":"Haematologica","issue":"2025 May 8. doi: 10.3324\/haematol.2025.287644. Online ahead of print.","author":"Stelmach P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40336317"},{"title01":"The birth of a paradigm: leukemia-initiating cells in acute myeloid leukemia","title02":"The birth of a paradigm: leukemia-initiating cells in acute myeloid leukemia","journal":"Haematologica","issue":"2025 May 1;110(5):1051-1052.","author":"Cruz-Rodriguez N, Deininger MW.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40321000"},{"title01":"Prophylactic and pre-emptive donor lymphocyte infusion in patients with acute myeloid leukemia and myelodysplastic syndrome: validation of current recommendations and proposal of a modified outcome assessment","title02":"Prophylactic and pre-emptive donor lymphocyte infusion in patients with acute myeloid leukemia and myelodysplastic syndrome: validation of current recommendations and proposal of a modified outcome assessment","journal":"Haematologica","issue":"2025 Apr 24. doi: 10.3324\/haematol.2024.287206. Online ahead of print.","author":"Vel\u00e1zquez GF, Weller JF, Rubeck A, Arndt T, Schiele S, Mezger M, Lengerke C, Bethge W, Trepel M, M\u00fcller G, Christopeit M, Schmid C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40270206"},{"title01":"Optimizing olverembatinib dose in chronic phase chronic myeloid leukemia","title02":"Optimizing olverembatinib dose in chronic phase chronic myeloid leukemia","journal":"Haematologica","issue":"2025 Apr 30. doi: 10.3324\/haematol.2024.287116. Online ahead of print.","author":"Zhang X, Yang Y, Liu B, Du X, Wang X, Zhu H, Yu L, Li Z, Zhao S, Yang L, Ma Y, Meng L, Zhang Y, Li G, Yang L, Wang B, Ran X, Huang J, Gao N, Wen Q, Wen Y, Zhao Y, Zhu Y, Han Y, Liu Z, Du X, Weng J, Gale RP, Zhou L, Zhang Y, Jiang Q.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40304058"},{"title01":"Different features of acute myeloid leukemia stem cell quantification in intensively treated patients","title02":"Different features of acute myeloid leukemia stem cell quantification in intensively treated patients","journal":"Haematologica","issue":"2025 Apr 30. doi: 10.3324\/haematol.2024.287090. Online ahead of print.","author":"Ngai LL, Reuvekamp T, Hanekamp D, Janssen F, Marsbergen LO, Carbaat-Ham J, Hofland MAM, Fayed MMHE, Kelder A, Scholten WJ, Snel AN, Bachas C, Tettero JM, Breems DA, Fischer T, Gjertsen BT, Gri\u0161kevi\u010dius L, Juliusson G, Van de Loosdrecht AA, Maertens JA, Manz MG, Pabst T, Passweg JR, Porkka K, Valk PJM, Gradowska P, L\u00f6wenberg B, Ossenkoppele GJ, De Leeuw DC, Cloos J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40304060"},{"title01":"Clonality analysis of HTLV-1-infected cells enhances prognostic precision in smoldering adult T-cell leukemia\/lymphoma","title02":"Clonality analysis of HTLV-1-infected cells enhances prognostic precision in smoldering adult T-cell leukemia\/lymphoma","journal":"Haematologica","issue":"2025 Apr 30. doi: 10.3324\/haematol.2025.287521. Online ahead of print.","author":"Saito M, Sato T, Hasegawa H, Tanabe K, Yoshida-Furihata H, Horibe E, Coler-Reilly A, Nojiri N, Yamauchi S, Nakashima M, Araya N, Yagishita N, Takahashi K, Sasaki D, Sagara Y, Uchimaru K, Utsunomiya A, Ki-Ryang K, Kato T, Itonaga H, Miyazaki Y, Yanagihara K, Oshima K, Arai A, Watanabe T, Yamano Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40304064"},{"title01":"Genomic variant profiling in blast-phase paediatric chronic myeloid leukaemia: Predisposing and driving alterations","title02":"Genomic variant profiling in blast-phase paediatric chronic myeloid leukaemia: Predisposing and driving alterations","journal":"Br J Haematol","issue":"2025 May 8. doi: 10.1111\/bjh.20133. Online ahead of print.","author":"Behrens YL, Reinkens T, Hofmann W, Gumann A, F\u00f6rster A, Gaschler L, Ghete T, Strasser R, Espenk\u00f6tter J, Haermeyer B, Losch M, Sembill S, Wotschofsky Z, von H\u00f6rsten S, Schuh W, Di Donato N, Suttorp M, Krumbholz M, Ripperger T, Schlegelberger B, G\u00f6hring G, Metzler M, Karow A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40344211"},{"title01":"The role of blinatumomab in adult acute B lymphoblastic leukaemia","title02":"The role of blinatumomab in adult acute B lymphoblastic leukaemia","journal":"Br J Haematol","issue":"2025 May 14. doi: 10.1111\/bjh.20134. Online ahead of print.","author":"Wilke AC, G\u00f6kbuget N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40368871"},{"title01":"Global spatiotemporal distribution characteristics and regional risk stratification model of acute myeloid leukaemia based on molecular genetics and cytogenetic features","title02":"Global spatiotemporal distribution characteristics and regional risk stratification model of acute myeloid leukaemia based on molecular genetics and cytogenetic features","journal":"Br J Haematol","issue":"2025 May 5. doi: 10.1111\/bjh.20138. Online ahead of print.","author":"Xiao J, Xia Y, Yin F, Shi Z, Meng G, Ye J, Sun T, Ji C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40325927"},{"title01":"Distinct characteristics and social determinants in adult T-cell leukaemia\/lymphoma patients at a tertiary cancer centre in Canada","title02":"Distinct characteristics and social determinants in adult T-cell leukaemia\/lymphoma patients at a tertiary cancer centre in Canada","journal":"Br J Haematol","issue":"2025 May 6. doi: 10.1111\/bjh.20132. Online ahead of print.","author":"Aoki T, Salib M, Suleman A, Ghanem N, Hong M, Boriano A, Vijenthira A, Prica A, Kuruvilla J, Kukreti V, Crump M, Kridel R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40328512"},{"title01":"Ciclosporin A potentiates venetoclax efficacy in FLT3-ITD AML by targeting the NFATC1-AKT-mTOR-BCL-2\/MCL-1 signaling axis","title02":"Ciclosporin A potentiates venetoclax efficacy in FLT3-ITD AML by targeting the NFATC1-AKT-mTOR-BCL-2\/MCL-1 signaling axis","journal":"Br J Haematol","issue":"2025 May 6. doi: 10.1111\/bjh.20137. Online ahead of print.","author":"Luo Y, Fu Y, Kuang M, Wang J, Zhao R, Luo S, Wang L, Chen J, Xu S, Zhou C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40328636"},{"title01":"Cord blood transplants: Advancing leukaemia treatments and addressing health disparities","title02":"Cord blood transplants: Advancing leukaemia treatments and addressing health disparities","journal":"Br J Haematol","issue":"2025 May;206(5):1312-1314.","author":"Scaradavou A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40275775"},{"title01":"Blastic erythrophagocytosis in monocytic AML with translocation t(8;22)","title02":"Blastic erythrophagocytosis in monocytic AML with translocation t(8;22)","journal":"Br J Haematol","issue":"2025 May;206(5):1270-1271.","author":"Faucheux L, Voirin E, Rault E, Herault O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40301671"},{"title01":"From prognostication to precision in acute myeloid leukemia","title02":"From prognostication to precision in acute myeloid leukemia","journal":"Blood","issue":"2025 May 8;145(19):2105-2106.","author":"Hourigan CS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40338575"},{"title01":"STING activation enhances immunotherapy of AML","title02":"STING activation enhances immunotherapy of AML","journal":"Blood","issue":"2025 May 8;145(19):2106-2108.","author":"Kabelitz D, Chitadze G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40338576"},{"title01":"GATA 2 much: stemness and resistance in AML chemotherapy","title02":"GATA 2 much: stemness and resistance in AML chemotherapy","journal":"Blood","issue":"2025 May 8;145(19):2110-2112.","author":"Mercher T, Arcangeli ML.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40338577"},{"title01":"How I Treat: Revisiting the myth of second remission in acute lymphoblastic leukemia in the era of immunotherapy","title02":"How I Treat: Revisiting the myth of second remission in acute lymphoblastic leukemia in the era of immunotherapy","journal":"Blood","issue":"2025 May 12:blood.2024027267. doi: 10.1182\/blood.2024027267. Online ahead of print.","author":"Aldoss I, Clark MC, Forman SJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40354576"},{"title01":"How I approach hematopoietic stem cell transplantation for CML in a TKI world","title02":"How I approach hematopoietic stem cell transplantation for CML in a TKI world","journal":"Blood","issue":"2025 May 12:blood.2024026512. doi: 10.1182\/blood.2024026512. Online ahead of print.","author":"Chalandon Y, Simonetta F, Masouridi-Levrat S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40354577"},{"title01":"Transcriptional remodeling shapes therapeutic vulnerability to necroptosis in acute lymphoblastic leukemia","title02":"Transcriptional remodeling shapes therapeutic vulnerability to necroptosis in acute lymphoblastic leukemia","journal":"Blood","issue":"2025 May 13:blood.2025028938. doi: 10.1182\/blood.2025028938. Online ahead of print.","author":"Saorin A, Dehler A, Galvan B, Steffen FD, Ray M, Lu D, Yu X, Kim J, Drakul A, Kisele S, Wang J, Bourquin JP, Bornhauser B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40359431"},{"title01":"Mixed-phenotype acute leukemia revisited: omics lead the way","title02":"Mixed-phenotype acute leukemia revisited: omics lead the way","journal":"Blood","issue":"2025 May 1;145(18):1969-1971.","author":"Bullinger L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40310658"},{"title01":"Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study","title02":"Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study","journal":"Blood","issue":"2025 May 7:blood.2025028357. doi: 10.1182\/blood.2025028357. Online ahead of print.","author":"Arellano ML, Thirman MJ, DiPersio JF, Heiblig M, Stein EM, Schuh AC, Zucenka A, De Botton S, Grove CS, Mannis GN, Papayannidis C, Perl AE, Issa GC, Aldoss I, Bajel A, Dickens DS, K\u00fchn MWM, Mantzaris I, Raffoux E, Traer E, Amitai I, D\u00f6hner H, Greco C, Kovacsovics TJ, McMahon CM, Montesinos P, Pigneux A, Shami PJ, Stone RM, Wolach O, Harpel JG, Chudnovsky Y, Yu L, Bagley RG, Smith AR, Blachly JS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40332046"},{"title01":"Ph-Positive Acute Lymphoblastic Leukemia – 25 Years of Progress","title02":"Ph-Positive Acute Lymphoblastic Leukemia – 25 Years of Progress","journal":"N Engl J Med","issue":"2025 May 15;392(19):1941-1952.","author":"Fo\u00e0 R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40367376"},{"title01":"Regulation of H3K4me3 breadth and MYC expression by the SETD1B catalytic domain in MLL-rearranged leukemia","title02":"Regulation of H3K4me3 breadth and MYC expression by the SETD1B catalytic domain in MLL-rearranged leukemia","journal":"Leukemia","issue":"2025 May 8. doi: 10.1038\/s41375-025-02638-y. Online ahead of print.","author":"Izumi S, Ohtani K, Matsumoto M, Shibata S, Rahmutulla B, Fukuyo M, Nishimoto M, Miyagawa H, Sakaida E, Yokote K, Kitabayashi I, Araki K, Kaneda A, Hoshii T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40341256"},{"title01":"Acute myeloid leukemia stem cells remodel the bone marrow niche via TGF-\u03b2-activated Alcam(+) bone lining cells, creating a self-sustaining environment","title02":"Acute myeloid leukemia stem cells remodel the bone marrow niche via TGF-\u03b2-activated Alcam(+) bone lining cells, creating a self-sustaining environment","journal":"Leukemia","issue":"2025 May 13. doi: 10.1038\/s41375-025-02640-4. Online ahead of print.","author":"Nguyen NTK, Yao H, Hosokawa K, Esaki Y, Yuta R, Adachi S, Arai F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40360881"},{"title01":"National cancer system metrics and leukemia outcomes: an analysis of global data for pediatric and adult patients","title02":"National cancer system metrics and leukemia outcomes: an analysis of global data for pediatric and adult patients","journal":"Leukemia","issue":"2025 Apr 23. doi: 10.1038\/s41375-025-02598-3. Online ahead of print.","author":"Wu JF, Feliciano EJG, Singh A, Tremblay D, Abid MB, Dee EC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40269270"},{"title01":"Asparaginase dosing for acute lymphoblastic leukemia: more questions than answers","title02":"Asparaginase dosing for acute lymphoblastic leukemia: more questions than answers","journal":"Haematologica","issue":"2025 Apr 24. doi: 10.3324\/haematol.2025.287429. Online ahead of print.","author":"Orgel E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40270204"},{"title01":"Recycling is “bad to the bone” in patients with myeloma","title02":"Recycling is “bad to the bone” in patients with myeloma","journal":"Blood","issue":"2025 Apr 24;145(17):1832-1833.","author":"Miller KC, Lesokhin AM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40272858"},{"title01":"Targetable Mutations in BRAF V600E-Negative Hairy-Cell Leukemia","title02":"Targetable Mutations in BRAF<\/i> V600E-Negative Hairy-Cell Leukemia","journal":"N Engl J Med","issue":"2025 Apr 10;392(14):1451-1452.","author":"Santi A, Venanzi A, Pucciarini A, Schiavoni G, Naccari M, Albi E, De Paoli L, Intermesoli T, Lazzi S, Conte E, Mancini A, Falini B, Gozzetti A, D'Elia GM, Genua A, Tiacci E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40214038"},{"title01":"Remission induction in refractory, drug resistant pediatric PICALM::MLLT10+\u2009B-cell acute lymphoblastic leukemia by venetoclax","title02":"Remission induction in refractory, drug resistant pediatric PICALM::MLLT10<\/i>+\u2009B-cell acute lymphoblastic leukemia by venetoclax","journal":"Leukemia","issue":"2025 Apr 15. doi: 10.1038\/s41375-025-02591-w. Online ahead of print.","author":"Niedermayer A, Stursberg J, Bergmann AK, Zimmermann M, Cario G, Br\u00fcggemann M, K\u00f6hler R, Steinbach D, Reimann C, Seyfried F, Meyer LH, Debatin KM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40234615"},{"title01":"Reduced incidence of relapse and graft-versus-host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantation","title02":"Reduced incidence of relapse and graft-versus<\/i>-host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantation","journal":"Haematologica","issue":"2025 Apr 10. doi: 10.3324\/haematol.2025.287390. Online ahead of print.","author":"Kim HT, Soiffer RJ, Cutler C, Koreth J, Nikiforow S, Shapiro RM, Kelkar A, Gooptu M, Romee R, Wu CJ, Antin JH, Ritz J, Ho VT.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40207714"},{"title01":"A phase II study of ponatinib for prevention of relapse after allotransplantation in FLT3 internal tandem duplication mutation positive (FLT3-ITD+) acute myeloid leukemia: the PONALLO trial","title02":"A phase II study of ponatinib for prevention of relapse after allotransplantation in FLT3<\/i> internal tandem duplication mutation positive (FLT3-ITD+) acute myeloid leukemia: the PONALLO trial","journal":"Haematologica","issue":"2025 Apr 17. doi: 10.3324\/haematol.2025.287681. Online ahead of print.","author":"Chevallier P, Thiebaut A, Fran\u00e7ois S, Chantepie S, Rubio MT, Labussiere-Wallet H, Brissot E, Maillard N, Huynh A, Coiteux V, Jullien M, Garnier A, Le Bourgeois A, Peterlin P, Guillaume T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40241541"},{"title01":"Impact of MYD88 and\/or CD79B mutations on central nervous system relapse in patients with diffuse large B-cell lymphoma","title02":"Impact of MYD88<\/i> and\/or CD79B<\/i> mutations on central nervous system relapse in patients with diffuse large B-cell lymphoma","journal":"Br J Haematol","issue":"2025 Apr 22. doi: 10.1111\/bjh.20099. Online ahead of print.","author":"Suzuki T, Fujii K, Matsunaga N, Sasaki H, Kanamori T, Asano A, Kinoshita S, Narita T, Masaki A, Sanda T, Ri M, Kusumoto S, Komatsu H, Iida S, Inagaki H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40263702"},{"title01":"An oncolytic adenovirus targeting SLAMF7 demonstrates anti-myeloma efficacy","title02":"An oncolytic adenovirus targeting SLAMF7<\/i> demonstrates anti-myeloma efficacy","journal":"Leukemia","issue":"2025 Apr 17. doi: 10.1038\/s41375-025-02617-3. Online ahead of print.","author":"Stewart G, Tazzyman S, Sun Y, Andrews RE, Harrison J, Lath D, Down J, Robinson G, Wang X, Muthana M, Chantry AD, Lawson MA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40247106"},{"title01":"Age-related mesenchymal stromal cell senescence is associated with progression from MGUS to multiple myeloma","title02":"Age-related mesenchymal stromal cell senescence is associated with progression from MGUS to multiple myeloma","journal":"Leukemia","issue":"2025 Apr 22. doi: 10.1038\/s41375-025-02621-7. Online ahead of print.","author":"Plakhova N, Panagopoulos V, Cantley MD, Trainor LJ, Hewett DR, Clark KC, Gardiner J, Yong A, Lee C, Horvath N, Croucher PI, Cakouros D, Stewart SA, Gronthos S, Zannettino ACW, Mrozik KM, Vandyke K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40263435"},{"title01":"Bortezomib, melphalan, and prednisone with or without daratumumab in transplant-ineligible patients with newly diagnosed multiple myeloma (ALCYONE): final analysis of an open-label, randomised, multicentre, phase 3 trial","title02":"Bortezomib, melphalan, and prednisone with or without daratumumab in transplant-ineligible patients with newly diagnosed multiple myeloma (ALCYONE): final analysis of an open-label, randomised, multicentre, phase 3 trial","journal":"Lancet Oncol","issue":"2025 Apr 9:S1470-2045(25)00018-X. doi: 10.1016\/S1470-2045(25)00018-X. Online ahead of print.","author":"Mateos MV, San-Miguel J, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Pour L, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Yoon SS, Iosava G, Fujisaki T, Garg M, Ngo M, Katz EG, Krevvata M, Bolyard K, Carson R, Borgsten F, Dimopoulos MA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40220771"},{"title01":"Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trial","title02":"Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trial","journal":"Lancet Haematol","issue":"2025 Apr 11:S2352-3026(25)00048-1. doi: 10.1016\/S2352-3026(25)00048-1. Online ahead of print.","author":"Xia J, Sun Q, Zhou D, Li H, Wang Y, Qi Y, Cao J, Yan Z, Li D, Cheng H, Sang W, Zhu F, Sun H, Chen W, Qi K, Yan D, Qiu T, Hu T, Gu W, Qian J, Xia F, Qi N, Jin C, Liu Y, Wang X, Zhang Y, Peng S, Li Z, Chang AH, Xu K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40228504"},{"title01":"Sequential CAR T-cell therapy in myeloma: going from BCMA to GPRC5D","title02":"Sequential CAR T-cell therapy in myeloma: going from BCMA to GPRC5D","journal":"Lancet Haematol","issue":"2025 Apr 11:S2352-3026(25)00074-2. doi: 10.1016\/S2352-3026(25)00074-2. Online ahead of print.","author":"van de Donk NWCJ, Fernandez de Larrea C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40228505"},{"title01":"Teclistamab versus B-cell maturation antigen-targeting chimeric antigen receptor T-cell therapy in multiple myeloma: a comparative effectiveness analysis","title02":"Teclistamab versus B-cell maturation antigen-targeting chimeric antigen receptor T-cell therapy in multiple myeloma: a comparative effectiveness analysis","journal":"Haematologica","issue":"2025 Apr 10. doi: 10.3324\/haematol.2024.287215. Online ahead of print.","author":"Song J, Chiang CH, Esagian S, Kim G, Chi KY, Chang Y, Parker T, Mehta AK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40207713"},{"title01":"Prognostic value of minimal residual disease detected by EuroFlow next-generation flow cytometry and next-generation sequencing in patients with multiple myeloma achieving complete response and receiving lenalidomide maintenance after autotransplant: a prospective comparison study","title02":"Prognostic value of minimal residual disease detected by EuroFlow next-generation flow cytometry and next-generation sequencing in patients with multiple myeloma achieving complete response and receiving lenalidomide maintenance after autotransplant: a prospective comparison study","journal":"Haematologica","issue":"2025 Apr 17. doi: 10.3324\/haematol.2025.287411. Online ahead of print.","author":"Yoroidaka T, Takamatsu H, Urushihara R, Itagaki M, Yoshihara S, Sato K, Takezako N, Ozaki S, Suzuki K, Kohno K, Muta T, Matsumoto M, Terasaki Y, Yamashita T, Fuchida SI, Sakamoto J, Ishida T, Suzuki K, Murakami H, Durie BGM, Shimizu K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40241540"},{"title01":"Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma","title02":"Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma","journal":"Haematologica","issue":"2025 Apr 17. doi: 10.3324\/haematol.2024.287047. Online ahead of print.","author":"Quist-Lokken I, Tilseth M, Andersson-Rusch C, Hanif MA, Walz M, Moen JFN, Vik MA, Slordahl TS, Sundan A, Hausch F, Holien T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40241574"},{"title01":"Multiple myeloma with 1q gain\/amplification exhibits reduced CD38 expression via interleukin-6 receptor overexpression","title02":"Multiple myeloma with 1q gain\/amplification exhibits reduced CD38 expression via interleukin-6 receptor overexpression","journal":"Br J Haematol","issue":"2025 Apr 22. doi: 10.1111\/bjh.20106. Online ahead of print.","author":"Kuroki W, Kitadate A, Takahashi Y, Iwama S, Yamada M, Kobayashi T, Ikeda S, Narita K, Matsue K, Takahashi N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40259818"},{"title01":"Enhancing risk stratification and treatment decision in multiple myeloma with SKY92 gene expression profiling in real-world data","title02":"Enhancing risk stratification and treatment decision in multiple myeloma with SKY92 gene expression profiling in real-world data","journal":"Br J Haematol","issue":"2025 Apr 15. doi: 10.1111\/bjh.20050. Online ahead of print.","author":"Biran N, Dhakal B, Niesvizky R, Lentzsch S, Bhutani D, McKay JT, Vesole DH, Nooka A, Paul B, Hari PN, D'Ambrosi S, Kuiper R, van Vliet M, Siegel D, Usmani SZ, van Rhee F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40231946"},{"title01":"The decline of transplant for relapsed myeloma","title02":"The decline of transplant for relapsed myeloma","journal":"Blood","issue":"2025 Apr 17;145(16):1711-1712.","author":"Perrot A, Touzeau C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40244643"},{"title01":"Daratumumab: a game changer in early myeloma","title02":"Daratumumab: a game changer in early myeloma","journal":"Blood","issue":"2025 Apr 10;145(15):1595-1596.","author":"Mateos MV, Gonz\u00e1lez-Calle V.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40208649"},{"title01":"Reduced incidence of relapse and graft-versus-host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantation","title02":"Reduced incidence of relapse and graft-versus<\/i>-host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantation","journal":"Haematologica","issue":"2025 Apr 10. doi: 10.3324\/haematol.2025.287390. Online ahead of print.","author":"Kim HT, Soiffer RJ, Cutler C, Koreth J, Nikiforow S, Shapiro RM, Kelkar A, Gooptu M, Romee R, Wu CJ, Antin JH, Ritz J, Ho VT.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40207714"},{"title01":"Reduced incidence of relapse and graft-versus-host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantation","title02":"Reduced incidence of relapse and graft-versus<\/i>-host disease in acute myeloid leukemia after allogeneic hematopoietic cell transplantation","journal":"Haematologica","issue":"2025 Apr 10. doi: 10.3324\/haematol.2025.287390. Online ahead of print.","author":"Kim HT, Soiffer RJ, Cutler C, Koreth J, Nikiforow S, Shapiro RM, Kelkar A, Gooptu M, Romee R, Wu CJ, Antin JH, Ritz J, Ho VT.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40207714"},{"title01":"How low can we go? Comparison of liberal and restrictive red cell transfusion thresholds in paediatric allogeneic haematopoietic stem cell transplantation: A randomized multicentre feasibility trial","title02":"How low can we go? Comparison of liberal and restrictive red cell transfusion thresholds in paediatric allogeneic haematopoietic stem cell transplantation: A randomized multicentre feasibility trial","journal":"Br J Haematol","issue":"2025 Apr 21. doi: 10.1111\/bjh.20051. Online ahead of print.","author":"New HV, Sanderson E, Hopkins V, Thomas H, Gassas A, Adams M, Gibson B, Patrick K, Wynn R, Hoole L, Smethurst H, Lobo-Clarke M, Smith L, Mora A, Stanworth SJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40258687\/"},{"title01":"Heterogeneity of high-potency multilineage hematopoietic stem cells and identification of ‘Super’ transplantability","title02":"Heterogeneity of high-potency multilineage hematopoietic stem cells and identification of ‘Super’ transplantability","journal":"Blood","issue":"2025 Apr 21:blood.2024027872. doi: 10.1182\/blood.2024027872. Online ahead of print.","author":"Dong F, Zhang S, Zhu C, Yang Z, Wang L, Ma Y, Lu J, Li X, Wang X, Wang N, Zhang S, Xie M, Wang J, Zhang X, Zheng Y, Ma S, Ema H, Cheng H, Hao S, Suda T, Lan Y, Liu B, Zhu P, Chen J, Cheng T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40258179"},{"title01":"An unbiased genomewide screen uncovers 7 genes that drive hematopoietic stem cell fate from mouse embryonic stem cells","title02":"An unbiased genomewide screen uncovers 7 genes that drive hematopoietic stem cell fate from mouse embryonic stem cells","journal":"Blood","issue":"2025 Apr 10:blood.2024027742. doi: 10.1182\/blood.2024027742. Online ahead of print.","author":"Palma LG PhD, Kartha GM, Maqueda M, Barrero M, Canton E, Iglesias A, Gonzalez Miranda J, Herrero Molinero P, Torres-Ru\u00edz R, Payer B, Bueno C, Menendez P, Espinosa L, Bigas A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40209065"},{"title01":"Interferon-\u03b3-mediated selective inhibition of hematopoiesis and the clonal advantage of HLA-lacking hematopoietic stem progenitor cells in aplastic anemia","title02":"Interferon-\u03b3-mediated selective inhibition of hematopoiesis and the clonal advantage of HLA-lacking hematopoietic stem progenitor cells in aplastic anemia","journal":"Leukemia","issue":"2025 Apr 11. doi: 10.1038\/s41375-025-02595-6. Online ahead of print.","author":"Takahashi R, Takahashi H, Seoka L, Iwasaki H, Takamatsu H, Imi T, Zaimoku Y, Hosokawa K, Katagiri T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40217071"},{"title01":"Optimizing CRISPR methodology for precise gene editing in the erythroid cell line BEL-A with high efficiency generation of a sickle cell anemia model","title02":"Optimizing CRISPR methodology for precise gene editing in the erythroid cell line BEL-A with high efficiency generation of a sickle cell anemia model","journal":"Haematologica","issue":"2025 Apr 10. doi: 10.3324\/haematol.2024.287221. Online ahead of print.","author":"Daniels DE, Hawksworth J, El Hoss S, Oyawoye FO, Ferrer-Vicens I, Wilson MC, Frayne J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40207730"},{"title01":"Comparison of severe aplastic anaemia and lower risk hypoplastic myelodysplastic neoplasms: Critical role of megakaryocyte count in distinguishing aplastic anaemia from myelodysplastic neoplasms","title02":"Comparison of severe aplastic anaemia and lower risk hypoplastic myelodysplastic neoplasms: Critical role of megakaryocyte count in distinguishing aplastic anaemia from myelodysplastic neoplasms","journal":"Br J Haematol","issue":"2025 Apr 22. doi: 10.1111\/bjh.20097. Online ahead of print.","author":"Maeda T, Matsuda A, Kanda J, Kawabata H, Ishikawa T, Tohyama K, Kitanaka A, Araseki K, Shimbo K, Hata T, Suzuki T, Kayano H, Usuki K, Shindo-Ueda M, Arima N, Nohgawa M, Ohta A, Chiba S, Miyazaki Y, Nakao S, Ozawa K, Arai S, Kurokawa M, Takaori-Kondo A, Mitani K; Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40259860"},{"title01":"PF4 promotes CXCR3+ Tfh1 cell differentiation through STAT1 in mouse immune thrombocytopenia","title02":"PF4 promotes CXCR3+<\/sup> Tfh1 cell differentiation through STAT1 in mouse immune thrombocytopenia","journal":"Br J Haematol","issue":"2025 Apr 16. doi: 10.1111\/bjh.20090. Online ahead of print.","author":"Hai L, Zheng Y, Yang Z, Wu S, Lv Y, Cui D, Xie J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40235276"},{"title01":"Impact of myelodysplasia-related gene mutations and residual mutations at remission in venetoclax\/azacitidine for AML","title02":"Impact of myelodysplasia-related gene mutations and residual mutations at remission in venetoclax\/azacitidine for AML","journal":"Leukemia","issue":"2025 Apr 21. doi: 10.1038\/s41375-025-02625-3. Online ahead of print.","author":"Ikoma Y, Nakamura N, Kaneda Y, Takamori H, Seki T, Hiramoto N, Kitagawa J, Kanda J, Fujita K, Morishita T, Ochi Y, Chiba S, Sasaki N, Ichii M, Imada K, Watanabe M, Hishizawa M, Miyahara Y, Maesako Y, Tanaka Y, Oka S, Tsuji M, Yoshihara S, Mitani K, Ueda Y, Kitano T, Watanabe M, Sezaki N, Kondo T, Kasahara S, Takaori-Kondo A, Kanemura N, Ogawa S, Nannya Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40259101"},{"title01":"Loss of NOL10 leads to impaired disease progression of NUP98::DDX10 leukemia","title02":"Loss of NOL10 leads to impaired disease progression of NUP98::DDX10 leukemia","journal":"Leukemia","issue":"2025 Apr 22. doi: 10.1038\/s41375-025-02607-5. Online ahead of print.","author":"Shima Y, Yamagata K, Kuroki Y, Sasaki K, Aikawa Y, Kitabayashi I.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40263434"},{"title01":"Fabp4 is essential for the maintenance of leukemia stem cells while sparing hematopoietic stem cells","title02":"Fabp4 is essential for the maintenance of leukemia stem cells while sparing hematopoietic stem cells","journal":"Leukemia","issue":"2025 Apr 10. doi: 10.1038\/s41375-025-02568-9. Online ahead of print.","author":"Xing C, Zhang H, Zheng M, Lu Q, Tao Y, Xu S, Xiao Y, Liang L, Xu H, Xu S, Peng H, Sheng Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40210768"},{"title01":"All genetic subtypes of B-cell acute lymphoblastic leukemia exhibit increased incidence rates in children with Down syndrome","title02":"All genetic subtypes of B-cell acute lymphoblastic leukemia exhibit increased incidence rates in children with Down syndrome","journal":"Leukemia","issue":"2025 Apr 11. doi: 10.1038\/s41375-025-02602-w. Online ahead of print.","author":"Hsu CJ, Schraw JM, Desrosiers TA, Janitz AE, Kirby RS, Nestoridi E, Nembhard WN, Salemi JL, Shumate C, Tanner JP, Yazdy MM, Scheurer ME, Rabin KR, Lupo PJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40217070"},{"title01":"Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial","title02":"Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial","journal":"Leukemia","issue":"2025 Apr 16. doi: 10.1038\/s41375-025-02608-4. Online ahead of print.","author":"Ashaye A, Shi L, Aldoss I, Montesinos P, Vachhani P, Rocha V, Papayannidis C, Leonard JT, Baer MR, Ribera JM, McCloskey J, Wang J, Gao S, Rane D, Guo S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40240572"},{"title01":"Acute pro-B-cell lymphoblastic leukemia evolving from myelodysplastic neoplasm post cytotoxic therapy: a case report","title02":"Acute pro-B-cell lymphoblastic leukemia evolving from myelodysplastic neoplasm post cytotoxic therapy: a case report","journal":"Haematologica","issue":"2025 Apr 10. doi: 10.3324\/haematol.2025.287357. Online ahead of print.","author":"Wobst J, Truger M, Baer C, Meggendorfer M, Kern W, Haferlach T, Haferlach C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40207709"},{"title01":"KMT2A-rearranged acute lymphoblastic leukemia in infants: current progress and challenges","title02":"KMT2A-rearranged acute lymphoblastic leukemia in infants: current progress and challenges","journal":"Haematologica","issue":"2025 Apr 10. doi: 10.3324\/haematol.2024.285642. Online ahead of print.","author":"Stutterheim J, Van der Sluis IM, Vrenken KS, Pieters R, Stam RW.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40207717"},{"title01":"Outcomes and treatment patterns in primary and secondary plasma cell leukemia: insights from a large US cohort study","title02":"Outcomes and treatment patterns in primary and secondary plasma cell leukemia: insights from a large US cohort study","journal":"Haematologica","issue":"2025 Apr 17. doi: 10.3324\/haematol.2024.287158. Online ahead of print.","author":"Singh S, Peshin S, Wertheim BC, Larsen A, Chineke I, Sborov DW, Green D, Liedtke M, Okoniewski M, Wazir M, Nadeem O, Schachter LG, DeGraaff D, Vardell VA, Coffey DG, Gowin K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40241568"},{"title01":"A rare case of nodal hairy cell leukemia exhibiting characteristic morphological and immunohistochemical features","title02":"A rare case of nodal hairy cell leukemia exhibiting characteristic morphological and immunohistochemical features","journal":"Blood","issue":"2025 Apr 17;145(16):1826.","author":"Chakraborty SR, Karrs JX.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40244637"},{"title01":"Early T-precursor acute lymphoblastic leukemia with mature plasmacytoid dendritic cell proliferation","title02":"Early T-precursor acute lymphoblastic leukemia with mature plasmacytoid dendritic cell proliferation","journal":"Blood","issue":"2025 Apr 17;145(16):1827.","author":"Podvin B, Hardeman A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40244639"},{"title01":"SMAC mimetics in action in chronic myeloid leukemia","title02":"SMAC mimetics in action in chronic myeloid leukemia","journal":"Blood","issue":"2025 Apr 10;145(15):1596-1597.","author":"Turhan AG.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40208653"},{"title01":"ZUMA-8: A Phase 1 Study of Brexucabtagene Autoleucel in Patients With Relapsed\/Refractory Chronic Lymphocytic Leukemia","title02":"ZUMA-8: A Phase 1 Study of Brexucabtagene Autoleucel in Patients With Relapsed\/Refractory Chronic Lymphocytic Leukemia","journal":"Blood","issue":"2025 Apr 10:blood.2024027460. doi: 10.1182\/blood.2024027460. Online ahead of print.","author":"Davids MS, Kenderian SS, Flinn IW, Hill BT, Maris MB, Ghia P, Byrne MT, Bartlett NL, Pagel J, Zheng Y, Kanska J, Zhang W, Granados E, Pinilla-Ibarz J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40209059"},{"title01":"Doubling down: the new deal in the clinical management of double-refractory chronic lymphocytic leukaemia","title02":"Doubling down: the new deal in the clinical management of double-refractory chronic lymphocytic leukaemia","journal":"Blood","issue":"2025 Apr 10:blood.2024024893. doi: 10.1182\/blood.2024024893. Online ahead of print.","author":"Grainger BT, Thompson PA, Cheah CY.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40209064"},{"title01":"The ENHANCE-3 study: venetoclax and azacitidine plus magrolimab or placebo for untreated AML unfit for intensive therapy","title02":"The ENHANCE-3 study: venetoclax and azacitidine plus magrolimab or placebo for untreated AML unfit for intensive therapy","journal":"Blood","issue":"2025 Apr 15:blood.2024027506. doi: 10.1182\/blood.2024027506. Online ahead of print.","author":"Daver NG, Vyas P, Huls GA, D\u00f6hner H, Maury S, Novak J, Papayannidis C, Martinez Chamorro C, Montesinos P, Niroula R, Fenaux P, Esteve J, Wu SJ, De Voeght A, Mayer J, Valk PJM, Johnson L, Dong M, Liu K, Kuwahara SB, Caldwell K, Guru Murthy GS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40233321"},{"title01":"How I individualize treatment for chronic-phase CML","title02":"How I individualize treatment for chronic-phase CML","journal":"Blood","issue":"2025 Apr 16:blood.2024026508. doi: 10.1182\/blood.2024026508. Online ahead of print.","author":"Leyte-Vidal AM, Shah NP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40239150"},{"title01":"The effect of ibrutinib on the myeloid cell compartment in CNS lymphoma","title02":"The effect of ibrutinib on the myeloid cell compartment in CNS lymphoma","journal":"Leukemia","issue":"2025 Apr 10. doi: 10.1038\/s41375-025-02600-y. Online ahead of print.","author":"Kuehn JC, Neidert NN, Zhang J, Mutter J, Alig S, Klingler C, Hummel F, Ranganathan L, Bleul S, Beck J, Prinz M, Diehn M, Alizadeh A, Duyster J, Sankowski R, Heiland DH, Scherer F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40210767"},{"title01":"Molecular landscape of distinct follicular lymphoma histologic grades: insights from genomic and transcriptome analyses","title02":"Molecular landscape of distinct follicular lymphoma histologic grades: insights from genomic and transcriptome analyses","journal":"Leukemia","issue":"2025 Apr 15. doi: 10.1038\/s41375-025-02603-9. Online ahead of print.","author":"Sun C, Li W, Yu J, Zhang T, Gong W, Liu H, Gao F, Song Z, Li L, Qiu L, Qian Z, Zhou S, Meng B, Gao Y, Li J, Liu X, Ren W, Pan-Hammarstr\u00f6m Q, Wang X, Zhang H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40234612"},{"title01":"Dynamic change in Epstein-Barr virus DNA predicts prognosis in early stage natural killer\/T-cell lymphoma with pegaspargase-based treatment: long-term follow-up and biomarker analysis from the NHL-004 multicenter randomized study","title02":"Dynamic change in Epstein-Barr virus DNA predicts prognosis in early stage natural killer\/T-cell lymphoma with pegaspargase-based treatment: long-term follow-up and biomarker analysis from the NHL-004 multicenter randomized study","journal":"Haematologica","issue":"2025 Apr 10. doi: 10.3324\/haematol.2025.287513. Online ahead of print.","author":"Zhong H, Cheng S, Xiong J, Chen J, Mu R, Yang H, Yi H, Song Q, Zhang H, Hu Y, Cui G, Wei J, Zhang X, Xu B, Qian W, Huang X, Hou M, Yan F, Wang X, Song Y, Liu Y, Ma X, Hu J, Li F, Wu C, Chen J, Yu L, Bai O, Xu J, Zhu Z, Liu L, Zhou X, Huang L, Tong Y, Niu T, Wu D, Jiang X, Wang C, Ouyang B, Cai G, Li B, Liu J, Li Z, Xiao R, Wang L, Jiang Y, Liu Y, Zheng X, Xu P, Wang L, Chen S, Zhao WL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40207715"},{"title01":"Evorpacept plus rituximab for the treatment of relapsed or refractory non-Hodgkin lymphoma: results from the phase I ASPEN-01 study","title02":"Evorpacept plus rituximab for the treatment of relapsed or refractory non-Hodgkin lymphoma: results from the phase I ASPEN-01 study","journal":"Haematologica","issue":"2025 Apr 10. doi: 10.3324\/haematol.2024.286208. Online ahead of print.","author":"Kim TM, Lakhani NJ, Soumerai J, Kamdar M, Gainor JF, Messersmith W, Fanning P, Guan S, Jin F, Forgie A, Wan HI, Pons J, Randolph SS, Kim WS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40207726"},{"title01":"An oncolytic vaccinia virus expressing anti-CD47 nanobody exerts enhanced antitumor activity by mediating innate and adaptive immune cell infiltration and activation in the lymphoma tumor microenvironment","title02":"An oncolytic vaccinia virus expressing anti-CD47 nanobody exerts enhanced antitumor activity by mediating innate and adaptive immune cell infiltration and activation in the lymphoma tumor microenvironment","journal":"Haematologica","issue":"2025 Apr 10. doi: 10.3324\/haematol.2024.286923. Online ahead of print.","author":"Li M, Zhang Y, Zong L, Zhang M, Wang S, Lei W, Qian W.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40207734"},{"title01":"Resource-adapted strategies in the management of paediatric Burkitt lymphoma in low- and middle-income country setting and outcomes: An Indian centre experience","title02":"Resource-adapted strategies in the management of paediatric Burkitt lymphoma in low- and middle-income country setting and outcomes: An Indian centre experience","journal":"Br J Haematol","issue":"2025 Apr 22. doi: 10.1111\/bjh.20093. Online ahead of print.","author":"Nirmal G, Thankamony P, Nair RA, Nair M, Rajeswari B, Guruprasad CS, Prasanth VR, Jacob PM, Krishna KMJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40260587"},{"title01":"Temporal trends in relative survival of diffuse large B-cell lymphoma in Sweden and Denmark in the era of targeted and cellular therapies","title02":"Temporal trends in relative survival of diffuse large B-cell lymphoma in Sweden and Denmark in the era of targeted and cellular therapies","journal":"Br J Haematol","issue":"2025 Apr 23. doi: 10.1111\/bjh.20104. Online ahead of print.","author":"Harrysson S, Eloranta S, Antonilli S, Runason Simonsen M, Sonnevi K, Brown P, Wahlin BE, Andersson PO, J\u00f8rgensen JM, Jerkeman M, Poulsen CB, Enblad G, El-Galaly TC, Smedby KE.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40266666"},{"title01":"Understandings 18 FDG PET radiomics and its application to lymphoma","title02":"Understandings 18 FDG PET radiomics and its application to lymphoma","journal":"Br J Haematol","issue":"2025 Apr 15. doi: 10.1111\/bjh.20074. Online ahead of print.","author":"Ceriani L, Milan L, Chauvie S, Zucca E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40230306"},{"title01":"Dual targeting of EZH2 and DOT1L in DLBCL","title02":"Dual targeting of EZH2 and DOT1L in DLBCL","journal":"Blood","issue":"2025 Apr 17;145(16):1714-1715. doi: 10.1182\/blood.2024027324.","author":"Moreaux J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40244641"},{"title01":"Appearances deceive: unmasking mantle cell lymphoma with prolymphocytic morphology","title02":"Appearances deceive: unmasking mantle cell lymphoma with prolymphocytic morphology","journal":"Blood","issue":"2025 Apr 10;145(15):1701.","author":"Marco-Ayala J, Ortu\u00f1o FJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40208646"},{"title01":"CD3\u00d7CD20 bispecifics\u00a0+ chemotherapy: good news for R\/R DLBCL","title02":"CD3\u00d7CD20 bispecifics\u00a0+ chemotherapy: good news for R\/R DLBCL","journal":"Blood","issue":"2025 Apr 10;145(15):1591-1592.","author":"Carlo-Stella C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40208652"},{"title01":"GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party","title02":"GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party","journal":"Leukemia","issue":"2025 Apr 17. doi: 10.1038\/s41375-025-02619-1. Online ahead of print.","author":"Penack O, Abouqateb M, Peczynski C, Boreland W, Benakli M, Kr\u00f6ger N, Blau IW, Blaise D, Sanz J, Eder M, Ozdogu H, Schneidawind D, Broers AEC, Wulf GG, Mussetti A, Moiseev I, Graham C, Schoemans H, Peric Z.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40247107"},{"title01":"Bortezomib, melphalan, and prednisone with or without daratumumab in transplant-ineligible patients with newly diagnosed multiple myeloma (ALCYONE): final analysis of an open-label, randomised, multicentre, phase 3 trial","title02":"Bortezomib, melphalan, and prednisone with or without daratumumab in transplant-ineligible patients with newly diagnosed multiple myeloma (ALCYONE): final analysis of an open-label, randomised, multicentre, phase 3 trial","journal":"Lancet Oncol","issue":"2025 Apr 9:S1470-2045(25)00018-X. doi: 10.1016\/S1470-2045(25)00018-X. Online ahead of print.","author":"Mateos MV, San-Miguel J, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Pour L, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Yoon SS, Iosava G, Fujisaki T, Garg M, Ngo M, Katz EG, Krevvata M, Bolyard K, Carson R, Borgsten F, Dimopoulos MA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40220771"},{"title01":"Need for VA-ECMO after heart transplantation with HOPE","title02":"Need for VA-ECMO after heart transplantation with HOPE","journal":"Lancet","issue":"2025 Apr 19;405(10487):1341-1342.","author":"Gonzalez-Costello J, Patel SR, Jorde UP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40253097"},{"title01":"Need for VA-ECMO after heart transplantation with HOPE – Authors’ reply","title02":"Need for VA-ECMO after heart transplantation with HOPE – Authors’ reply","journal":"Lancet","issue":"2025 Apr 19;405(10487):1342.","author":"Rega F, Lebreton G, Dellgren G, Wallinder A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40253098"},{"title01":"A taste of your own medicine: the experience of a transplant","title02":"A taste of your own medicine: the experience of a transplant","journal":"Lancet","issue":"2025 Apr 12;405(10486):1220-1221.","author":"Carel H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40221153"},{"title01":"Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized Controlled Clinical Trial","title02":"Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized Controlled Clinical Trial","journal":"J Clin Oncol","issue":"2025 Apr 15:JCO2402119. doi: 10.1200\/JCO-24-02119. Online ahead of print.","author":"Yao H, Huang R, Fu H, Lin R, Zhang Y, Feng Y, Wang Y, Chen T, Wang X, Zhu L, Liu J, Liu Y, Zhao L, Wang L, Kong P, Wen Q, Zhang C, Gao L, Gao L, Liu Q, Zhang X, Huang X, Zhang X.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40233291"},{"title01":"Two heads are better than one: a synergistic strategy for conquering graft-versus-host disease","title02":"Two heads are better than one: a synergistic strategy for conquering graft-versus-host disease","journal":"Haematologica","issue":"2025 Apr 17. doi: 10.3324\/haematol.2025.287776. Online ahead of print.","author":"Stolz D, Giesler S, Zeiser R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40241575"},{"title01":"How low can we go? Comparison of liberal and restrictive red cell transfusion thresholds in paediatric allogeneic haematopoietic stem cell transplantation: A randomized multicentre feasibility trial","title02":"How low can we go? Comparison of liberal and restrictive red cell transfusion thresholds in paediatric allogeneic haematopoietic stem cell transplantation: A randomized multicentre feasibility trial","journal":"Br J Haematol","issue":"2025 Apr 21. doi: 10.1111\/bjh.20051. Online ahead of print.","author":"New HV, Sanderson E, Hopkins V, Thomas H, Gassas A, Adams M, Gibson B, Patrick K, Wynn R, Hoole L, Smethurst H, Lobo-Clarke M, Smith L, Mora A, Stanworth SJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40258687"},{"title01":"The decline of transplant for relapsed myeloma","title02":"The decline of transplant for relapsed myeloma","journal":"Blood","issue":"2025 Apr 17;145(16):1711-1712.","author":"Perrot A, Touzeau C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40244643"},{"title01":"Heterogeneity of high-potency multilineage hematopoietic stem cells and identification of ‘Super’ transplantability","title02":"Heterogeneity of high-potency multilineage hematopoietic stem cells and identification of ‘Super’ transplantability","journal":"Blood","issue":"2025 Apr 21:blood.2024027872. doi: 10.1182\/blood.2024027872. Online ahead of print.","author":"Dong F, Zhang S, Zhu C, Yang Z, Wang L, Ma Y, Lu J, Li X, Wang X, Wang N, Zhang S, Xie M, Wang J, Zhang X, Zheng Y, Ma S, Ema H, Cheng H, Hao S, Suda T, Lan Y, Liu B, Zhu P, Chen J, Cheng T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40258179"},{"title01":"Hitting the bullseye in GVHD","title02":"Hitting the bullseye in GVHD","journal":"Blood","issue":"2025 Apr 10;145(15):1598-1599.","author":"Teshima T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40208654"},{"title01":"GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party","title02":"GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party","journal":"Leukemia","issue":"2025 Apr 17. doi: 10.1038\/s41375-025-02619-1. Online ahead of print.","author":"Penack O, Abouqateb M, Peczynski C, Boreland W, Benakli M, Kr\u00f6ger N, Blau IW, Blaise D, Sanz J, Eder M, Ozdogu H, Schneidawind D, Broers AEC, Wulf GG, Mussetti A, Moiseev I, Graham C, Schoemans H, Peric Z.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40247107"},{"title01":"Fabp4 is essential for the maintenance of leukemia stem cells while sparing hematopoietic stem cells","title02":"Fabp4 is essential for the maintenance of leukemia stem cells while sparing hematopoietic stem cells","journal":"Leukemia","issue":"2025 Apr 10. doi: 10.1038\/s41375-025-02568-9. Online ahead of print.","author":"Xing C, Zhang H, Zheng M, Lu Q, Tao Y, Xu S, Xiao Y, Liang L, Xu H, Xu S, Peng H, Sheng Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40210768"},{"title01":"Interferon-\u03b3-mediated selective inhibition of hematopoiesis and the clonal advantage of HLA-lacking hematopoietic stem progenitor cells in aplastic anemia","title02":"Interferon-\u03b3-mediated selective inhibition of hematopoiesis and the clonal advantage of HLA-lacking hematopoietic stem progenitor cells in aplastic anemia","journal":"Leukemia","issue":"2025 Apr 11. doi: 10.1038\/s41375-025-02595-6. Online ahead of print.","author":"Takahashi R, Takahashi H, Seoka L, Iwasaki H, Takamatsu H, Imi T, Zaimoku Y, Hosokawa K, Katagiri T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40217071"},{"title01":"Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized Controlled Clinical Trial","title02":"Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized Controlled Clinical Trial","journal":"J Clin Oncol","issue":"2025 Apr 15:JCO2402119. doi: 10.1200\/JCO-24-02119. Online ahead of print.","author":"Yao H, Huang R, Fu H, Lin R, Zhang Y, Feng Y, Wang Y, Chen T, Wang X, Zhu L, Liu J, Liu Y, Zhao L, Wang L, Kong P, Wen Q, Zhang C, Gao L, Gao L, Liu Q, Zhang X, Huang X, Zhang X.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40233291"},{"title01":"Genome-edited peripheral blood stem cell-derived erythroid progenitor-4 cell line as the unique and beneficial panel cell for antibody identification","title02":"Genome-edited peripheral blood stem cell-derived erythroid progenitor-4 cell line as the unique and beneficial panel cell for antibody identification","journal":"Haematologica","issue":"2025 Apr 10. doi: 10.3324\/haematol.2024.287187. Online ahead of print.","author":"Funato K, Kikuchi G, Maebara K, Kurita R, Isa K, Miyazaki T, Okuda M, Miyata S, Satake M, Tani Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40207710"},{"title01":"T-cell acute lymphoblastic leukaemia: subtype prevalence, clinical outcome, and emerging targeted treatments","title02":"T-cell acute lymphoblastic leukaemia: subtype prevalence, clinical outcome, and emerging targeted treatments","journal":"Leukemia","issue":"2025 Apr 17. doi: 10.1038\/s41375-025-02599-2. Online ahead of print.","author":"Buckley M, Yeung DT, White DL, Eadie LN.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40247105"},{"title01":"Prognostic scoring systems in chronic myeloid leukaemia","title02":"Prognostic scoring systems in chronic myeloid leukaemia","journal":"Leukemia","issue":"2025 Apr 15. doi: 10.1038\/s41375-025-02606-6. Online ahead of print.","author":"Lauseker M, Hoffmann VS, Pfirrmann M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40234613"},{"title01":"Dual STAT3\/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia","title02":"Dual STAT3\/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia","journal":"Leukemia","issue":"2025 Apr 15. doi: 10.1038\/s41375-025-02577-8. Online ahead of print.","author":"Dechow A, Timonen S, Ianevski A, Jiang Q, Wahnschaffe L, Peng Y, Jungherz D, Becker K, Neubauer HA, Sch\u00f6nefeldt S, de Araujo E, Gunning P, Fleck R, Schrader A, Hallek M, Pflug N, Moriggl R, Aittokallio T, Mustjoki S, Braun T, Herling M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40234614"},{"title01":"Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1(T315I) treated with at least 2 prior TKIs: Phase 1 final results","title02":"Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1(T315I)<\/i> treated with at least 2 prior TKIs: Phase 1 final results","journal":"Leukemia","issue":"2025 Apr 9. doi: 10.1038\/s41375-025-02578-7. Online ahead of print.","author":"Hochhaus A, Kim DW, Cortes JE, Sasaki K, Mauro MJ, Hughes TP, Breccia M, Talpaz M, Minami H, Goh YT, DeAngelo DJ, Lang F, Ottmann O, Heinrich MC, Gomez Garcia de Soria V, le Coutre P, Sanchez-Olle G, Cao M, Pognan N, Kapoor S, Hoch M, Rea D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40204892"},{"title01":"DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition","title02":"DYRK1A inhibition results in MYC and ERK activation rendering KMT2A<\/i>-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition","journal":"Leukemia","issue":"2025 Mar 27. doi: 10.1038\/s41375-025-02575-w. Online ahead of print.","author":"Ayyadevara VSSA, Wertheim G, Gaur S, Chukinas JA, Loftus JP, Lee SJ, Kumar A, Swaminathan S, Bhansali RS, Childers W, Geng H, Milne TA, Hua X, Bernt KM, Besson T, Shi J, Crispino JD, Carroll M, Tasian SK, Hurtz C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40148558"},{"title01":"Prognostic impacts of RHOA G17V mutation in cell-free DNA assessed by droplet digital polymerase chain reaction in patients with angioimmunoblastic T-cell lymphoma","title02":"Prognostic impacts of RHOA G17V<\/i> mutation in cell-free DNA assessed by droplet digital polymerase chain reaction in patients with angioimmunoblastic T-cell lymphoma","journal":"Br J Haematol","issue":"2025 Apr 7. doi: 10.1111\/bjh.20071. Online ahead of print.","author":"Miao Y, Qian S, Gao L, Zhou Z, Dai L, Sha Y, Lu X, Xia Y, Cao L, Qin S, Fan L, Li J, Zhu H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40195059"},{"title01":"Acalabrutinib-Obinutuzumab Improves Survival vs Chemoimmunotherapy in treatment-naive CLL in the 6-year Follow-up of ELEVATE-TN","title02":"Acalabrutinib-Obinutuzumab Improves Survival vs Chemoimmunotherapy in treatment-naive CLL in the 6-year Follow-up of ELEVATE-TN","journal":"Blood","issue":"2025 Apr 8:blood.2024024476. doi: 10.1182\/blood.2024024476. Online ahead of print.","author":"Sharman JP, Egyed M, Jurczak W, Skarbnik AP, Patel K, Flinn IW, Kamdar M, Munir T, Walewska R, Hughes M, Fogliato LM, Herishanu Y, Banerji V, Follows GA, Walker PA, Ghia P, Janssens AM, Byrd JC, Ferrant EF, Ferrajoli A, Wierda WG, Wachira CW, Suterwala BT, Palhares de Miranda PA, Munugalavadla V, Wun CC, Woyach JA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40198878"},{"title01":"Atypical chronic myeloid leukemia: from cytology to molecular characterization","title02":"Atypical chronic myeloid leukemia: from cytology to molecular characterization","journal":"Blood","issue":"2025 Mar 27;145(13):1438.","author":"Calo-P\u00e9rez A, Mart\u00ednez-Fern\u00e1ndez R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40146153"},{"title01":"Warthin-Finkeldey cells seen in a setting other than measles: chronic lymphocytic leukemia\/small lymphocytic lymphoma","title02":"Warthin-Finkeldey cells seen in a setting other than measles: chronic lymphocytic leukemia\/small lymphocytic lymphoma","journal":"Blood","issue":"2025 Mar 27;145(13):1437.","author":"Bakhshi TJ, Pina-Oviedo S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40146154"},{"title01":"Targeting an AML-sustaining metabolic node","title02":"Targeting an AML-sustaining metabolic node","journal":"Blood","issue":"2025 Mar 27;145(13):1341-1343.","author":"Achyutuni S, Xu J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40146158"},{"title01":"PGE2 inhibition to prevent AML escape from NK cells","title02":"PGE2 inhibition to prevent AML escape from NK cells","journal":"Blood","issue":"2025 Mar 27;145(13):1338-1339.","author":"Simonetta F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40146159"},{"title01":"Efficacy of a Novel BCL-xL Degrader, DT2216, in Preclinical Models of JAK2-mutated Post-MPN AML","title02":"Efficacy of a Novel BCL-xL Degrader, DT2216, in Preclinical Models of JAK2-mutated Post-MPN AML","journal":"Blood","issue":"2025 Mar 31:blood.2024027117. doi: 10.1182\/blood.2024027117. Online ahead of print.","author":"Wang Z, Skwarska A, Poigaialwar G, Chaudhry S, Rodriguez-Meira A, Sui P, Olivier E, Jia Y, Gupta V, Fiskus W, Ramage CL, Zheng G, Schurer A, Gritsman K, Papapetrou EP, Bhalla KN, Zhou D, Mead AJ, Rampal RK, Tyner JW, Abbas HA, Pemmaraju N, Tatarata QZ, Konopleva MY.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40163809"},{"title01":"Emerging T-cell lymphomas after CAR T-cell therapy","title02":"Emerging T-cell lymphomas after CAR T-cell therapy","journal":"Leukemia","issue":"2025 Apr 7. doi: 10.1038\/s41375-025-02574-x. Online ahead of print.","author":"Braun T, Kuschel F, Reiche K, Merz M, Herling M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40195525"},{"title01":"Guiding clinical management of patients with CNS lymphomas by minimal-invasive detection of ctDNA in cerebrospinal fluid","title02":"Guiding clinical management of patients with CNS lymphomas by minimal-invasive detection of ctDNA in cerebrospinal fluid","journal":"Leukemia","issue":"2025 Apr 9. doi: 10.1038\/s41375-025-02583-w. Online ahead of print.","author":"Weinschenk S, Philipp U, Kuehn JC, Mueller K, Fauser J, Boeckle D, Gebhard I, Hinz M, Neidert N, Bleul S, Lauer EM, Mutter JA, Alig SK, Kurtz DM, Finke J, Marks R, Diehn M, Alizadeh AA, Reinacher PC, Wehrle J, Keller U, Wolf D, Kocher F, Chapuy B, Beck J, Prinz M, von Baumgarten L, Schorb E, Duyster J, Scherer F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40204895"},{"title01":"Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden","title02":"Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden","journal":"Leukemia","issue":"2025 Mar 26. doi: 10.1038\/s41375-025-02573-y. Online ahead of print.","author":"Jerkeman M, Mellgren K, Sonnevi K, Lisak M, Lagerl\u00f6f I, Kapas B, Sj\u00f6lund H, Toporski J, Hagberg H, Mielke S, Enblad G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40140632"},{"title01":"Discrete genetic subtypes and tumor microenvironment signatures correlate with peripheral T-cell lymphoma outcomes","title02":"Discrete genetic subtypes and tumor microenvironment signatures correlate with peripheral T-cell lymphoma outcomes","journal":"Leukemia","issue":"2025 Mar 31. doi: 10.1038\/s41375-025-02563-0. Online ahead of print.","author":"Suehara Y, Sakamoto K, Fujisawa M, Fukumoto K, Abe Y, Makishima K, Suma S, Sakamoto T, Hattori K, Sugio T, Kato K, Akashi K, Matsue K, Narita K, Takeuchi K, Carreras J, Nakamura N, Chiba K, Shiraishi Y, Miyano S, Ogawa S, Chiba S, Sakata-Yanagimoto M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40164718"},{"title01":"A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma","title02":"A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma","journal":"Haematologica","issue":"2025 Apr 3. doi: 10.3324\/haematol.2024.287053. Online ahead of print.","author":"Biran N, Zolotov E, Vesole D, Parmar H, Phull P, Doucette K, Roney P, Ahn J, Feinman R, Zenreich J, Anand P, Pace M, Pia AD, DeAgresta B, Biamonte L, Aleman A, Rutanen E, Chappell A, Kumka S, Siegel DS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40176757"},{"title01":"Early identification of functional high-risk multiple myeloma patients after transplant: the predictive power of fat fraction and Response Assessment Category score in diffusion-weighted whole-body magnetic resonance imaging","title02":"Early identification of functional high-risk multiple myeloma patients after transplant: the predictive power of fat fraction and Response Assessment Category score in diffusion-weighted whole-body magnetic resonance imaging","journal":"Haematologica","issue":"2025 Apr 3. doi: 10.3324\/haematol.2025.287409. Online ahead of print.","author":"Belotti A, Frittoli B, Terlizzi S, Ribolla R, Crippa C, Saeli C, Ferrari S, Bianchetti N, Bottelli C, Cattaneo C, Carbone C, Gullino A, Chiarini M, Giustini V, Roccaro A, Grazioli L, Tucci A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40176762"},{"title01":"Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant response","title02":"Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant response","journal":"Br J Haematol","issue":"2025 Mar 30. doi: 10.1111\/bjh.20062. Online ahead of print.","author":"Pasvolsky O, Abid MB, Milton DR, Tanner MR, Bashir Q, Srour S, Saini N, Jatoi A, Khan HN, Lin P, Ramdial J, Nieto Y, Tang G, Siddiqui U, Aljawai Y, Kebriaei P, Lee HC, Patel KK, Gaballa MR, Thomas SK, Orlowski RZ, Champlin RE, Shpall EJ, Qazilbash MH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40159289"},{"title01":"Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma","title02":"Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma","journal":"Blood","issue":"2025 Apr 7:blood.2024027674. doi: 10.1182\/blood.2024027674. Online ahead of print.","author":"Giri S, Dhakal B, Callander NS, Medvedova E, Godby K, Dholaria B, Bal S, Ravi G, Chhabra S, Silbermann R, Costa LJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40193714"},{"title01":"A phase 1 trial of fully human BCMA CAR-T therapy for relapsed\/refractory multiple myeloma with 5-year follow-up","title02":"A phase 1 trial of fully human BCMA CAR-T therapy for relapsed\/refractory multiple myeloma with 5-year follow-up","journal":"Blood","issue":"2025 Apr 8:blood.2024027681. doi: 10.1182\/blood.2024027681. Online ahead of print.","author":"Tuazon SA, Portuguese AJ, Pont MJ, Cowan AJ, Cole GO, Sather BD, Song X, Thomas S, Wood BL, Blake ML, Works MG, Shadman M, Liang EC, Wu Q, Voutsinas JM, Gooley TA, Turtle CJ, Till BG, Coffey DG, Maloney DG, Riddell SR, Green DJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40198877"},{"title01":"Standard-of-Care Idecabtagene Vicleucel for Relapsed\/Refractory Multiple Myeloma: A CIBMTR Analysis","title02":"Standard-of-Care Idecabtagene Vicleucel for Relapsed\/Refractory Multiple Myeloma: A CIBMTR Analysis","journal":"Blood","issue":"2025 Apr 8:blood.2024026216. doi: 10.1182\/blood.2024026216. Online ahead of print.","author":"Sidana S, Ahmed N, Akhtar OS, Brazauskas R, Oloyede T, Bye M, Hansen DK, Ferreri CJ, Freeman CL, Afrough A, Anderson LD Jr, Dhakal B, Dhanda DS, Gowda L, Hashmi H, Harrison MJ, Kitali A, Landau HJ, Mirza AS, Patwardhan P, Qazilbash MH, Usmani SZ, Patel KK, Nishihori T, Ganguly S, Pasquini MC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40198886"},{"title01":"Hallmarks of terminal T-cell exhaustion are absent in multiple myeloma from diagnosis through maintenance therapy","title02":"Hallmarks of terminal T-cell exhaustion are absent in multiple myeloma from diagnosis through maintenance therapy","journal":"Blood","issue":"2025 Mar 31:blood.2024025655. doi: 10.1182\/blood.2024025655. Online ahead of print.","author":"Shasha C, Glass DR, Moelhman E, Islas L, Tian Y, Chour T, Xu G, Szeto GL, Peng T, Song X, Wurscher M, Cowan AJ, Bumol TF, Torgerson TR, Greenberg PD, Green DJ, Newell EW.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40163891"},{"title01":"Establishment of a haematopoietic cell transplantation programme for children with sickle cell disease in Tanzania","title02":"Establishment of a haematopoietic cell transplantation programme for children with sickle cell disease in Tanzania","journal":"Lancet Haematol","issue":"2025 Apr;12(4):e244-e245.","author":"Giglio F, Malangahe S, Jumanne S, Mhozya M, Chandika A, Uderzo C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40174999"},{"title01":"Early identification of functional high-risk multiple myeloma patients after transplant: the predictive power of fat fraction and Response Assessment Category score in diffusion-weighted whole-body magnetic resonance imaging","title02":"Early identification of functional high-risk multiple myeloma patients after transplant: the predictive power of fat fraction and Response Assessment Category score in diffusion-weighted whole-body magnetic resonance imaging","journal":"Haematologica","issue":"2025 Apr 3. doi: 10.3324\/haematol.2025.287409. Online ahead of print.","author":"Belotti A, Frittoli B, Terlizzi S, Ribolla R, Crippa C, Saeli C, Ferrari S, Bianchetti N, Bottelli C, Cattaneo C, Carbone C, Gullino A, Chiarini M, Giustini V, Roccaro A, Grazioli L, Tucci A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40176762"},{"title01":"Hematopoietic cell transplants for acute leukemias","title02":"Hematopoietic cell transplants for acute leukemias","journal":"Haematologica","issue":"2025 Apr 1;110(4):817-818.","author":"Gale RP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40165731"},{"title01":"Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant response","title02":"Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant response","journal":"Br J Haematol","issue":"2025 Mar 30. doi: 10.1111\/bjh.20062. Online ahead of print.","author":"Pasvolsky O, Abid MB, Milton DR, Tanner MR, Bashir Q, Srour S, Saini N, Jatoi A, Khan HN, Lin P, Ramdial J, Nieto Y, Tang G, Siddiqui U, Aljawai Y, Kebriaei P, Lee HC, Patel KK, Gaballa MR, Thomas SK, Orlowski RZ, Champlin RE, Shpall EJ, Qazilbash MH.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40159289"},{"title01":"Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis","title02":"Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis","journal":"Blood","issue":"2025 Mar 27:blood.2024027287. doi: 10.1182\/blood.2024027287. Online ahead of print.","author":"Hernandez-Boluda JC, Mosquera Orgueira A Dr, Gras L, Koster L, Tuffnell J, Kr\u00f6ger N, Gambella M, Schroeder T, Robin M, Sockel K, Passweg JR, Blau IW, Yakoub-Agha I, Van Dijck R, Stelljes M, Sengeloev H, Vydra J, Platzbecker U, Dewitte M, Baron F, Carlson K, Rojas Mart\u00ednez JA, P\u00e9rez M\u00edguez C, Crucitti D, Raj K, Drozd-Sokolowska J, Battipaglia G, Polverelli N, Czerw T, McLornan DP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40145857"},{"title01":"Taming JAK cytokine release in haplo-transplant","title02":"Taming JAK cytokine release in haplo-transplant","journal":"Blood","issue":"2025 Mar 27;145(13):1336-1338.","author":"von Bubnoff N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40146157"},{"title01":"Current landscape of vector safety and genotoxicity after hematopoietic stem or immune cell gene therapy","title02":"Current landscape of vector safety and genotoxicity after hematopoietic stem or immune cell gene therapy","journal":"Leukemia","issue":"2025 Apr 8. doi: 10.1038\/s41375-025-02585-8. Online ahead of print.","author":"Ottaviano G, Qasim W.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40200078"},{"title01":"Immune checkpoints regulate acute myeloid leukemia stem cells","title02":"Immune checkpoints regulate acute myeloid leukemia stem cells","journal":"Leukemia","issue":"2025 Apr 2. doi: 10.1038\/s41375-025-02566-x. Online ahead of print.","author":"Reinhardt C, Ochsenbein AF.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40175626"},{"title01":"Establishment of a haematopoietic cell transplantation programme for children with sickle cell disease in Tanzania","title02":"Establishment of a haematopoietic cell transplantation programme for children with sickle cell disease in Tanzania","journal":"Lancet Haematol","issue":"2025 Apr;12(4):e244-e245.","author":"Giglio F, Malangahe S, Jumanne S, Mhozya M, Chandika A, Uderzo C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40174999"},{"title01":"Hematopoietic cell transplants for acute leukemias","title02":"Hematopoietic cell transplants for acute leukemias","journal":"Haematologica","issue":"2025 Apr 1;110(4):817-818.","author":"Gale RP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40165731"},{"title01":"Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis","title02":"Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis","journal":"Blood","issue":"2025 Mar 27:blood.2024027287. doi: 10.1182\/blood.2024027287. Online ahead of print.","author":"Hernandez-Boluda JC, Mosquera Orgueira A Dr, Gras L, Koster L, Tuffnell J, Kr\u00f6ger N, Gambella M, Schroeder T, Robin M, Sockel K, Passweg JR, Blau IW, Yakoub-Agha I, Van Dijck R, Stelljes M, Sengeloev H, Vydra J, Platzbecker U, Dewitte M, Baron F, Carlson K, Rojas Mart\u00ednez JA, P\u00e9rez M\u00edguez C, Crucitti D, Raj K, Drozd-Sokolowska J, Battipaglia G, Polverelli N, Czerw T, McLornan DP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40145857"},{"title01":"Greater prevalence of anaemia and heavy menstrual bleeding reported in women of reproductive age in the United Kingdom compared to Australia","title02":"Greater prevalence of anaemia and heavy menstrual bleeding reported in women of reproductive age in the United Kingdom compared to Australia","journal":"Br J Haematol","issue":"2025 Apr 9. doi: 10.1111\/bjh.20075. Online ahead of print.","author":"MacLean B, Fuller J, Lim J, Dugan C, Richards T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40200857"},{"title01":"CD19 chimeric antigen receptor-T cell therapy in murine immune thrombocytopenia","title02":"CD19 chimeric antigen receptor-T cell therapy in murine immune thrombocytopenia","journal":"Br J Haematol","issue":"2025 Mar 26. doi: 10.1111\/bjh.20061. Online ahead of print.","author":"Han F, Jiang Z, Guo Q, Li Y, Li C, Liang X, Han L, Gallant RC, Hou M, Peng J, Xu M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40139759"},{"title01":"What is radiation-induced acute myeloid leukaemia\/can it be accurately identified?","title02":"What is radiation-induced acute myeloid leukaemia\/can it be accurately identified?","journal":"Leukemia","issue":"2025 Mar 27. doi: 10.1038\/s41375-025-02561-2. Online ahead of print.","author":"Badie C, Gale RP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40148557"},{"title01":"Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric study","title02":"Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric study","journal":"Leukemia","issue":"2025 Apr 1. doi: 10.1038\/s41375-025-02555-0. Online ahead of print.","author":"Bussot L, Poulain S, Nudel Ortmans M, Davi F, Roos-Weil D, Lepretre S, Richard D, Pastoret C, Desmares A, Ferrant E, Huet S, Sujobert P, Delabesse E, Ysebaert L, Lazarian G, Michallet AS, Bidet A, Dilhuydy MS, Delfau-Larue MH, Dupuis J, Clavert A, Drenou B, Maitre E, Troussard X, Cornet E, Le Bris Y, Lok A, Villemagne B, Barbier H, B\u00e9n\u00e9 MC, Tomowiak C, Tardy S, Cornillet-Lefebvre P, Quinquenel A, Gui\u00e8ze R, Barbieux S, Plantier I, Hieulle J, Gresta PF, Cornillon J, Dupire S, Laribi K, Feugier P, Algrin C, Lachenal F, Caillet A, Murati A, Inchiappa L, Lechat C, Dartigeas C, Montaut \u00c9, Molina L, Carras S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40169763"},{"title01":"CircTADA2A stabilizes p53 via interacting with TRIM28 and suppresses the maintenance of FLT3-ITD acute myeloid leukemia","title02":"CircTADA2A stabilizes p53 via interacting with TRIM28 and suppresses the maintenance of FLT3-ITD acute myeloid leukemia","journal":"Leukemia","issue":"2025 Apr 2. doi: 10.1038\/s41375-025-02589-4. Online ahead of print.","author":"Li R, Wu X, Xue K, Wu S, Jiang G, He M, Xia Y, Liu H, Zhong M, Li J, Fan L, Li J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40175625"},{"title01":"Immune checkpoints regulate acute myeloid leukemia stem cells","title02":"Immune checkpoints regulate acute myeloid leukemia stem cells","journal":"Leukemia","issue":"2025 Apr 2. doi: 10.1038\/s41375-025-02566-x. Online ahead of print.","author":"Reinhardt C, Ochsenbein AF.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40175626"},{"title01":"iPSCs unlock clues to pediatric AML onset","title02":"iPSCs unlock clues to pediatric AML onset","journal":"Blood","issue":"2025 Apr 3;145(14):1442-1444.","author":"Pronk CJ, B\u00f6iers C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40178848"},{"title01":"Blood-Based Proteomic Profiling Identifies OSMR as a Novel Biomarker of AML Outcomes","title02":"Blood-Based Proteomic Profiling Identifies OSMR as a Novel Biomarker of AML Outcomes","journal":"Blood","issue":"2025 Apr 3:blood.2024027244. doi: 10.1182\/blood.2024027244. Online ahead of print.","author":"Reville PK, Wang B, Marvin-Peek J, Yuan B, Kuo YA, Garza AI, Root JL, Qiao W, Arruda A, Veletic I MD, Liu Y, Short NJ, DiNardo CD, Kadia TM, Daver NG, Lorenzi PL, Sasaki K, Kornblau SM, Minden MD, Ravandi F, Kantarjian HM, Abbas HA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40179376"},{"title01":"Project EVOLVE: An international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia","title02":"Project EVOLVE: An international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia","journal":"Blood","issue":"2025 Apr 7:blood.2024026655. doi: 10.1182\/blood.2024026655. Online ahead of print.","author":"Silbert SK, Rankin AW, Hoang CN, Semchenkova A, Myers RM, Zerkalenkova E PhD, Wang HW, Kovach AE, Yuan CM, Delgado Colon D, Vasseur L, Bataller A, John S, Utley Lyons K, Friedes BD, Alonso-Saladrigues A, Abdel-Azim H, Balducci E, Aljudi A, Balsat M, Biery DN, Chamdin A, Chang BH, Cuevo RS MD, De Moerloose B, Dickens DS, Duffner UA, Duployez N, El Chaer F, Elliott MA, Escherich G, Fernandes S, Fitzjohn MR, Gahvari ZJ, Grupp SA, He RR MD, Harrison C, Hergott CB, Hsieh EM, Kim AS, Kuo DJ, Larson DP, Lee BJ, Leguay TT, Lindsley RC, Mangaonkar AA, Mezger K, Pacenta HL, Pan J, Provost MRM, Puri L, Raikar SS, Martinez AJ, Bristol IQ, Murphy KD, Reiman L, Redell MS, Reed K, Roth Guepin G, Rubinstein JD, Sava\u015fan S, Schafernak KT, McLean Stevens A, Talleur AC, Torres Carapia N, Vargaftig J, Vatsayan A, W\u00f6lfl M, Zhao L, Rives S, Fabrizio VA, Sasaki K, Aldoss I, Boissel N, Rheingold SR, Davis KL, Ghorashian S, Jacoby E, Popov A, Lamble AJ, Shah NN.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40193715"},{"title01":"Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapy","title02":"Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapy","journal":"Leukemia","issue":"2025 Apr 1. doi: 10.1038\/s41375-025-02582-x. Online ahead of print.","author":"Iacoboni G, Rejeski K, Navarro V, van Meerten T, Rampotas A, Mart\u00edn-L\u00f3pez A\u00c1, Bastos M, Benzaqu\u00e9n A, Reguera-Ortega JL, Carpio C, Roddie C, L\u00f3pez-Corral L, Delgado-Serrano J, Landwehr M, Stock S, Silva de Tena P, Abrisqueta P, de Boer J, Martin Garcia-Sancho A, Hernani R, Kwon M, Subklewe M, O'Reilly M, Barba P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40169762"},{"title01":"HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large\u00a0cell lymphoma: implications for HDAC inhibitor therapy","title02":"HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large\u00a0cell lymphoma: implications for HDAC inhibitor therapy","journal":"Leukemia","issue":"2025 Apr 2. doi: 10.1038\/s41375-025-02584-9. Online ahead of print.","author":"Zrim\u0161ek M, Dragani\u0107 K, Malzer A, Doblmayr V, Mi\u0161ura K, de Freitas E Silva R, Matthews JD, Iannelli F, Wohlhaupter S, P\u00e9rez Malla CU, Fischer H, Schachner H, Schiefer AI, Sheibani-Tezerji R, Chiarle R, Turner SD, Ellmeier W, Seiser C, Egger G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40175628"},{"title01":"Celebrating 5 years of Women in Lymphoma: a road to equality, diversity, and inclusion in the field","title02":"Celebrating 5 years of Women in Lymphoma: a road to equality, diversity, and inclusion in the field","journal":"Lancet Haematol","issue":"2025 Apr;12(4):e246-e247.","author":"Sureda A, Pavlosky A, Poon ML, Smith S; Women in Lymphoma Steering Committee.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40175000"},{"title01":"Quality-of-life endpoints collection, reporting, and framing in randomised trials of indolent lymphomas: a systematic review","title02":"Quality-of-life endpoints collection, reporting, and framing in randomised trials of indolent lymphomas: a systematic review","journal":"Lancet Haematol","issue":"2025 Apr;12(4):e312-e317.","author":"Milrod CJ, Rubin L, Martinez B, Ollila TA, Olszewski AJ, Pelcovits A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40175003"},{"title01":"PET evaluation in Hodgkin lymphoma: when to change treatment","title02":"PET evaluation in Hodgkin lymphoma: when to change treatment","journal":"Lancet","issue":"2025 Apr 5;405(10485):1144-1145.","author":"Shimazu Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40187837"},{"title01":"PET evaluation in Hodgkin lymphoma: when to change treatment – Authors’ reply","title02":"PET evaluation in Hodgkin lymphoma: when to change treatment – Authors’ reply","journal":"Lancet","issue":"2025 Apr 5;405(10485):1145.","author":"Ferdinandus J, Schneider G, Borchmann P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40187840"},{"title01":"High-Dose Methotrexate in Children and Young Adults With ALL and Lymphoblastic Lymphoma: Results of the Randomized Phase III Study UKALL 2011","title02":"High-Dose Methotrexate in Children and Young Adults With ALL and Lymphoblastic Lymphoma: Results of the Randomized Phase III Study UKALL 2011","journal":"J Clin Oncol","issue":"2025 Apr 7:JCO2401851. doi: 10.1200\/JCO-24-01851. Online ahead of print.","author":"Kirkwood AA, Goulden N, Moppett J, Samarasinghe S, Hough R, Rowntree C, Lawson S, Kearns P, Lawson A, Vora A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40193822"},{"title01":"Phase I\/II Study of Adaptive Manufactured Lentiviral Anti-CD20\/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell Lymphoma","title02":"Phase I\/II Study of Adaptive Manufactured Lentiviral Anti-CD20\/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell Lymphoma","journal":"J Clin Oncol","issue":"2025 Mar 31:JCO2402158. doi: 10.1200\/JCO-24-02158. Online ahead of print.","author":"Shah NN, Colina AS, Johnson BD, Szabo A, Furqan F, Kearl T, Schneider D, Vargas-Cortes M, Schmeling JL, Dwinell MB, Palen K, Longo W, Hematti P, Zamora AE, Hari P, Bucklan D, Cunningham A, Hamadani M, Fenske TS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40163793"},{"title01":"Bendamustine supercharge plus brentuximab vedotin as early salvage therapy following failure to obtain complete metabolic remission after two cycles of adriamycin-bleomycin-vinblastine-dacarbazine for classic Hodgkin lymphoma in patients aged\u2009\u2264\u200960\u2009years: Long-term efficacy results of a retrospective multicentre study","title02":"Bendamustine supercharge plus brentuximab vedotin as early salvage therapy following failure to obtain complete metabolic remission after two cycles of adriamycin-bleomycin-vinblastine-dacarbazine for classic Hodgkin lymphoma in patients aged\u2009\u2264\u200960\u2009years: Long-term efficacy results of a retrospective multicentre study","journal":"Br J Haematol","issue":"2025 Apr 2. doi: 10.1111\/bjh.20053. Online ahead of print.","author":"Giordano C, Picardi M, Pugliese N, Vincenzi A, Avilia S, De Fazio L, Lamagna M, Reina R, Scarpa A, Lombardi A, Vigliar E, Troncone G, Mascolo M, Mainolfi C, Fonti R, Del Vecchio S, Damiano V, Bianco R, Trastulli F, Annunziata M, Salemme A, Carchia M, Pane F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40176291"},{"title01":"A chemotherapy-free regimen of acalabrutinib, umbralisib and ublituximab achieved high response rates and undetectable minimal residual disease in patients with untreated mantle cell lymphoma","title02":"A chemotherapy-free regimen of acalabrutinib, umbralisib and ublituximab achieved high response rates and undetectable minimal residual disease in patients with untreated mantle cell lymphoma","journal":"Br J Haematol","issue":"2025 Apr 2. doi: 10.1111\/bjh.20041. Online ahead of print.","author":"Lopedote P, Shouse G, Puverel S, Muir A, Roleder C, Sportelli P, Miskin H, Chen L, Phillips TJ, Danilov AV.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40176303"},{"title01":"Dissection of single-cell landscapes for the development of chimeric antigen receptor T cells in Hodgkin lymphoma","title02":"Dissection of single-cell landscapes for the development of chimeric antigen receptor T cells in Hodgkin lymphoma","journal":"Blood","issue":"2025 Apr 3;145(14):1536-1552.","author":"Gottschlich A, Gr\u00fcnmeier R, Hoffmann GV, Nandi S, Kavaka V, M\u00fcller PJ, Jobst J, Oner A, Kaiser R, G\u00e4rtig J, Piseddu I, Frenz-Wiessner S, Fairley SD, Schulz H, Igl V, Janert TA, Di Fina L, Mulkers M, Thomas M, Briukhovetska D, Simnica D, Carlini E, Tsiverioti CA, Trefny MP, Lorenzini T, M\u00e4rkl F, Mesquita P, Brabenec R, Strzalkowski T, Stock S, Michaelides S, Hellmuth J, Thelen M, Reinke S, Klapper W, Gelebart PF, Nicolai L, Marr C, Beltr\u00e1n E, Megens RTA, Klein C, Baran-Marszak F, Rosenwald A, von Bergwelt-Baildon M, Br\u00f6ckelmann PJ, Endres S, Kobold S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40178843"},{"title01":"The immunotherapy real estate of Hodgkin lymphoma","title02":"The immunotherapy real estate of Hodgkin lymphoma","journal":"Blood","issue":"2025 Apr 3;145(14):1445-1447.","author":"Steidl C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40178846"},{"title01":"Warthin-Finkeldey cells seen in a setting other than measles: chronic lymphocytic leukemia\/small lymphocytic lymphoma","title02":"Warthin-Finkeldey cells seen in a setting other than measles: chronic lymphocytic leukemia\/small lymphocytic lymphoma","journal":"Blood","issue":"2025 Mar 27;145(13):1437.","author":"Bakhshi TJ, Pina-Oviedo S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40146154"},{"title01":"How well do different chatbots respond to multiple myeloma treatment guidelines?","title02":"How well do different chatbots respond to multiple myeloma treatment guidelines?","journal":"Leukemia","issue":"2025 Apr 7. doi: 10.1038\/s41375-025-02604-8. Online ahead of print.","author":"Su\u00e1rez EU, Torres-Saavedra F, Domingo-Gonz\u00e1lez A, Cardete J, Llamas-Sillero P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40195524"},{"title01":"Cold-induced urticaria in multiple myeloma","title02":"Cold-induced urticaria in multiple myeloma","journal":"Lancet Haematol","issue":"2025 Apr;12(4):e318.","author":"Kwakernaak AJ, von dem Borne PA, Vos JMI.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40175004"},{"title01":"CLL cell-derived exosomes alter the immune and hematopoietic systems","title02":"CLL cell-derived exosomes alter the immune and hematopoietic systems","journal":"Leukemia","issue":"2025 Apr 4. doi: 10.1038\/s41375-025-02590-x. Online ahead of print.","author":"Veletic I, Harris DM, Rozovski U, Bertilaccio MTS, Calin GA, Takahashi K, Li P, Liu Z, Manshouri T, Drula RC, Furudate K, Muftuoglu M, Hossain A, Wierda WG, Keating MJ, Estrov Z.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40186065"},{"title01":"Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL)","title02":"Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL)","journal":"Leukemia","issue":"2025 Apr 9. doi: 10.1038\/s41375-025-02586-7. Online ahead of print.","author":"Pagano L, Maschmeyer G, Lamoth F, Blennow O, Xhaard A, Spadea M, Busca A, Cordonnier C, Maertens J; ECIL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40200079"},{"title01":"DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes","title02":"DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes","journal":"Leukemia","issue":"2025 Apr 9. doi: 10.1038\/s41375-025-02593-8. Online ahead of print.","author":"Kaya F, Bewicke-Copley F, Miettinen JJ, Casado P, Leddy E, Deniz \u00d6, Lavall\u00e9e VP, Philippe C, Zheng J, Grebien F, Khan N, Krizs\u00e1n S, Saad J, Nolin-Lapalme A, H\u00e9bert J, Lemieux S, Audemard E, Matthews J, Grantham M, Di Bella D, Wennerberg K, Parsons A, Gribben J, Cavenagh JD, Freeman SD, B\u00f6d\u00f6r C, Sauvageau G, Wang J, Llamas-Sillero P, Cazier JB, Taussig DC, Bonnet D, Cutillas PR, Heckman CA, Fitzgibbon J, Rouault-Pierre K, Rio-Machin A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40204893"},{"title01":"Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: phase 1 study final results","title02":"Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: phase 1 study final results","journal":"Leukemia","issue":"2025 Apr 9. doi: 10.1038\/s41375-025-02592-9. Online ahead of print.","author":"Cortes JE, Lang F, Rea D, Hochhaus A, Breccia M, Goh YT, Heinrich MC, Hughes TP, Janssen JJWM, le Coutre P, Minami H, Sasaki K, DeAngelo DJ, Sanchez-Olle G, Pognan N, Cao M, Hoch M, Mauro MJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40204896"},{"title01":"Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden","title02":"Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden","journal":"Leukemia","issue":"2025 Mar 26. doi: 10.1038\/s41375-025-02573-y. Online ahead of print.","author":"Jerkeman M, Mellgren K, Sonnevi K, Lisak M, Lagerl\u00f6f I, Kapas B, Sj\u00f6lund H, Toporski J, Hagberg H, Mielke S, Enblad G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40140632"},{"title01":"XPO1-dependency of DEK::NUP214 leukemia","title02":"XPO1-dependency of DEK::NUP214 leukemia","journal":"Leukemia","issue":"2025 Mar 27. doi: 10.1038\/s41375-025-02570-1. Online ahead of print.","author":"Charles Cano F, Kloos A, Hebalkar RY, Plenge T, Geffers R, Kirchhoff H, Kattre N, G\u00f6rlich K, B\u00fcsche G, Shcherbata HR, Scherr M, D\u00f6hner K, Gabdoulline R, Heuser M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40148556"},{"title01":"Improving SARS-CoV-2 vaccine response is challenging in chronic lymphocytic leukaemia","title02":"Improving SARS-CoV-2 vaccine response is challenging in chronic lymphocytic leukaemia","journal":"Lancet Haematol","issue":"2025 Apr;12(4):e238-e239.","author":"Mauro FR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40174993"},{"title01":"A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trial","title02":"A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trial","journal":"Lancet Haematol","issue":"2025 Apr;12(4):e294-e303.","author":"Cook JA, Patten PEM, Peckham N, Moss P, Phillips N, Abhishek A, Roberts T, Hodges M, Talbot G, Barber V, Francis A, Shields AM, Duley L, Hoogeboom R, Willett BJ, Scott S, Parry-Jones N, Eyre TA, Plested G, Vandici G, Wandroo FA, Hutchinson C, Paneesha S, Murray DJ, Martinez-Calle N, Jenkins S, Heartin E, Parry HM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40175001"},{"title01":"Risk of leukemia in twins","title02":"Risk of leukemia in twins","journal":"Haematologica","issue":"2025 Apr 3. doi: 10.3324\/haematol.2024.287135. Online ahead of print.","author":"Greaves M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40176761"},{"title01":"Long-term kidney complications in childhood leukemia survivors: a study from the Childhood and Adolescent Leukaemia (LEA) project","title02":"Long-term kidney complications in childhood leukemia survivors: a study from the Childhood and Adolescent Leukaemia (LEA) project","journal":"Haematologica","issue":"2025 Apr 3. doi: 10.3324\/haematol.2024.286940. Online ahead of print.","author":"Domenech C, Saultier P, Hamidou Z, Tabone MD, Pasquet M, Gandemer V, Ducassou S, Poir\u00e9e M, Plantaz D, Dalle JH, Chastagner P, Thouvenin S, Kanold J, Theron A, Pellier I, Reguerres Y, Baruchel A, Auquier P, Bacchetta J, Michel G, Derain-Dubourg L.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40176764"},{"title01":"Patients with high-risk acute promyelocytic leukemia need maintenance therapy for one year – the PROS","title02":"Patients with high-risk acute promyelocytic leukemia need maintenance therapy for one year – the PROS","journal":"Haematologica","issue":"2025 Apr 3. doi: 10.3324\/haematol.2025.287417. Online ahead of print.","author":"Tallman MS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40176767"},{"title01":"Patients with high-risk acute promyelocytic leukemia need maintenance therapy for one year – the CONS","title02":"Patients with high-risk acute promyelocytic leukemia need maintenance therapy for one year – the CONS","journal":"Haematologica","issue":"2025 Apr 3. doi: 10.3324\/haematol.2025.287418. Online ahead of print.","author":"Iland HJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40176770"},{"title01":"Hematopoietic cell transplants for acute leukemias","title02":"Hematopoietic cell transplants for acute leukemias","journal":"Haematologica","issue":"2025 Apr 1;110(4):817-818.","author":"Gale RP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40165731"},{"title01":"The mechanism of EZH2\/H3K27me3 downregulating CXCL10 to affect CD8(+) T cell exhaustion to participate in the transformation from myelodysplastic syndrome to acute myeloid leukaemia","title02":"The mechanism of EZH2\/H3K27me3 downregulating CXCL10 to affect CD8(+) T cell exhaustion to participate in the transformation from myelodysplastic syndrome to acute myeloid leukaemia","journal":"Br J Haematol","issue":"2025 Apr 9. doi: 10.1111\/bjh.20066. Online ahead of print.","author":"Zheng Z, Wang W, Feng M, Chen X, Ren F, Hou Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40201935"},{"title01":"Hypomethylating agent and venetoclax are effective salvage therapies in relapsed\/refractory early T-cell precursor acute lymphoblastic leukaemia","title02":"Hypomethylating agent and venetoclax are effective salvage therapies in relapsed\/refractory early T-cell precursor acute lymphoblastic leukaemia","journal":"Br J Haematol","issue":"2025 Apr 9. doi: 10.1111\/bjh.20065. Online ahead of print.","author":"Agrawal V, Arslan S, Pourhassan H, Koller P, Aldoss I, Pullarkat V.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40205647"},{"title01":"RNA-sequencing: A reliable tool to unveil transcriptional landscape of paediatric B-other acute lymphoblastic leukaemia","title02":"RNA-sequencing: A reliable tool to unveil transcriptional landscape of paediatric B-other acute lymphoblastic leukaemia","journal":"Br J Haematol","issue":"2025 Mar 30. doi: 10.1111\/bjh.20056. Online ahead of print.","author":"Vicente-Garc\u00e9s C, Fern\u00e1ndez G, Esperanza-Cebollada E, Richarte-Franqu\u00e9s M, Crespo-Carrasco A, Montesdeoca S, Isola I, Sarrate E, Cuatrecasas E, Rives S, Dapena JL, Cam\u00f3s M, Vega-Garc\u00eda N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40159352"},{"title01":"Introduction to a review series on acute lymphoblastic leukemia","title02":"Introduction to a review series on acute lymphoblastic leukemia","journal":"Blood","issue":"2025 Apr 3;145(14):1439.","author":"Dombret H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40178847"},{"title01":"Acute myeloid leukemia with RUNX1::CBFA2T3 fusion","title02":"Acute myeloid leukemia with RUNX1::CBFA2T3<\/i> fusion","journal":"Blood","issue":"2025 Mar 13;145(11):1226.","author":"Wang WJ, Loghavi S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40080002"},{"title01":"Monitoring the KMT2A gene post-chemotherapy independently predicts the relapse and survival risk after allogeneic haematopoietic stem cell transplantation","title02":"Monitoring the KMT2A<\/i> gene post-chemotherapy independently predicts the relapse and survival risk after allogeneic haematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2025 Mar 13. doi: 10.1111\/bjh.20036. Online ahead of print.","author":"Liu J, Zhao XS, Chang YJ, Qin YZ, Jiang Q, Jiang H, Zhang XH, Xu LP, Wang Y, Lv M, Liu KY, Huang XJ, Zhao XY.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40081934"},{"title01":"Monitoring the KMT2A gene post-chemotherapy independently predicts the relapse and survival risk after allogeneic haematopoietic stem cell transplantation","title02":"Monitoring the KMT2A<\/i> gene post-chemotherapy independently predicts the relapse and survival risk after allogeneic haematopoietic stem cell transplantation","journal":"Br J Haematol","issue":"2025 Mar 13. doi: 10.1111\/bjh.20036. Online ahead of print.","author":"Liu J, Zhao XS, Chang YJ, Qin YZ, Jiang Q, Jiang H, Zhang XH, Xu LP, Wang Y, Lv M, Liu KY, Huang XJ, Zhao XY.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40081934"},{"title01":"The proto-oncogenic miR-106a-363 cluster enhances adverse risk acute myeloid leukemia through mitochondrial activation","title02":"The proto-oncogenic miR-106a-363 cluster enhances adverse risk acute myeloid leukemia through mitochondrial activation","journal":"Leukemia","issue":"2025 Mar 17. doi: 10.1038\/s41375-025-02558-x. Online ahead of print.","author":"Sperb N, Maksakova IA, Escano L, Abraham L, MacPhee L, Cabantog A, Kim D, Yu M, Krowiorz K, Im J, Grasedieck S, Pochert N, Ruess C, R\u00f6sler R, Flibotte S, Maetzig T, Calzia E, Palmqvist L, Wiese S, Fogelstrand L, Gold MR, Rouhi A, Kuchenbauer F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40097604"},{"title01":"Frequency and prognostic value of unconventional genetic subtypes in paediatric and young adult B-cell precursor acute lymphoblastic leukaemia in Taiwan","title02":"Frequency and prognostic value of unconventional genetic subtypes in paediatric and young adult B-cell precursor acute lymphoblastic leukaemia in Taiwan","journal":"Br J Haematol","issue":"2025 Mar 25. doi: 10.1111\/bjh.20057. Online ahead of print.","author":"Huang YJ, Liu HC, Kuo MC, Yeh TC, Lin TL, Chen SH, Jaing TH, Wang SC, Chang TK, Yen HJ, Sheen JM, Wang MC, Lin TH, Huang TY, Kao HW, Ou CW, Hung YS, Hsiao CC, Shih LY.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40132994"},{"title01":"Introduction to a How I Treat series on acute myeloid leukemia","title02":"Introduction to a How I Treat series on acute myeloid leukemia","journal":"Blood","issue":"2025 Mar 20;145(12):1227-1228.","author":"Luger SM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40111332"},{"title01":"Megakaryocyte mitotic figures in de novo AML, myelodysplasia related, with STAG2, SRSF2, and ASXL1 comutations","title02":"Megakaryocyte mitotic figures in de novo AML, myelodysplasia related, with STAG2, SRSF2, and ASXL1 comutations","journal":"Blood","issue":"2025 Mar 20;145(12):1333.","author":"Xu Z, Roland K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40111333"},{"title01":"Zanubrutinib, venetoclax, and obinutuzumab in R\/R CLL","title02":"Zanubrutinib, venetoclax, and obinutuzumab in R\/R CLL","journal":"Blood","issue":"2025 Mar 20;145(12):1334.","author":"No authors listed","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40111334"},{"title01":"NGS-based IG\/TR rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturation","title02":"NGS-based IG\/TR rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturation","journal":"Blood","issue":"2025 Mar 25:blood.2024027175. doi: 10.1182\/blood.2024027175. Online ahead of print.","author":"Kotrova M, Proske C, Darzentas N, Laqua A, Kehden B, K\u00e4ssens JC, Bendig S, Kohlscheen S, Szczepanowski M, Wessels W, Anti\u0107 \u017d, Pott C, Ritgen M, van Dongen JJM, G\u00f6kbuget N, Chitadze G, Bergmann A, Bastian L, Baldus CD, Cario G, Schrappe M, Schwartz S, Alten J, Koehler R, Br\u00fcggemann M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40132160"},{"title01":"How I treat chronic myeloid leukemia in children and adolescents","title02":"How I treat chronic myeloid leukemia in children and adolescents","journal":"Blood","issue":"2025 Mar 25:blood.2024026514. doi: 10.1182\/blood.2024026514. Online ahead of print.","author":"Chen J, Suttorp M, Hijiya N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40132166"},{"title01":"The chromatin accessibility landscape of pediatric AML","title02":"The chromatin accessibility landscape of pediatric AML","journal":"Blood","issue":"2025 Mar 13;145(11):1109-1111.","author":"Giguelay AM, Ludwig LS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40080008"},{"title01":"A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia","title02":"A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia","journal":"Blood","issue":"2025 Mar 16:blood.2024025440. doi: 10.1182\/blood.2024025440. Online ahead of print.","author":"Falg\u00e0s A, L\u00e1zaro-Gorines R, Zanetti SR, Rubio-P\u00e9rez L, Martinez-Moreno A, Vinyoles M, Guerrero-Murillo M, Fernandez-Fuentes N, Roca-Ho H, Tirado N, Panisello C, Velasco-Hernandez T, Mayado A, P\u00e9rez-Pons A, Genesca E, Ribera JM, Ribera J, Camos M, Ram\u00edrez-Orellana M, Anguita E, Ballerini P, Fuster JL, Juan M, Gonz\u00e1lez-Navarro EAA, Locatelli F, Stam RWW, Querol S, Velasco P, Ortiz-Maldonado V, Mart\u00ednez-Cibrian N, Delgado J, Orfao A, Alvarez-Vallina L, Bueno C, Menendez P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40090006"},{"title01":"Considerations on the Dose and Schedule of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: Does Dose Matter?","title02":"Considerations on the Dose and Schedule of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: Does Dose Matter?","journal":"Blood","issue":"2025 Mar 18:blood.2024027944. doi: 10.1182\/blood.2024027944. Online ahead of print.","author":"Dalgetty M, Cortes J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40101136"},{"title01":"PI3K\u03b3 in leukemia: class IB PI3 kinase reemerges as a cancer-intrinsic target","title02":"PI3K\u03b3 in leukemia: class IB PI3 kinase reemerges as a cancer-intrinsic target","journal":"Blood","issue":"2025 Mar 19:blood.2024027376. doi: 10.1182\/blood.2024027376. Online ahead of print.","author":"Luo Q, Fortune AL, Lane AA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40106765"},{"title01":"Correlation of progression-free survival and overall survival after treatment for relapsed Hodgkin lymphoma: individual patient data analysis of randomized German Hodgkin Study Group (GHSG) Trials","title02":"Correlation of progression-free survival and overall survival after treatment for relapsed Hodgkin lymphoma: individual patient data analysis of randomized German Hodgkin Study Group (GHSG) Trials","journal":"Leukemia","issue":"2025 Mar 24. doi: 10.1038\/s41375-025-02567-w. Online ahead of print.","author":"Br\u00f6ckelmann PJ, M\u00fcller H, Fuchs M, Gillessen S, Eichenauer DA, Borchmann S, Robertz AS, Behringer K, Welters J, Ferdinandus J, B\u00f6ll B, Tharmaseelan H, Yang X, Kobe C, Eich H-, Baues C, Klapper W, Borchmann P, von Tresckow B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40128562"},{"title01":"Establishment and molecular characterisation of patient-derived organoids for primary central nervous system lymphoma","title02":"Establishment and molecular characterisation of patient-derived organoids for primary central nervous system lymphoma","journal":"Leukemia","issue":"2025 Mar 18. doi: 10.1038\/s41375-025-02562-1. Online ahead of print.","author":"Li S, Ren J, Wu J, Xia Z, Li Y, Li C, Cao W.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40102628"},{"title01":"The real-world application of T-cell receptor constant beta-1 chain antibody assay in cutaneous T-cell lymphoma","title02":"The real-world application of T-cell receptor constant beta-1 chain antibody assay in cutaneous T-cell lymphoma","journal":"Br J Haematol","issue":"2025 Mar 24. doi: 10.1111\/bjh.20060. Online ahead of print.","author":"Pierog O, Craig T, Jennings J, Borowitz MJ, Munjal A, Owusu-Agyei M, Weiner D, Peske JD, Paul S, Rozati S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40127907"},{"title01":"Biology as vulnerability in follicular lymphoma: genetics, epigenetics, and immunogenetics","title02":"Biology as vulnerability in follicular lymphoma: genetics, epigenetics, and immunogenetics","journal":"Blood","issue":"2025 Mar 16:blood.2024026020. doi: 10.1182\/blood.2024026020. Online ahead of print.","author":"Araujo-Ayala F, B\u00e9guelin W.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40089999"},{"title01":"Impact of HLA Alloimmunization in Gene-Modified Autologous Stem Cell Transplant For Transfusion-Dependent Thalassemia","title02":"Impact of HLA Alloimmunization in Gene-Modified Autologous Stem Cell Transplant For Transfusion-Dependent Thalassemia","journal":"Blood","issue":"2025 Mar 16:blood.2024027034. doi: 10.1182\/blood.2024027034. Online ahead of print.","author":"Gibson NM, Khandros E, Elgarten CW, Worster E, Monos DS, Thompson AA, Kwiatkowski JL, Olson T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40089998"},{"title01":"HLA-haploidentical stem cell transplantation for chronic granulomatous disease: an EBMT-IEWP retrospective study","title02":"HLA-haploidentical stem cell transplantation for chronic granulomatous disease: an EBMT-IEWP retrospective study","journal":"Blood","issue":"2025 Mar 16:blood.2024026915. doi: 10.1182\/blood.2024026915. Online ahead of print.","author":"Riller Q, Hauri-Hohl MM, Lum SH, Knippenberg J, Sirait T, Laberko A, Halahleh K, Hashem H, Karakukcu M, Sengeloev H, Porta F, Bruno B, Zecca M, Aksoylar S, Barlogis V, Schuetz C, Buechner J, Faraci M, Wehr C, Holter W, Mellgren KM, Locatelli F, P\u00e9rez-Mart\u00ednez A, Suarez F, Moshous D, Gennery AR, Balashov D, Albert MH, Slatter MA, G\u00fcng\u00f6r T, Neven B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40090009"},{"title01":"Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT","title02":"Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT","journal":"Blood","issue":"2025 Mar 19:blood.2024028005. doi: 10.1182\/blood.2024028005. Online ahead of print.","author":"DeFilipp Z, Kim HT, Knight LW, O'Connor SM, Dhaver SE, White M, Dholaria B, Schroeder MA, Vasu S, Abedin SM, Chung J, El-Jawahri A, Frigault MJ, McAfee SL, Newcomb RA, O'Donnell PV, Spitzer TR, Chen YB, Hobbs GS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40106768"},{"title01":"Tracking clusterin expression in hematopoietic stem cells reveals their heterogeneous composition across the lifespan","title02":"Tracking clusterin expression in hematopoietic stem cells reveals their heterogeneous composition across the lifespan","journal":"Blood","issue":"2025 Mar 25:blood.2024025776. doi: 10.1182\/blood.2024025776. Online ahead of print.","author":"Koide S, Oshima M, Kamiya T, Zheng Z, Liu Z, Rizq O, Nishiyama A, Murakami K, Yamada Y, Nakajima-Takagi Y, Rahmutulla B, Kaneda A, Yokoyama K, Yusa N, Imoto S, Miura F, Ito T, Tamura T, Nerlov C, Yamashita M, Iwama A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40132120"},{"title01":"Impact of HLA Alloimmunization in Gene-Modified Autologous Stem Cell Transplant For Transfusion-Dependent Thalassemia","title02":"Impact of HLA Alloimmunization in Gene-Modified Autologous Stem Cell Transplant For Transfusion-Dependent Thalassemia","journal":"Blood","issue":"2025 Mar 16:blood.2024027034. doi: 10.1182\/blood.2024027034. Online ahead of print.","author":"Gibson NM, Khandros E, Elgarten CW, Worster E, Monos DS, Thompson AA, Kwiatkowski JL, Olson T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40089998"},{"title01":"HLA-haploidentical stem cell transplantation for chronic granulomatous disease: an EBMT-IEWP retrospective study","title02":"HLA-haploidentical stem cell transplantation for chronic granulomatous disease: an EBMT-IEWP retrospective study","journal":"Blood","issue":"2025 Mar 16:blood.2024026915. doi: 10.1182\/blood.2024026915. Online ahead of print.","author":"Riller Q, Hauri-Hohl MM, Lum SH, Knippenberg J, Sirait T, Laberko A, Halahleh K, Hashem H, Karakukcu M, Sengeloev H, Porta F, Bruno B, Zecca M, Aksoylar S, Barlogis V, Schuetz C, Buechner J, Faraci M, Wehr C, Holter W, Mellgren KM, Locatelli F, P\u00e9rez-Mart\u00ednez A, Suarez F, Moshous D, Gennery AR, Balashov D, Albert MH, Slatter MA, G\u00fcng\u00f6r T, Neven B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40090009"},{"title01":"Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT","title02":"Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT","journal":"Blood","issue":"2025 Mar 19:blood.2024028005. doi: 10.1182\/blood.2024028005. Online ahead of print.","author":"DeFilipp Z, Kim HT, Knight LW, O'Connor SM, Dhaver SE, White M, Dholaria B, Schroeder MA, Vasu S, Abedin SM, Chung J, El-Jawahri A, Frigault MJ, McAfee SL, Newcomb RA, O'Donnell PV, Spitzer TR, Chen YB, Hobbs GS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40106768"},{"title01":"Proteostasis Disruption in Inherited Bone Marrow Failure Syndromes","title02":"Proteostasis Disruption in Inherited Bone Marrow Failure Syndromes","journal":"Blood","issue":"2025 Mar 16:blood.2024024956. doi: 10.1182\/blood.2024024956. Online ahead of print.","author":"Yu H, Signer R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40089997"},{"title01":"Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study","title02":"Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study","journal":"Blood","issue":"2025 Mar 16:blood.2024027336. doi: 10.1182\/blood.2024027336. Online ahead of print.","author":"Kuter DJ, Ghanima W, Cooper N, Liebman HA, Zhang L, Hu Y, Miyakawa Y, Homenda W, Morales Galindo LEE MD, Basquiera AL, Tan CW, Saydam G Prof Dr, H\u00fctter-Kr\u00f6nke ML, Chai-Adisaksopha C, Gomez-Almaguer D, Tran H, Shin HJ, Dantas da Cunha Junior A, Lazar Z, Pascual-Izquierdo C, Kirgner I, Lucchini E, Kuzmina G, Fillitz M, Audia S, Taparia M, Cordoba M, Diab R, Yao M, Gouia I Dr, Lee M, Daak AAA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40090011"},{"title01":"Bcor loss promotes Richter transformation of chronic lymphocytic leukemia associated with Notch1 activation in mice","title02":"Bcor loss promotes Richter transformation of chronic lymphocytic leukemia associated with Notch1 activation in mice","journal":"Leukemia","issue":"2025 Mar 20. doi: 10.1038\/s41375-025-02557-y. Online ahead of print.","author":"Rompietti C, Adamo FM, Sorcini D, De Falco F, Stella A, Martino G, Bigerna B, Dorillo E, Silva Barcelos EC, Esposito A, Geraci C, Arcaleni R, Bordini J, Scarf\u00f2 L, Rosati E, Ghia P, Falini B, Sportoletti P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40113912"},{"title01":"Preclinical characterization of the anti-leukemia activity of the CD123 antibody-drug conjugate, pivekimab sunirine (IMGN632)","title02":"Preclinical characterization of the anti-leukemia activity of the CD123 antibody-drug conjugate, pivekimab sunirine (IMGN632)","journal":"Leukemia","issue":"2025 Mar 21. doi: 10.1038\/s41375-025-02571-0. Online ahead of print.","author":"Cole FM, Laszlo GS, Lunn-Halbert MC, Kehret AR, Zweidler-McKay PA, Rodr\u00edguez-Arbol\u00ed E, Wu D, Nyberg K, Li J, Lim SYT, Pettenger-Willey CM, Lakshmikanthan S, Walter RB.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40119158"},{"title01":"Real-time genomic characterization of pediatric acute leukemia using adaptive sampling","title02":"Real-time genomic characterization of pediatric acute leukemia using adaptive sampling","journal":"Leukemia","issue":"2025 Mar 24. doi: 10.1038\/s41375-025-02565-y. Online ahead of print.","author":"Geyer J, Opoku KB, Lin J, Ramkissoon L, Mullighan C, Bhakta N, Alexander TB, Wang JR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40128561"},{"title01":"Overt and covert genetic causes of pediatric acute lymphoblastic leukemia","title02":"Overt and covert genetic causes of pediatric acute lymphoblastic leukemia","journal":"Leukemia","issue":"2025 Mar 24. doi: 10.1038\/s41375-025-02535-4. Online ahead of print.","author":"Stoltze U, Junk SV, Byrjalsen A, Cav\u00e9 H, Cazzaniga G, Elitzur S, Fronkova E, Hjalgrim LL, Kuiper RP, Lundgren L, Mescher M, Mikkelsen T, Pastorczak A, Strullu M, Trka J, Wadt K, Izraeli S, Borkhardt A, Schmiegelow K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40128563"},{"title01":"Blunted CD40-responsive enhancer activation in CREBBP-mutant lymphomas can be restored by enforced CD4 T-cell engagement","title02":"Blunted CD40-responsive enhancer activation in CREBBP-mutant lymphomas can be restored by enforced CD4 T-cell engagement","journal":"Blood","issue":"2025 Mar 16:blood.2024026664. doi: 10.1182\/blood.2024026664. Online ahead of print.","author":"Yang H, Zhang W, Ravanmehr V, Cui G, Bowman K, Chen R, Henderson J, Lockman SR, Rojas E, Wilson AL, Parsons S, Mechaly A, Regad L, Haouz A, Flowers CR, Neelapu SS, Nastoupil LJ, Davis RE, Deng Q, Rodrigues Lima F, Green MR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40090010"},{"title01":"Prognostic Biomarkers in MCL: Insights from the SHINE Trial on the impact of MCL35 score and TP53 Mutation Status","title02":"Prognostic Biomarkers in MCL: Insights from the SHINE Trial on the impact of MCL35 score and TP53 Mutation Status","journal":"Blood","issue":"2025 Mar 18:blood.2024026003. doi: 10.1182\/blood.2024026003. Online ahead of print.","author":"Freeman CL, Srinivasan S, Hodkinson B, Deshpande S, Henninger T, Boyle M, Wang ML, Dreyling M, Scott DW.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40101138"},{"title01":"Outcomes of frailty subgroups of older adults (age \u2265 70) treated with teclistamab: an International Myeloma Foundation immunotherapy database real-world analysis","title02":"Outcomes of frailty subgroups of older adults (age \u2265 70) treated with teclistamab: an International Myeloma Foundation immunotherapy database real-world analysis","journal":"Leukemia","issue":"2025 Mar 20. doi: 10.1038\/s41375-025-02552-3. Online ahead of print.","author":"Mian H, Martin TG, Pond GR, Asoori S, Popat R, Kastritis E, Martinez-Lopez J, Abdallah N, Chhabra S, Parrondo R, Ailawadhi S, Dimopoulos MA, Yong K, Durie BG, Usmani SZ, Lin Y, Tan CR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40113913"},{"title01":"Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1-2 study","title02":"Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1-2 study","journal":"Lancet Haematol","issue":"2025 Mar 13:S2352-3026(24)00385-5. doi: 10.1016\/S2352-3026(24)00385-5. Online ahead of print.","author":"Chari A, Touzeau C, Schinke C, Minnema MC, Berdeja JG, Oriol A, van de Donk NWCJ, Rodr\u00edguez-Otero P, Morillo D, Martinez-Chamorro C, Mateos MV, Costa LJ, Caers J, Rasche L, Krishnan A, Ye JC, Karlin L, Lipe B, Vishwamitra D, Skerget S, Verona R, Ma X, Qin X, Ludlage H, Campagna M, Masterson T, Hilder B, Tolbert J, Renaud T, Goldberg JD, Kane C, Heuck C, San-Miguel J, Moreau P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40090350"},{"title01":"Monumen-TAL progress in the treatment of relapsed multiple myeloma","title02":"Monumen-TAL progress in the treatment of relapsed multiple myeloma","journal":"Lancet Haematol","issue":"2025 Mar 13:S2352-3026(25)00009-2. doi: 10.1016\/S2352-3026(25)00009-2. Online ahead of print.","author":"Bal S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40090351"},{"title01":"BCL2 inhibition for multiple myeloma and AL amyloidosis","title02":"BCL2 inhibition for multiple myeloma and AL amyloidosis","journal":"Br J Haematol","issue":"2025 Mar 16. doi: 10.1111\/bjh.20046. Online ahead of print.","author":"Cani L, Gupta VA, Kaufman JL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40090369"},{"title01":"Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes","title02":"Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes","journal":"Blood","issue":"2025 Mar 20:blood.2024026236. doi: 10.1182\/blood.2024026236. Online ahead of print.","author":"Lionetti M, Scopetti M, Matera A, Maeda A, Marella A, Lazzaroni F, Castellano G, Fabris S, Pioggia S, Lonati S, Marchetti A, Cattaneo A, Tornese M, Neri A Dr, Leoni C, Pettine L, Traini V, Silvestris I, Barbieri M, Fabbiano G, Ronchetti D, Taiana E, De Magistris C, Da Via' MC, Passamonti F, Bolli N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40112284"},{"title01":"Daratumumab-Bortezomib-Thalidomide-Dexamethasone for Newly Diagnosed Myeloma: CASSIOPEIA Minimal Residual Disease Results","title02":"Daratumumab-Bortezomib-Thalidomide-Dexamethasone for Newly Diagnosed Myeloma: CASSIOPEIA Minimal Residual Disease Results","journal":"Blood","issue":"2025 Mar 24:blood.2024027620. doi: 10.1182\/blood.2024027620. Online ahead of print.","author":"Corre J, Vincent L, Moreau P, Hebraud B, Hulin C, B\u00e9n\u00e9 MC, Broijl A, Caillot D, Delforge M, Dejoie T, Facon T, Lambert J, Leleu X, Macro M Dr, Perrot A, Zweegman S, Filleron T, Cabarrou B, van de Donk NWCJ, Mah\u00e9o S, Hua W, Wang J, Krevvata M, Vanquickelberghe V, de Boer C, Tuozzo A, Borgsten F, Rowe M, Carson R, Wuilleme S, Sonneveld P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40127397"},{"title01":"Loss of BCL7A Permits IRF4 Transcriptional Activity and Cellular Growth in Multiple Myeloma","title02":"Loss of BCL7A Permits IRF4 Transcriptional Activity and Cellular Growth in Multiple Myeloma","journal":"Blood","issue":"2025 Mar 16:blood.2024026588. doi: 10.1182\/blood.2024026588. Online ahead of print.","author":"Chakraborty C, Talluri S, Binder M, Morelli E, Mayoral JE, Derebail S, Aktas Samur A, Epstein CB, Anderson KC, Shammas MA, Samur MK, Fulciniti M, Munshi NC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40090008"},{"title01":"Genetic and epigenetic mechanisms of GPRC5D loss after anti-GPRC5D CAR T-cell therapy in multiple myeloma","title02":"Genetic and epigenetic mechanisms of GPRC5D loss after anti-GPRC5D CAR T-cell therapy in multiple myeloma","journal":"Blood","issue":"2025 Mar 16:blood.2024026622. doi: 10.1182\/blood.2024026622. Online ahead of print.","author":"Ma S, Xia J, Zhang M, Li W, Xiao M, Sha Y, Wang W, Zhou J, Wang Y, Qi K, Fu C, Sun Z, Zhou D, Sun Q, Qiu T, Yan Z, Zhu F, Chen W, Cheng H, Sang W, Cao J, Li D, Li ZZ, Fulciniti M, Yao Y, Xu K, Niu M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40090012"},{"title01":"NKG2D-mediated cytotoxicity of CD4 cytotoxic T cells in multiple myeloma","title02":"NKG2D-mediated cytotoxicity of CD4 cytotoxic T cells in multiple myeloma","journal":"Blood","issue":"2025 Mar 19:blood.2024025875. doi: 10.1182\/blood.2024025875. Online ahead of print.","author":"Kim S, Kwak JE, Koh JY, Lee JE, Kook HW, Kim M, Chung H, Kim Y, Kim SJ, Kim JS, Cheong JW, Lee MG, Lee H, Park SH, Shin EC, Shin S, Yoon SO, Choi IK, Lee JS, Cho H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40106762"},{"title01":"Role of allo-HCT in “nonclassical” MPNs and MDS\/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT","title02":"Role of allo-HCT in “nonclassical” MPNs and MDS\/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT","journal":"Blood","issue":"2025 Mar 19:blood.2024028000. doi: 10.1182\/blood.2024028000. Online ahead of print.","author":"Polverelli N, Hernandez-Boluda JC, Onida F, Gurnari C, Raj K, Czerw T, Kenyon M, Robin M, Sockel K, Ruggeri A, S\u00e1nchez-Ortega I, Arber DA, Arcaini L, Duarte FB, Battipaglia G, Chalandon Y, Ciceri F, Cross NCP, Drozd-Sokolowska J, Funke VAM, Gagelmann N, Gangat N, Gotlib J, Guglielmelli P, Harrison CN, Hobbs GS, Jain T, Khoury JD, Kiladjian JJ, Kr\u00f6ger N, Malcovati L, Martino M, Mesa R, Orazi A, Padron E, Palandri F, Passamonti F, Patnaik MM, Pemmaraju N, Radia DH, Reiter A, Russo D, Scheid C, Tefferi A, Vannucchi AM, Wiseman DH, Yakoub-Agha I, McLornan DP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40106773"},{"title01":"The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML","title02":"The IKZF1<\/i> N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML","journal":"Br J Haematol","issue":"2025 Mar 5. doi: 10.1111\/bjh.20027. Online ahead of print.","author":"Stasik S, Eckardt JN, R\u00f6llig C, Baldus CD, Platzbecker U, Serve H, M\u00fcller-Tidow C, Sch\u00e4fer-Eckart K, Kaufmann M, Krause SW, Sauer T, H\u00e4nel M, Neubauer A, Ehninger G, Bornh\u00e4user M, Schetelig J, Middeke JM, Thiede C; Study Alliance Leukemia (SAL).","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40041934"},{"title01":"Efficacy of Combined CD38 and PD1 Inhibition with Isatuximab and Cemiplimab for Relapsed\/Refractory NK\/T-Cell Lymphoma","title02":"Efficacy of Combined CD38 and PD1 Inhibition with Isatuximab and Cemiplimab for Relapsed\/Refractory NK\/T-Cell Lymphoma","journal":"Blood","issue":"2025 Mar 12:blood.2024027109. doi: 10.1182\/blood.2024027109. Online ahead of print.","author":"Kim SJ, Lim JQ, Yoon SE, Yang DH, Lee JH, Oh SY, Choi YS, Jeong SH, Kim MK, Lim SN, Cho J, Park B, Ryu KJ, Choi S, Park Y, Lim KMH, Binte Muhammad Taib NA, Ong CK, Lim ST, Kim WS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40073374"},{"title01":"The Future of Follicular Lymphoma Management: Strategies on the Horizon","title02":"The Future of Follicular Lymphoma Management: Strategies on the Horizon","journal":"Blood","issue":"2025 Feb 28:blood.2024026017. doi: 10.1182\/blood.2024026017. Online ahead of print.","author":"Mulvey E, Rutherford SC, Leonard JP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40019447"},{"title01":"End points and Outcomes in Follicular Lymphoma: What should we measure, how, and why?","title02":"End points and Outcomes in Follicular Lymphoma: What should we measure, how, and why?","journal":"Blood","issue":"2025 Feb 28:blood.2024026978. doi: 10.1182\/blood.2024026978. Online ahead of print.","author":"Di M, Maurer MJ, Flowers CR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40019453"},{"title01":"Daratumumab\/lenalidomide\/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes","title02":"Daratumumab\/lenalidomide\/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes","journal":"Leukemia","issue":"2025 Feb 27. doi: 10.1038\/s41375-024-02505-2. Online ahead of print.","author":"Facon T, Moreau P, Weisel K, Goldschmidt H, Usmani SZ, Chari A, Plesner T, Orlowski RZ, Bahlis N, Basu S, Hulin C, Quach H, O'Dwyer M, Perrot A, Jacquet C, Venner CP, Raje N, Tiab M, Macro M, Frenzel L, Leleu X, Cook G, Wang G, Pei H, Krevvata M, Carson R, Borgsten F, Kumar SK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40016302"},{"title01":"Implications of lymphocyte kinetics after chimeric antigen receptor T cell therapy for multiple myeloma","title02":"Implications of lymphocyte kinetics after chimeric antigen receptor T cell therapy for multiple myeloma","journal":"Leukemia","issue":"2025 Mar 5. doi: 10.1038\/s41375-025-02547-0. Online ahead of print.","author":"Dingli S, Rothweiler P, Binder M, Cook J, Gertz MA, Hayman S, Kapoor P, Kourelis T, Kumar SK, Siddiqui M, Warsame R, Lin Y, Erdman AG, Dingli D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40044958"},{"title01":"Accelerating Myeloma Drug Development: Will Minimal Residual Disease Replace Progression-Free Survival as an Intermediate Surrogate End Point?","title02":"Accelerating Myeloma Drug Development: Will Minimal Residual Disease Replace Progression-Free Survival as an Intermediate Surrogate End Point?","journal":"J Clin Oncol","issue":"2025 Mar 6:JCO2500048. doi: 10.1200\/JCO-25-00048. Online ahead of print.","author":"Mateos MV, Puig N.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40048684"},{"title01":"Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomidedexamethasone in relapsed\/refractory multiple myeloma patients: a target trial emulation using real-world data","title02":"Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomidedexamethasone in relapsed\/refractory multiple myeloma patients: a target trial emulation using real-world data","journal":"Haematologica","issue":"2025 Mar 6. doi: 10.3324\/haematol.2025.287325. Online ahead of print.","author":"Martino EA, Pitino A, Offidani M, Pepa RD, Gozzetti A, Bongarzoni V, Maroccia A, Amico V, Stefanoni P, Zamagni E, Terlizzi S, Derudas D, Palmieri S, Bianco R, Conticello C, Brunori M, Rago A, Lotti F, Fontana R, Sgherza N, Rossi E, Cafro AM, Febbo MA, Quinto AM, Cerchione C, Casaluci GM, Citro A, Califano C, Zambello R, Mangiacavalli S, Liberatore C, Buda G, De Magistris C, Amendola A, Vigna E, Bruzzese A, Barbieri E, Quaresima M, Roccotelli D, Farina F, Micozzi J, Vincelli ID, Tarantini G, Antonioli E, Aquino S, Maggi A, Lombardo A, Bertuglia G, Furlan A, Mele A, Annibali O, Cotzia E, Benvenuti P, De Paoli L, Baril\u00e0 G, Mor\u00e8 S, De Stefano V, Di Raimondo F, Petrucci MT, Bolli N, Musto P, Neri A, Morabito F, Tripepi G, Gentile M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40045883"},{"title01":"Significant risk of venous thromboembolism associated with targeted anti-myeloma immunomodulatory drugs. Comment on: Targeted anti-cancer agents and risk of venous thromboembolism","title02":"Significant risk of venous thromboembolism associated with targeted anti-myeloma immunomodulatory drugs. Comment on: Targeted anti-cancer agents and risk of venous thromboembolism","journal":"Haematologica","issue":"2025 Mar 6. doi: 10.3324\/haematol.2025.287442. Online ahead of print.","author":"Duane C, Glavey S, Quinn J, Murphy P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40045904"},{"title01":"Large-scale dependency and drug screens characterize the therapeutic vulnerabilities of Multiple Myeloma with 1q","title02":"Large-scale dependency and drug screens characterize the therapeutic vulnerabilities of Multiple Myeloma with 1q","journal":"Blood","issue":"2025 Mar 12:blood.2024025102. doi: 10.1182\/blood.2024025102. Online ahead of print.","author":"Sklavenitis-Pistofidis R, Lightbody ED, Reidy M, Tsuji J, Alberge JB, Aranha MP, Heilpern-Mallory DL, Roweth HG, Huyng D, Chong SJF, Chung AY, Zhang J, Hackett L, Haradhvala NJ, Wu T, Su NK, Berrios B, Belkin S, Dutta AK, Knudson RA, Brandt C, Greipp PT, Davids MS, Papaioannou M, Getz G, Ghobrial IM, Manier S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40073369"},{"title01":"CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents","title02":"CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents","journal":"Leukemia","issue":"2025 Feb 27. doi: 10.1038\/s41375-025-02539-0. Online ahead of print.","author":"Reuvekamp T, Ngai LL, den Hartog D, Carbaat-Ham J, Fayed MMHE, Scholten WJ, Mocking TR, Chitu DA, Pabst T, Klein SK, Stussi G, Griskevicius L, Breems D, van Lammeren-Venema D, Boersma R, Ossenkoppele GJ, van de Loosdrecht AA, Bachas C, Huls G, de Leeuw DC, Cloos J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40016301"},{"title01":"Global paediatric haematopoietic stem-cell transplantation training and access: providing strategies to overcome challenges","title02":"Global paediatric haematopoietic stem-cell transplantation training and access: providing strategies to overcome challenges","journal":"Lancet Haematol","issue":"2025 Mar;12(3):e178-e179.","author":"Hendricks CL, Spadea M, Du Toit JR, Gurnari C, Muratori R, Jimenez V, Radici V, Torrado S, Desai N, Ibrahimova A, Muhsen IN, Ropero J, Gagelmann N, Horgan C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40044255"},{"title01":"Enforcement of stem-cell dormancy by nucleophosmin mutation is a critical determinant of unrestricted self-renewal during myeloid leukemogenesis","title02":"Enforcement of stem-cell dormancy by nucleophosmin mutation is a critical determinant of unrestricted self-renewal during myeloid leukemogenesis","journal":"Haematologica","issue":"2025 Mar 13. doi: 10.3324\/haematol.2024.286577. Online ahead of print.","author":"Merlo MEB, Mallardo M, Luzi L, De Conti G, Caprioli C, Hillje R, Faretta M, Restelli C, Polazzi A, Tabanelli V, Calleri A, Pileri S, Pelicci PG, Colombo E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40079083"},{"title01":"Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial","title02":"Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial","journal":"Haematologica","issue":"2025 Mar 13. doi: 10.3324\/haematol.2024.286623. Online ahead of print.","author":"Schlenk RF, Montesinos P, Kim HJ, Romero-Aguilar A, Vrhovac R, Patkowska E, \u017dak P, Wang PN, Hanyok J, Liu L, Kamel YM, Imadalou K, Lesegretain A, Cortes J, Sekeres MA, Dombret H, Amadori S, Wang J, Perl AE, Levis MJ, Erba HP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40079105"},{"title01":"Successful autologous haematopoietic stem cell transplantation in a refractory anti-myelin-associated glycoprotein antibody neuropathy","title02":"Successful autologous haematopoietic stem cell transplantation in a refractory anti-myelin-associated glycoprotein antibody neuropathy","journal":"Br J Haematol","issue":"2025 Mar;206(3):996-999.","author":"Urbain F, Labeyrie C, Castilla-Llorente C, Noel N, Farge D, Echaniz-Laguna A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40052451"},{"title01":"Cullin’ the herd: Cul5 limits megakaryocyte-biased HSCs","title02":"Cullin’ the herd: Cul5 limits megakaryocyte-biased HSCs","journal":"Blood","issue":"2025 Mar 6;145(10):996-998.","author":"Pietras EM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40048228"},{"title01":"Social Determinants of Health and Access to Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia","title02":"Social Determinants of Health and Access to Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia","journal":"Blood","issue":"2025 Mar 11:blood.2024027543. doi: 10.1182\/blood.2024027543. Online ahead of print.","author":"Wuliji N, Jones SMW, Gooley TA, Gerds AT, Medeiros BC, Shami PJ, Galvin JP, Adekola KUA, Luger SM, Baer MR, Rizzieri DA, Wildes T, Wang ES, Sekeres MA, Mukherjee S, Smith J, Garrison M, Kojouri K, Appelbaum JS, Percival MM, Sandmaier BM, Lee SJ, Appelbaum F, Rouce RH, Sorror ML.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40067123"},{"title01":"Hepatocyte senescence and persistent liver injury in Fanconi anemia","title02":"Hepatocyte senescence and persistent liver injury in Fanconi anemia","journal":"Haematologica","issue":"2025 Mar 6. doi: 10.3324\/haematol.2024.287096. Online ahead of print.","author":"Koo J, Snyder AJ, Campbell K, Miller E, O'Conner A, Grompe M, Mehta PA, Myers KC, Davies SM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40045901"},{"title01":"Real-world insights from a cohort of approximately 2000 individuals who were analysed using a freely available next-generation sequencing anaemia screening programme","title02":"Real-world insights from a cohort of approximately 2000 individuals who were analysed using a freely available next-generation sequencing anaemia screening programme","journal":"Br J Haematol","issue":"2025 Mar 9. doi: 10.1111\/bjh.20049. Online ahead of print.","author":"Balciuniene J, Yilmaz S, Chonat S, Grace RF, Soff GA, Ravindranath Y, Glader B, Bianchi P, McGee B, Agarwal AM, Puthenveetil G.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40058880"},{"title01":"A Controlled Trial for Preventing Priapism in Sickle Cell Anemia: Hydroxyurea plus Placebo vs Hydroxyurea plus Tadalafil","title02":"A Controlled Trial for Preventing Priapism in Sickle Cell Anemia: Hydroxyurea plus Placebo vs Hydroxyurea plus Tadalafil","journal":"Blood","issue":"2025 Mar 12:blood.2024027898. doi: 10.1182\/blood.2024027898. Online ahead of print.","author":"Idris IM, Yusuf AA, Ismail II, Borodo AM, Hikima MS, Kana SA, Aliyu T, Gedu KM, Jibrillah AU MBBS, FWACS, Aji SA, Kuliya-Gwarzo A, Mohammed KB, Galadanci JA, Alkassim RS, Suwaid MA, Hussaini N, Rodeghier M, Burnett AL 2nd, DeBaun MR.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40073378"},{"title01":"Effects of orelabrutinib, a BTK inhibitor, on antibody-mediated platelet destruction in primary immune thrombocytopenia","title02":"Effects of orelabrutinib, a BTK inhibitor, on antibody-mediated platelet destruction in primary immune thrombocytopenia","journal":"Br J Haematol","issue":"2025 Mar 11. doi: 10.1111\/bjh.20045. Online ahead of print.","author":"Yu TS, Han SQ, Wang LJ, Wang HY, Ni XF, Wang RT, Li GS, Hou Y, Peng J, Yan ZY, Zhao YJ, Hou M, Liu XG.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40069128"},{"title01":"Do we need another TKI for chronic myeloid leukaemia?","title02":"Do we need another TKI for chronic myeloid leukaemia?","journal":"Lancet Haematol","issue":"2025 Mar;12(3):e167-e168.","author":"Hjorth-Hansen H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40044250"},{"title01":"Reply to: Treatment Intensification Based on Residual Disease in Elderly Patients With AML","title02":"Reply to: Treatment Intensification Based on Residual Disease in Elderly Patients With AML","journal":"J Clin Oncol","issue":"2025 Feb 28:JCO2500198. doi: 10.1200\/JCO-25-00198. Online ahead of print.","author":"Russell NH, Thomas A, Freeman SD.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40020205"},{"title01":"Treatment Intensification Based on Residual Disease in Elderly Patients With AML","title02":"Treatment Intensification Based on Residual Disease in Elderly Patients With AML","journal":"J Clin Oncol","issue":"2025 Feb 28:JCO2402645. doi: 10.1200\/JCO-24-02645. Online ahead of print.","author":"Shimazu Y, Shimazu Y.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40020211"},{"title01":"Bruton tyrosine kinase covalent inhibition shapes the immune microenvironment in chronic lymphocytic leukemia","title02":"Bruton tyrosine kinase covalent inhibition shapes the immune microenvironment in chronic lymphocytic leukemia","journal":"Haematologica","issue":"2025 Mar 13. doi: 10.3324\/haematol.2024.286663. Online ahead of print.","author":"Medina-Gil D, Palomo L, Navarro V, L\u00e1zaro G, Mart\u00edn-Mur B, Hern\u00e1ndez C, Castells O, S\u00e1nchez B, Mu\u00f1oz-Torres PM, Pag\u00e8s C, Pujadas G, Esteve-Codina A, Cabirta A, Ferr\u00e0 C, Alcoceba M, Terol MJ, Andreu R, Mart\u00ed M, Abrisqueta P, Bosch F, Crespo M; Spanish Group of Chronic Lymphocytic Leukemia - GELLC.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40079085"},{"title01":"Plasma exchange for hyperammonemia-induced reduced consciousness after PEG-asparaginase in an adult patient with acute lymphoblastic leukemia","title02":"Plasma exchange for hyperammonemia-induced reduced consciousness after PEG-asparaginase in an adult patient with acute lymphoblastic leukemia","journal":"Haematologica","issue":"2025 Mar 13. doi: 10.3324\/haematol.2024.286972. Online ahead of print.","author":"Klingler F, Forstreuter A, Stegat L, K\u00e4mereit S, Ullrich F, Udonta F, Krebs C, Wichmann D, Bokemeyer C, Goekbuget N, Fiedler W, Modemann F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40079089"},{"title01":"Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial","title02":"Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial","journal":"Haematologica","issue":"2025 Mar 13. doi: 10.3324\/haematol.2024.286623. Online ahead of print.","author":"Schlenk RF, Montesinos P, Kim HJ, Romero-Aguilar A, Vrhovac R, Patkowska E, \u017dak P, Wang PN, Hanyok J, Liu L, Kamel YM, Imadalou K, Lesegretain A, Cortes J, Sekeres MA, Dombret H, Amadori S, Wang J, Perl AE, Levis MJ, Erba HP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40079105"},{"title01":"The first classification of acute myelogenous leukemia","title02":"The first classification of acute myelogenous leukemia","journal":"Haematologica","issue":"2025 Mar 1;110(3):541-542. doi: 10.3324\/haematol.2024.287222.","author":"Lichtman MA.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40025999"},{"title01":"Acute therapy-related toxicities in pediatric acute lymphoblastic leukemia","title02":"Acute therapy-related toxicities in pediatric acute lymphoblastic leukemia","journal":"Haematologica","issue":"2025 Mar 6. doi: 10.3324\/haematol.2024.285702. Online ahead of print.","author":"Birenboim SB, Rabinowicz R.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40045890"},{"title01":"Social Determinants of Health and Access to Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia","title02":"Social Determinants of Health and Access to Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia","journal":"Blood","issue":"2025 Mar 11:blood.2024027543. doi: 10.1182\/blood.2024027543. Online ahead of print.","author":"Wuliji N, Jones SMW, Gooley TA, Gerds AT, Medeiros BC, Shami PJ, Galvin JP, Adekola KUA, Luger SM, Baer MR, Rizzieri DA, Wildes T, Wang ES, Sekeres MA, Mukherjee S, Smith J, Garrison M, Kojouri K, Appelbaum JS, Percival MM, Sandmaier BM, Lee SJ, Appelbaum F, Rouce RH, Sorror ML.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40067123"},{"title01":"CD38 in the pathobiology of cutaneous T-cell lymphoma and the potential for combination therapeutic intervention","title02":"CD38 in the pathobiology of cutaneous T-cell lymphoma and the potential for combination therapeutic intervention","journal":"Leukemia","issue":"2025 Mar 8. doi: 10.1038\/s41375-025-02551-4. Online ahead of print.","author":"Isabelle C, Boles A, McConnell K, Keller R, Burzinski R, Hutchins Z, Calabretto G, Cheslow L, Xu J, Chakravarti N, Porcu P, Nikbakht N, Mishra A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40057636"},{"title01":"Subgrouping germinal center-derived B-cell lymphomas based on machine learning-deduced DNA methylation modules","title02":"Subgrouping germinal center-derived B-cell lymphomas based on machine learning-deduced DNA methylation modules","journal":"Leukemia","issue":"2025 Mar 10. doi: 10.1038\/s41375-025-02533-6. Online ahead of print.","author":"Glaser S, Fischer A, Mart\u00ednez-Manj\u00f3n JE, L\u00f3pez C, Kretzmer H, Burkhardt B, H\u00fcbschmann D, Hummel M, Klapper W, Kolarova J, Kreuz M, Ott G, Radlwimmer B, Rosolowski M, Schlesner M, Rosenwald A, Stilgenbauer S, Wagener R, Zwir I, Tr\u00fcmper L, K\u00fcppers R, Lichter P, Ammerpohl O, Del Val C, Siebert R; ICGC MMML-Seq consortium.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40065077"},{"title01":"Epidemiology, clinical features, and outcomes of peripheral T-cell lymphoma in Latin America: an international, retrospective, cohort study","title02":"Epidemiology, clinical features, and outcomes of peripheral T-cell lymphoma in Latin America: an international, retrospective, cohort study","journal":"Lancet Haematol","issue":"2025 Mar 5:S2352-3026(25)00011-0. doi: 10.1016\/S2352-3026(25)00011-0. Online ahead of print.","author":"Malpica L, Idrobo H, Pavlovsky A, Miranda ECM, Castro D, Beltran B, Enriquez DJ, Vasquez JF, Roche C, Valvert F, Villela L, Fischer T, Pereira J, Baptista RLR, Duffles G, Brasil SAB, Oliver C, Tavarez JV, Warley F, Fiad L, Korin L, Pereyra PH, Roa M, Torres MA, Mahuad CV, Quiroz AR, Gazitua R, Federico M, Valcarcel B, Chiattone C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40056928"},{"title01":"Peripheral T-cell lymphoma in the Latin American population","title02":"Peripheral T-cell lymphoma in the Latin American population","journal":"Lancet Haematol","issue":"2025 Mar 5:S2352-3026(25)00039-0. doi: 10.1016\/S2352-3026(25)00039-0. Online ahead of print.","author":"Domingo Domenech E.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40056929"},{"title01":"Multisystem lymphomatoid granulomatosis in an immunocompetent woman","title02":"Multisystem lymphomatoid granulomatosis in an immunocompetent woman","journal":"Lancet Haematol","issue":"2025 Mar;12(3):e230.","author":"Tecayehuatl-Negrete LN, Peralta-Amaro AL, Romero-Cuevas KA, Z\u00fa\u00f1iga-Espinosa JE, de Le\u00f3n RAI.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40044258"},{"title01":"Leukemic presentation in nodal mantle cell lymphoma is characterized by frequent SOX11 negativity, a poor risk genomic landscape including higher TP53 alterations, and worse overall survival","title02":"Leukemic presentation in nodal mantle cell lymphoma is characterized by frequent SOX11 negativity, a poor risk genomic landscape including higher TP53 alterations, and worse overall survival","journal":"Haematologica","issue":"2025 Mar 13. doi: 10.3324\/haematol.2024.287108. Online ahead of print.","author":"Yan M, Sethi S, Kumar J, Kumar A, Dogan A, Galera P.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40079077"},{"title01":"Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow up","title02":"Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow up","journal":"Haematologica","issue":"2025 Mar 13. doi: 10.3324\/haematol.2024.287010. Online ahead of print.","author":"Portuguese AJ, Huang JJ, Jeon Y, Taheri M, Albittar A, Liang EC, Hirayama AV, Kimble EL, Iovino L, Poh C, Gopal AK, Shadman M, Till BG, Milano F, Chapuis AG, Otegbeye F, Cassaday RD, Basom RS, Wu QV, Maloney DG, Gauthier J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40079097"},{"title01":"A low lymphocyte-to-monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis","title02":"A low lymphocyte-to-monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis","journal":"Br J Haematol","issue":"2025 Mar 3. doi: 10.1111\/bjh.20038. Online ahead of print.","author":"Mozas P, Ould Ammar R, Chartier L, Nastoupil L, Bachy E, Bezsera SM, Barnes J, Bijou F, Goy A, Zerazhi H, Cartron G, Ojeda-Uribe M, Choquet S, Joly B, Cheminant M, Mart\u00edn Garc\u00eda-Sancho A, Eradat H, Gressin R, Abrisqueta P, Parcelier A, Rodr\u00edguez Salazar MJ, Bonnet C, Johnson NA, L\u00f3pez-Guillermo A, Morschhauser F.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40031898"},{"title01":"In vitro comparison of CD20xCD3 biosimilar antibodies against diffuse large B-cell lymphoma (DLBCL) cell lines with different levels of expression of CD20","title02":"In vitro comparison of CD20xCD3 biosimilar antibodies against diffuse large B-cell lymphoma (DLBCL) cell lines with different levels of expression of CD20","journal":"Br J Haematol","issue":"2025 Mar 3. doi: 10.1111\/bjh.20033. Online ahead of print.","author":"Bray JS, Thomas GR, Smith VM, Wright A, Jayne S, Dyer MJS, Walter HS.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40032583"},{"title01":"ALK+ anaplastic large cell lymphoma expressing CD33 and myeloid nuclear differentiation antigen","title02":"ALK+ anaplastic large cell lymphoma expressing CD33 and myeloid nuclear differentiation antigen","journal":"Blood","issue":"2025 Mar 6;145(10):1098.","author":"Gonzalez Mancera M, Silva O.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40048222"},{"title01":"Prolymphocytic progression of splenic marginal zone lymphoma","title02":"Prolymphocytic progression of splenic marginal zone lymphoma","journal":"Blood","issue":"2025 Mar 6;145(10):1097.","author":"Prats-Mart\u00edn C, Morales-Camacho RM.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40048223"},{"title01":"Therapy for MYD88 L265P DLBCL","title02":"Therapy for MYD88 L265P DLBCL","journal":"Blood","issue":"2025 Mar 6;145(10):998-1000.","author":"Vermaat JSP, de Groen RAL.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40048229"},{"title01":"The bone marrow NK cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy","title02":"The bone marrow NK cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy","journal":"Blood","issue":"2025 Feb 28:blood.2024026455. doi: 10.1182\/blood.2024026455. Online ahead of print.","author":"Korst CLBM, Tahri S, Duetz C, Bruins WSC, de Jonge AV, de Jong MME, Fokkema C, Smits F, Groen K, Verkleij CPM, Frerichs KA, Papazian N, van Duin M, van Beek G, Hoogenboezem R, Baardemans T, Dal Collo G, Stoetman ECG, Cosovic M, Twickler I, Rentenaar R, Eken M, Homan-Weert PM, Saraci E, D'Agostino M, van der Velden VHJ, Sanders MA, Gay F, Broijl A, Moreau P, Sonneveld P, Zweegman S, Mutis T, Cupedo T, van de Donk NWCJ.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40019438"},{"title01":"Daratumumab\/lenalidomide\/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes","title02":"Daratumumab\/lenalidomide\/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes","journal":"Leukemia","issue":"2025 Feb 27. doi: 10.1038\/s41375-024-02505-2. Online ahead of print.","author":"Facon T, Moreau P, Weisel K, Goldschmidt H, Usmani SZ, Chari A, Plesner T, Orlowski RZ, Bahlis N, Basu S, Hulin C, Quach H, O'Dwyer M, Perrot A, Jacquet C, Venner CP, Raje N, Tiab M, Macro M, Frenzel L, Leleu X, Cook G, Wang G, Pei H, Krevvata M, Carson R, Borgsten F, Kumar SK.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40016302"},{"title01":"Global paediatric haematopoietic stem-cell transplantation training and access: providing strategies to overcome challenges","title02":"Global paediatric haematopoietic stem-cell transplantation training and access: providing strategies to overcome challenges","journal":"Lancet Haematol","issue":"2025 Mar;12(3):e178-e179.","author":"Hendricks CL, Spadea M, Du Toit JR, Gurnari C, Muratori R, Jimenez V, Radici V, Torrado S, Desai N, Ibrahimova A, Muhsen IN, Ropero J, Gagelmann N, Horgan C.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40044255"},{"title01":"Ask, do not tell: consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe","title02":"Ask, do not tell: consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe","journal":"Lancet Haematol","issue":"2025 Mar;12(3):e214-e223.","author":"Schoemans H, Stienissen E, Goris K, Stewart SK, Cowden M, Arnahoutova K, Pavletic SZ, Greinix H, Barata A, Warwick L, Bolanos N, Barbosa I, Bouguet G, Lhenry-Yvon I, Manninen RL, Pavukova S, Tavori G, van Amerongen M, Lawitschka A, Schultz KR, Wolff D, Herrmann A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40044256"},{"title01":"Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial","title02":"Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial","journal":"Haematologica","issue":"2025 Mar 13. doi: 10.3324\/haematol.2024.286623. Online ahead of print.","author":"Schlenk RF, Montesinos P, Kim HJ, Romero-Aguilar A, Vrhovac R, Patkowska E, \u017dak P, Wang PN, Hanyok J, Liu L, Kamel YM, Imadalou K, Lesegretain A, Cortes J, Sekeres MA, Dombret H, Amadori S, Wang J, Perl AE, Levis MJ, Erba HP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40079105"},{"title01":"Successful autologous haematopoietic stem cell transplantation in a refractory anti-myelin-associated glycoprotein antibody neuropathy","title02":"Successful autologous haematopoietic stem cell transplantation in a refractory anti-myelin-associated glycoprotein antibody neuropathy","journal":"Br J Haematol","issue":"2025 Mar;206(3):996-999.","author":"Urbain F, Labeyrie C, Castilla-Llorente C, Noel N, Farge D, Echaniz-Laguna A.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40052451"},{"title01":"Indirect presentation of mismatched human leukocyte antigen-B associates with outcomes of cord blood transplantation","title02":"Indirect presentation of mismatched human leukocyte antigen-B associates with outcomes of cord blood transplantation","journal":"Br J Haematol","issue":"2025 Mar 10. doi: 10.1111\/bjh.20035. Online ahead of print.","author":"Sugio T, Miyawaki K, Uchida N, Niemann M, Spierings E, Mori K, Ohno Y, Eto T, Mori Y, Yoshimoto G, Kikushige Y, Kunisaki Y, Mizuno S, Nagafuji K, Iwasaki H, Kamimura T, Ogawa R, Miyamoto T, Taniguchi S, Akashi K, Kato K.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40065633"},{"title01":"CD7 CAR-T: a bridge to transplant in AML","title02":"CD7 CAR-T: a bridge to transplant in AML","journal":"Blood","issue":"2025 Mar 6;145(10):995-996.","author":"Mamonkin M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40048225"},{"title01":"Social Determinants of Health and Access to Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia","title02":"Social Determinants of Health and Access to Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia","journal":"Blood","issue":"2025 Mar 11:blood.2024027543. doi: 10.1182\/blood.2024027543. Online ahead of print.","author":"Wuliji N, Jones SMW, Gooley TA, Gerds AT, Medeiros BC, Shami PJ, Galvin JP, Adekola KUA, Luger SM, Baer MR, Rizzieri DA, Wildes T, Wang ES, Sekeres MA, Mukherjee S, Smith J, Garrison M, Kojouri K, Appelbaum JS, Percival MM, Sandmaier BM, Lee SJ, Appelbaum F, Rouce RH, Sorror ML.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40067123"},{"title01":"Models for T-large granular lymphocytic leukemia: how to mimic the cellular interplays in malignant autoimmunity","title02":"Models for T-large granular lymphocytic leukemia: how to mimic the cellular interplays in malignant autoimmunity","journal":"Leukemia","issue":"2025 Mar 7. doi: 10.1038\/s41375-025-02553-2. Online ahead of print.","author":"Klepzig H, Herling M, Pflug N, Braun T.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40055531"},{"title01":"Intensive post-remission therapy does not decrease relapse after allotransplants for acute myeloid leukaemia in 1st remission and should not be given","title02":"Intensive post-remission therapy does not decrease relapse after allotransplants for acute myeloid leukaemia in 1st remission and should not be given","journal":"Leukemia","issue":"2025 Mar 12. doi: 10.1038\/s41375-025-02560-3. Online ahead of print.","author":"Rodr\u00edguez-Arbol\u00ed E, Phillips GL, Pardee TS, Lazarus HM, Gale RP.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40074851"},{"title01":"Comparison of subcutaneous injection versus intravenous infusion of cytarabine for induction therapy in adult acute myeloid leukemia","title02":"Comparison of subcutaneous injection versus intravenous infusion of cytarabine for induction therapy in adult acute myeloid leukemia","journal":"Leukemia","issue":"2025 Mar 12. doi: 10.1038\/s41375-025-02556-z. Online ahead of print.","author":"Wang H, Suo S, Li D, Li J, Liu L, Lu Y, Shen J, Ji C, Chen T, Yu K, Ren H, Li Y, Chen Y, Zang S, Liang B, Kang S, Wang J, Cheng W, Yu W, Meng H, Tong H, Jin J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40074854"},{"title01":"CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents","title02":"CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents","journal":"Leukemia","issue":"2025 Feb 27. doi: 10.1038\/s41375-025-02539-0. Online ahead of print.","author":"Reuvekamp T, Ngai LL, den Hartog D, Carbaat-Ham J, Fayed MMHE, Scholten WJ, Mocking TR, Chitu DA, Pabst T, Klein SK, Stussi G, Griskevicius L, Breems D, van Lammeren-Venema D, Boersma R, Ossenkoppele GJ, van de Loosdrecht AA, Bachas C, Huls G, de Leeuw DC, Cloos J.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40016301"},{"title01":"Living, not just surviving, with chronic myeloid leukemia – quality of life to the front of the line","title02":"Living, not just surviving, with chronic myeloid leukemia – quality of life to the front of the line","journal":"Leukemia","issue":"2025 Mar 5. doi: 10.1038\/s41375-025-02548-z. Online ahead of print.","author":"Lipton JH, Rea D.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40044959"},{"title01":"Management of children and adolescents with chronic myeloid leukemia in chronic phase: International pediatric chronic myeloid leukemia expert panel recommendations","title02":"Management of children and adolescents with chronic myeloid leukemia in chronic phase: International pediatric chronic myeloid leukemia expert panel recommendations","journal":"Leukemia","issue":"2025 Mar 5. doi: 10.1038\/s41375-025-02543-4. Online ahead of print.","author":"Millot F, Ampatzidou M, Moulik NR, Tewari S, Elhaddad A, Hammad M, Pichler H, Lion T, Tragiannidis A, Shima H, An W, Yang W, Karow A, Farah R, Luesink M, Dworzak M, Sembill S, De Moerloose B, Sedlacek P, Schultz KR, Kalwak K, Versluys B, Athale U, Hijiya N, Metzler M, Suttorp M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40044960"},{"title01":"Venetoclax combined with escalating doses of homoharringtonine, low-dose cytarabine, and granulocyte colony-stimulating factor demonstrates feasibility and tolerability for remission induction in pediatric acute myeloid leukemia","title02":"Venetoclax combined with escalating doses of homoharringtonine, low-dose cytarabine, and granulocyte colony-stimulating factor demonstrates feasibility and tolerability for remission induction in pediatric acute myeloid leukemia","journal":"Haematologica","issue":"2025 Mar 6. doi: 10.3324\/haematol.2024.286832. Online ahead of print.","author":"Cheng S, Gao L, Lu J, Hu Y, Wang Y, He H, Li J, Liu S, Yang F, Wu X, Fan L, Fan J, Yao Y, Sun Y, Li B, Zhang Y, Wu S, Cheng C, Xiao P, Ribeiro RC, Shaoyan H.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40045891"},{"title01":"Revaccination with pneumococcal conjugate vaccine five years after primary immunization improves immunity in patients with chronic lymphocytic leukemia","title02":"Revaccination with pneumococcal conjugate vaccine five years after primary immunization improves immunity in patients with chronic lymphocytic leukemia","journal":"Haematologica","issue":"2025 Mar 6. doi: 10.3324\/haematol.2024.286942. Online ahead of print.","author":"K\u00e4ttstr\u00f6m M, Uggla B, Virta C, Melin M, Ekstr\u00f6m N, Magnuson A, Andersson PO, Hammarlund Y, Lockmer S, Nilsson I, Roth D, Svensson M, Tolf T, Kimby E, Nor\u00e9n T, Athlin S.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40045895"},{"title01":"A machine learning approach for the rapid identification of measurable residual disease in acute myeloid leukemia","title02":"A machine learning approach for the rapid identification of measurable residual disease in acute myeloid leukemia","journal":"Haematologica","issue":"2025 Mar 6. doi: 10.3324\/haematol.2024.286019. Online ahead of print.","author":"Vahedi A, Royaei M, Madani T, Mercier F, Poopak B.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40045896"},{"title01":"Therapeutic drug monitoring of imatinib in paediatric chronic myeloid leukaemia: Data from a real-world setting","title02":"Therapeutic drug monitoring of imatinib in paediatric chronic myeloid leukaemia: Data from a real-world setting","journal":"Br J Haematol","issue":"2025 Mar 10. doi: 10.1111\/bjh.20047. Online ahead of print.","author":"Suttorp M, Sembill S, Lensker P, Hildebrand V, Schirmer E, Karow A, Krumbholz M, Rauh M, Metzler M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40059620"},{"title01":"CD7 CAR-T: a bridge to transplant in AML","title02":"CD7 CAR-T: a bridge to transplant in AML","journal":"Blood","issue":"2025 Mar 6;145(10):995-996.","author":"Mamonkin M.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/40048225"}]